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Abstract
High rates of Cardiovascular disease (CVD) and ischemic heart disease (IHD) have led to everincreasing numbers of percutaneous coronary interventions (PCI) performed. The prevalence of
IHD and subsequent PCI has been found to limit bed availability and access to cardiovascular
care. Historically, the standard of care following elective PCI has included overnight
observation (OO) though clinical advances to PCI procedures have made it possible for same day
discharge (SDD) following elective PCI. There are many benefits of SDD following elective
PCI that include increased access to cardiovascular care, hospital cost savings, and patient
satisfaction without compromising patient safety. The DNP project took place at an inpatient
facility in Pulaski County, Arkansas where practice most often included OO following elective
PCI. The purpose of the project was to increase access to cardiovascular care through the
creation and implementation of a SDD protocol following elective PCI. The overall project aim
was to increase the percentage of SDD to 50% by March 31, 2021. The project did not meet this
goal as implementation failed during the planned implementation period at the clinical site due to
the lack of physician engagement. Despite the lack of SDD protocol implementation, data from
the 10-week collection period was analyzed to describe baseline data and current practices at the
clinical site. During the 10-week collection period, 20 of 55 patients, or 36.36%, were discharged
via other non-established SDD methods. The SDD protocol is still projected to become the
standard of practice at the clinical site after future implementation.
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cardiovascular care
Implementation of Same Day Discharge Following Elective Percutaneous Coronary
Intervention
The purpose of this paper is to detail a DNP quality improvement project designed to
increase access to cardiovascular care in Pulaski County, Arkansas through the creation of a
same day discharge (SDD) protocol following elective percutaneous coronary intervention
(PCI). The paper will discuss the incidence of elective PCIs completed at the clinical site, the
significance of the problem, a review of literature related to establishing a SDD protocol,
protocol development, methodology, and outcomes following SDD protocol implementation.
Background and Significance
Cardiovascular Disease
Cardiovascular disease (CVD) is the leading cause of death worldwide (WHO, 2017). In
2017, CVD was responsible for 17.9 million deaths worldwide and 647,000 deaths within the
United States (Centers for Disease Control and Prevention [CDC], 2019); WHO, 2017).
Ischemic heart disease (IHD) is the most common type of CVD and was responsible for almost
366,000 deaths within the United States in 2017 (CDC, 2019). Arkansas had much higher death
rates per 100,000 in both genders and all races above 35 years old compared to national data
between 2016 and 2018 (CDC, 2020). Mortality rates due to IHD within Arkansas per 100,000
was 263.6, which are substantially higher than national numbers per 100,000 at 181.2. While
death rates per 100,000 due to IHD in Pulaski County, Arkansas are lower than the state’s
numbers at 226.9; mortality remains much higher than national numbers per 100,000 (CDC,
2020). As rates of CVD are increasing, the need for cardiovascular bed availability is crucial.
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Revascularization
Ischemic heart disease is associated with inadequate blood flow to the heart due to
calcified coronary arteries (Kannam, Aroesty, & Gersh, 2020). Patients with IHD may have
disease that is either chronic and stable or acute and unstable. Patients with chronic IHD often
experience angina pectoris, or chest discomfort, that results as one’s oxygen demand surpasses
his or her available oxygen supply. The mismatch of oxygen supply and demand in stable IHD
is associated with known atherosclerosis of coronary vessels (Kannam, Aroesty, & Gersh, 2020).
Elective angiography and revascularization via PCI is considered as a treatment option for many
patients with stable IHD (Cutlip & Levin, 2019). Revascularization is defined as a surgical
technique used to provide additional or improved blood supply to the heart (Merriam-Webster,
2020). The most common procedure for revascularization of coronary arteries occurs through
PCI with balloon angioplasty and coronary stenting (Abdelaal, 2013; Amin et al., 2018;
Chambers et al., 2009). Revascularization via PCI is considered for patients with stable IHD if
angina interferes with lifestyle despite maximum guideline directed therapy, if PCI is to be
completed to improve quality of life and activity level, and if PCI is proven beneficial for
survival based on location of disease such a disease of the left main coronary artery (Cutlip &
Levin, 2019; Kannam, Aroesty, & Gersh, 2020). PCI through balloon angioplasty and coronary
stenting increases the lumen diameter of coronary arteries leading to improved blood flow and
decreased chest discomfort (Abbott & Cutlip, 2020; Kannam, Aroesty, & Gersh, 2020).
History of Coronary Interventions
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The use of percutaneous transluminal coronary angioplasty (PTCA) in the treatment of
ischemic heart disease began in 1977 (Venkitachalam et al., 2009). At that time, PTCA relied
upon balloon dilatation of coronary arteries that provided a controlled injury of occluded arteries
(Cutlip & Abbott, 2019; Newsome, Kutcher, & Royster, 2008). Two major complications
occurred as a result of PTCA. These complications included acute vessel collapse and vessel
restenosis. Acute vessel collapse occurred within the first 24 hours in 6% to 8% of cases with
PTCA alone (Newsome, Kutcher, & Royster, 2008). Severe complications, including acute
coronary syndrome (ACS) and the need for emergent coronary artery bypass grafting (CABG),
often occur following acute vessel collapse (Iqbal, Gunn & Serruys, 2013). Vessel restenosis is
defined as a gradual narrowing of the ballooned portion of an artery that happens within 3 to 12
months following PTCA (Levin & Cutlip, 2019). Restenosis is often associated with angina
pectoris but can present as ACS in up to 10% of patients (Levin & Cutlip, 2019). Vessel
restenosis following PTCA often occurred within the first six months due to mechanical and
histological factors (Newson, Kutcher, & Royster, 2008). PTCA was associated with a high
incidence of restenosis requiring repeat revascularization in 20% to 35% of patients within the
first year (Byrne et al., 2009; Cutlip & Abbott, 2019).
The next innovation was the development of bare metal stents (BMS), which represented
a major advancement in the treatment for symptomatic ischemic heart disease (Byrne et al.,
2009; Cutlip & Abbott, 2019). The first BMS implantation within coronary arteries occurred in
1986 (Newsome, Kutcher, & Royster, 2008). BMS were used to maintain lumen dilatation
following balloon angioplasty (Byrne et al., 2009). BMS were approved to treat acute
impending vessel closure following PTCA in the US in 1993 (Newsome, Kutcher, & Royster,
2008). Two landmark trials confirmed that BMS enhanced angiographic and clinical outcomes

11
quickly leading to its acceptance as standard of care. By 1999, almost 85% of coronary
interventions involved BMS implantation (Newsome, Kutcher, & Royster, 2008). Following
BMS use, rates of target lesion revascularization decreased from 20 to 35% with only PTCA to
10-15%. Though BMS had decreased abrupt vessel closure rates, stent thrombosis between
implant and 30 days occurred in 16% to 24% of patients. At that time, the use of aggressive
anticoagulants was implemented (Newsome, Kutcher, & Royster, 2008). The use of dual
therapy with aspirin and clopidogrel reduced BMS thrombosis rates to 1.2% (Newsome,
Kutcher, & Royster, 2008). Stent restenosis in BMS occurred in 20-25% of patients within six
months (Newsome, Kutcher, & Royster, 2008). Restenosis was due to neo-intimal hyperplasia, a
similar process as scar tissue formation at stent implantation sites, often requiring repeat
revascularization (Byrne et al., 2009; Newsome, Kutcher, & Royster, 2008).
In 2007, the use of drug eluting stents (DES) was recommended as an alternative to BMS
to prevent neo-intimal hyperplasia and consequent restenosis and revascularization (Cutlip &
Abbott, 2019; Newsome, Kutcher, & Royster, 2008). DES have a metal stent platform, a robust
polymer, and an antirestenotic drug found within the polymer that is slowly released to eliminate
or delay tissue formation (Cutlip & Abbott, 2020). First generation DES utilized sirolimus and
paclitaxel to prevent neo-intimal hyperplasia while current generation DES utilize everolimus
and zotarolimus (Levin & Cutlip, 2019; Newsome, Kutcher, & Royster, 2008). Stent restenosis
rates in first generation DES were between 13% and 16% at five years, while stent restenosis
rates for current DES are 5% to 6.3% at up to five years post placement (Levin & Cutlip, 2019).
Though uncommon, stent thrombosis between implant and greater than one year can occur
following DES placement (Newsome, Kutcher, & Royster, 2008). The risk of late restenosis
following DES placement prompted the use of long-term dual antiplatelet therapy including
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aspirin plus a platelet P2Y12 receptor blocker (Cutlip & Nicolau, 2019). The most common drug
combination used is aspirin and clopidogrel for 6 to 12 months following DES placement (Cutlip
& Nicolau, 2019). The use of DES has continued as the preference during PCI today (Cutlip &
Abbott, 2020).
Percutaneous Coronary Interventions
Since the development of DES, PCI with DES has become the most common method of
coronary revascularization (Chambers et al., 2009). Within the United States, about 600,000
percutaneous coronary interventions (PCI) take place each year (Amin et al., 2017; Amin et al.,
2018). According to data from the NCDR CathPCI registry of 667,424 patients found that
35.3% percent of procedures were elective PCI procedures (Masoudi et al., 2017). Demographic
information of 667,424 patients who underwent PCI in 2014 were reported in the NCDR
CathPCI Program of 1,612 hospitals and centers in the US (Masoudi et al., 2017). Of the
667,424 patients, 68.7% were male and 31.3% were female. The mean age was 64.6 years old.
Caucasians held the majority of procedures completed at 86.5%. Of the procedures completed,
8.8% were African Americans, 2.8% were Asian 2.8%, and 5.8% were Hispanic or Latino.
Clinical characteristics of the 667,424 patients who underwent PCI in 2014 were also collected
in the NCDR CathPCI registry. Common comorbidities found in patients who underwent PCI
were diabetes at 38.8%, prior myocardial infarction at 30.4%, heart failure within 2 weeks at
13.9%, previous PCI at 41.2%, and previous CABG at 17.8%. The average body mass index
(BMI) of the 667,424 patients who underwent PCI in 2014 was 29.6 ± 5.4, though it is important
to note that 36.9% were overweight with BMIs from 25 to 29.9 and 42.5% were obese with
BMIs greater than or equal to 30 (Masoudi et al., 2017).
Previous Recommendations
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In 2009, the Society of Cardiovascular Angiography and Interventions (SCAI) published
an expert consensus regarding the length of stay (LOS) following elective PCI (Chambers et al.,
2009). The SCAI proposed assessing clinical characteristics, co-morbidities, anatomy of the
disease, and procedural requirements when considering SDD. Additionally, the criteria
stipulated that the patient must not have any perioperative or postoperative complications, live or
stay within 20 miles from the facility, and have adequate home and emergency medical service
support available. The expert consensus recognized the final decision regarding length of stay
following PCI up to physician discretion (Chambers et al., 2009). Though SDD was addressed
in the expert consensus, preprocedural, peri-procedural and post-procedural criteria severely
limited the number of patients that qualified for SDD despite procedure success, leading to very
minimal adaptation (Shroff et al., 2016). The SCAIs inclusion criteria for SDD was very
restricted and required patients to meet a defined set of ten systematic criteria (Chambers et al.,
2009). Some of the most restricted criteria included that the patient be asymptomatic, be less
than 70 years old, have no significant co-morbidities, normal renal and left ventricular function,
and a single vessel disease (Chambers et al., 2009; Shroff et al., 2016). A case series of 100
consecutive patients that were safely discharged home via SDD following PCI were compared to
the SCAIs 2009 recommendations. Only 15% of the 100 patients would have qualified as
appropriate candidates for SDD after applying the SCAIs recommendations (Shroff et al., 2016).
Further Clinical Advancement
Concerns regarding acute ischemic events due to sudden vessel closure, vascular access
site complications, and the management of comorbidities were reasons that patients with elective
PCI remained in the hospital for overnight observation (OO) (Chambers et al., 2009; Shroff et
al., 2016). Since the 2009 consensus document was published, many advancements in clinical
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practice have occurred. The practice of OO has persisted despite many improvements in PCI
procedures including improvements in stent designs, the use of transradial approach (TRA),
adjunctive pharmacotherapy, and vascular closure devices used to reduce bleeding complications
(Abdelaal et al., 2013; Amin et al., 2018; Shroff et al., 2016). The first reported use of TRA was
in 1989 and has been identified as one of the most significant improvements made to PCI
procedures over the past several years (Elfandi & Safirstein, 2018). TRA is associated with
fewer bleeding and access site complications, rapid ambulation, increased patient comfort, and
improved mortality outcomes in high risk patient populations (Israeli et al., 2017). The
incorporation of TRA has improved the safety and feasibility of discharging patients who have
met criteria for SDD following elective PCI (Alyasin, 2016; Elfandi & Safirstein, 2018). Within
the US, the use of TRA is now recommended as the standard of practice when feasible. Since
2007, the use of TRA has increased from 1.2% to 37% in 2017 within the US (Seto et al., 2018).
Current Recommendations
In 2018, experts from SCAI published an updated consensus regarding LOS following
elective PCI. It was concluded that advances in clinical practice have made selective SDD safe
and feasible when considering clinical stability, success of the procedures, and process measures
(Seto et al., 2018). SCAIs 2018 updated consensus suggests using three categories to determine
a patient’s readiness for discharge. The three categories include procedure, patient, and program.
Procedural factors include successful procedure, adequate hemostasis, and no complications.
Patient factors include clinical stability at baseline mental status with stable vital signs and
comorbidities. Program factors include safe monitoring at home, appropriate guideline directed
medical therapy, compliance with PCI performance measures, and timely follow up (Seto et al.,
2018). PCI via SDD is also associated with high patient satisfaction and cost savings, especially
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via TRA (Amin et al., 2018, Shroff et al., 2016). Though selective SDD following PCI has been
found to be effective, it has not been adopted by many facilities nationwide due to resistance to
change and lack of knowledge.
Problem Statement
The problem statement for this DNP quality improvement project is that this inpatient
facility in Pulaski County, Arkansas is currently experiencing limited access to cardiovascular
care due to the lack of cardiac beds available. The implementation of a SDD protocol following
elective PCI has emerged as a solution to increase access to cardiovascular care by decreasing
bed shortages (Madan et al., 2019). Approximately 2,000 elective PCI procedures occur per
year at the clinical site. The Needs Assessment yielded that approximately 85% of these
patients stay for overnight observation thus limiting cardiac bed availability and subsequent
access to cardiovascular care. The Needs Assessment found increasing access to care as the
most critical health outcome to be improved through SDD. Key influencers expressed their
interest in instituting a SDD protocol in an attempt to increase access to care, improve health
outcomes, decrease hospital spending, and increase patient satisfaction.
Purpose Statement
The purpose statement for this DNP quality improvement project was to increase access
to cardiovascular care through the creation and implementation of a SDD protocol following
elective PCI at an inpatient facility in Pulaski County, Arkansas. Establishing a SDD protocol
would facilitate an increase in the number of elective PCI procedures able to be completed,
increase cardiac bed availability, improve bed utilization, and decrease hospital costs.
PICOT Question
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To improve quality care at an inpatient facility in Pulaski County, Arkansas, a focused
PICOT question will guide the DNP project. The question is as follows: In patients who undergo
elective percutaneous coronary intervention at an inpatient facility in Pulaski County, Arkansas
(P), how does instituting a same day discharge protocol (I) compared to standard practice of
overnight observation (C) affect access to care (O) within 6 months (T)?
Needs Assessment of an Inpatient Facility in Pulaski County, Arkansas
Objective
The objective of the Needs Assessment was to ascertain common adverse effects
following elective PCI and potential barriers to establishing a safe, effective SDD protocol at an
inpatient facility in Pulaski County, Arkansas through key informant interviews. These members
of the project team will help combat potential problems before implementation begins to
improve protocol processes and effectiveness.
Participants
The participants of the Needs Assessment include key influencers and target group
members with a variety of professional qualifications to identify complications and potential
barriers of establishing a SDD protocol. Key influencers included in the Needs Assessment are
members of administration who influence the target group. The President of the heart institute
has a master’s in Health Services Administration and has served for 24 years. The Market
Director of the Cardiovascular Service Line for the last five years holds a master’s in business
administration. The target group includes a Doctor of Medicine who has been the director of
interventional cardiology for one year; an advanced practice nurse who has worked with the
cardiology group for 10 years; and two registered nurses from the Catheterization (Cath) lab with
15 and 9 years of experience.
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Rationale of the Needs Assessment
Ischemic heart disease remains responsible for almost 33% of deaths in individuals over
35 (Wilson & Douglas, 2018). More than 600,000 PCI procedures are performed each year
within the United States (Amin et al., 2018). Historically, overnight observation was the
standard of care following uncomplicated PCI; however, current evidence indicates that
hospitalization is no longer required, especially via a TRA (Amin et al., 2017; Amin et al., 2018;
Seto et al., 2018). The clinical site reports that approximately 85% of the patients who undergo
elective PCI procedures are admitted for OO. Identifying potential barriers to implementation,
current barriers to TRA, and complications following elective PCI is crucial in establishing a
safe and effective protocol. Information yielded from the Needs Assessment will be used by the
project team to establish a SDD protocol with clear criteria that addresses potential
complications. This will improve health outcomes, access to care, and cost savings.
Data Collection Tool
The Needs Assessment of an inpatient facility in Pulaski County, Arkansas applied key
informant interviews to gather concepts related to gaps in care and barriers to establishing a SDD
program. The main agenda was to identify health outcomes to be improved with SDD.
Additional concepts to be assessed include common complications, use of TRA, readiness for
change, and potential barriers including resistance and physician buy-in. The questionnaire
utilized 11 open ended questions that were formulated and presented to two key influencers and
four members of the target group. See Appendix J for Needs Assessment Questionnaire.
Sample, Sample Size, and Sample Procedure
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The participants interviewed for the Needs Assessment were chosen based on their
influence on proposed changes in current processes and their knowledge of patients who undergo
elective PCI. A convenience sample was used in selecting participants for interviews. A total
of six open ended interviews took place with key influencers and target group members between
February 25, 2020 and March 4, 2020. Interviews took approximately 15 minutes to conduct.
Implementation and Data Analysis
Interviews were conducted via phone conference or in person in a quiet, uninterrupted
setting for approximately 15 minutes. Interviews took place by appointment with each key
influencer between February 25, 2020 and March 4, 2020 based on individual availability.
Clarification and prompts were offered when requested during interviews.
Key findings via open-ended questions identified that 100% of participants found
increasing access to cardiovascular care the most crucial health outcome to be improved.
Additional findings indicated that 66.67% of participants found increasing TRA usage with
subsequent decreases in bleeding complications as a key health outcome to be improved. The
interventional cardiologist was asked an additional question regarding readmission and acute
illness following elective PCI. Chest pain, hematoma, and acute kidney injury were identified as
complications seen following elective PCI. The most common complication before discharge
identified in 100% of the target group was bleeding. One hundred percent of participants
identified physician resistance and 33.3% identified staff nurse resistance as a potential barrier.
All participants agreed to help develop a protocol for SDD. All agreed that management would
support improvement efforts.
It was identified that there were process improvements, health outcomes, and common
complications that can be improved through SDD. The data collected was used to address all
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concerns including complications, hospital readmission, TRA, and resistance to change when
establishing a SDD protocol following elective PCI. After evaluation of the Needs Assessment
results, the project team met to discuss health outcomes and possible barriers to protocol
implementation. See Appendix A and Appendix B for global aims and process flowchart.
Aim and Objectives
The aim for this DNP quality improvement project was to improve access to healthcare
by creating and implementing a SDD protocol following elective PCI at an inpatient facility in
Pulaski County, Arkansas. Following protocol implementation, the project expected to increase
the percentage of patients that underwent SDD following elective PCI from 15% to 50% by
March 2021. The objectives are as follows:
•

To create a tool to determine each patient’s pre-procedure eligibility for SDD
based on clinical and socio-demographic factors

•

To implement SDD protocol for all identified patients who meet criteria for SDD
following elective PCI

•

To evaluate care management of patients undergoing PCI following SDD
protocol implementation
Review of Literature

An electronic search of two scholarly databases, CINAHL Complete and MEDLINE
Complete, was conducted. Additional searches were conducted via UpToDate and the Centers
for Disease Control and Prevention (CDC). The search terms included same day discharge and
percutaneous coronary intervention. Inclusion criteria included scholarly peer reviewed articles
between 2015 and 2020 and articles that pertained to the DNP topic. Exclusion criteria included
articles written before 2015, editorials, articles not written in English, and research unrelated to
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the DNP topic. Twelve landmark articles pertaining to the history of PCI, advancements in PCI,
previously recommended standards of care, and original studies of SDD utilization have been
included in the review despite the fact that they were published prior to 2015. A research
librarian assisted with the literature search. The initial search of MEDLINE complete and
CINAHL using the search terms same day discharge and percutaneous coronary intervention
yielded 190 results. After applying inclusion and exclusion criteria, 41 articles remained. A
total of 23 articles were included in the review of literature based on relevance to the safety and
implementation of a SDD following elective PCI. See Appendix C for EMSON Evidence Table.
Ischemic Heart Disease, the Use of PCI, and SDD
Ischemic heart disease is associated with an inadequate blood supply to the heart tissue
due to obstructed coronary arteries (Kannam, Aroesty, & Gersh, 2020). The most common
method of coronary revascularization for patients with IHD is now PCI (Abdelaal, 2013; Amin et
al., 2018; Chambers et al., 2009). Revascularization is considered when angina interferes with a
patient’s lifestyle despite maximum guideline directed therapy, if PCI is to be completed to
improve quality of life and activity level, and if PCI is proven beneficial for survival based on
location of disease such a disease of the left main coronary artery (Cutlip & Levin, 2019;
Kannam, Aroesty, & Gersh, 2020). Though PCI is the most common form of treatment, there is
variability in the length of stay following elective PCI across the US despite advances in
practice.
Traditionally, patients who underwent PCI stayed for overnight observation (OO) due to
concern for complication. Following clinical advancements in recent years, the use of SDD has
been implemented in facilities across the world. Changes in reimbursement for elective PCI has
pushed facilities throughout the US to implement SDD (Seto et al., 2018). Same day discharge
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specifically means that a patient presents for an elective PCI, undergoes the procedure, and,
following a specified recovery time, is sent home or to a nonmedical facility, for example, a
hotel, on the same calendar day (Chambers et al., 2009; Seto et al., 2018). Utilization of SDD
offers an opportunity for facilities to reduce length of stay, increase bed availability, and improve
resource efficiency (Chen, Lin, & Marshall, 2018; Din et al., 2017). The safety, feasibility, and
impact of SDD will be discussed below.
Safety of SDD
Several studies within and outside the US have demonstrated the feasibility and safety of
SDD following PCI (Abdelaal et al., 2013; Amin et al., 2018; Brayton et al., 2013; Din et al.,
2017; Heyde et al., 2007; Madan et al., 2019). In a 10 year, single-center study, 1,035 patients
were treated via SDD. Of the 1,035 patients, only two patients required readmission due to chest
pain. None of the patients required repeat PCI, experienced major adverse cardiac events
(MACE), death, or stent thrombosis (Rubimbura et al., 2019).
As advancements in practice have been made, the rates of postprocedural complications
have declined. Some of the advancements in practice include improvements in stent design, the
transradial approach (TRA), adjunctive pharmacotherapy, and vascular closure devices
(Abdelaal et al., 2013; Amin et al., 2018; Din et al., 2017; Madan et al., 2019; Shroff et al., 2016;
Seto et al., 2018). These improvements have led to decreases in bleeding complications, reduced
concerns regarding inadequate platelet inhibition, and lower rates of restenosis (Din et al., 2017;
Seto et al., 2018). According to a National Cardiovascular Data Registry (NCDR) CathPCI
Registry, the overall incidence of complications within the hospital from 2016 to 2017,
comprising over 600,000 patients, was 4.8%. This includes the incidence of stroke at 0.2%,
bleeding within 72 hours of the procedure at 1.4%, pericardial tamponade at 0.1%, heart failure
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at 0.9%, and acute kidney injury (AKI) that required dialysis at 0.2%. Mortality within the
hospital was 0.93% overall, including those who went for CABG (Seto et al., 2018). The
advances in clinical practice support the safety and feasibility of SDD following elective PCI.
In a landmark study conducted by Heyde et al. (2007), 800 consecutive patients were
randomized before elective PCI into SDD or OO. The study was designed to evaluate the safety
and feasibility of SDD following elective PCI. Patients with acute coronary syndrome were
excluded due to their risk of acute stent thrombosis. There were 403 in the SDD group and 397
in the OO group. Some patients in the SDD group did cross over into OO due to procedural
complications or issues that developed during the observation period. It was found that there
were no differences in complications between SDD and OO in primary endpoints which included
death, myocardial infarction, coronary artery bypass graft surgery, repeat PCI, or puncture
related complications within 24 hours following PCI (Heyde et al., 2007). This study further
supports the safety of SDD.
Growing evidence indicates hazards of hospitalization. These hazards can include
contraction of an infection, accidents, medication errors, and post-hospitalization stress
syndromes (Shroff et al., 2016). Evidence indicates that a single night stay in the hospital carries
significant risks of adverse events (Hauck & Zhao, 2011). Hauck & Zhao (2011) report the risk
of suffering an adverse medication reaction is 3.4%, infection is 11.1%, and pressure ulcer is
0.4%. The implementation of a SDD protocol following elective PCI is an approach to be taken
to decrease exposure to the hazards of hospitalization (Shroff et al., 2016).
Timing of Adverse Events
Evidence has shown that OO is not superior to SDD in regard to complication rates
following elective PCI (Koshy, George, & Das, 2020; Seto et al., 2018). In the STRIDE study
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conducted by Jabara et al. (2008) 450 patients underwent PCI via TRA and were monitored for
adverse events between six and 24 hours following the procedure. Of the 450 participants, 24
post-procedural complications occurred. Twenty of the 24 complications occurred within 6
hours following the procedure while zero occurred between six and 24 hours (Jabara et al.,
2008). Furthermore, the DISCHARGE study included approximately 2,000 patients who
underwent TRA PCI who were monitored for adverse events following PCI. Among the 1,174
higher-risk patients that stayed for OO, all complications either occurred within 6 hours
following the procedure, or after 24 hours (Small et al., 2007). Data indicates that complications
following elective PCI are rare. This data supports the notion that adverse events are not
impacted by OO, and thus supports the safety of SDD for uncomplicated PCI procedures.
Transfemoral and Transradial Approach
Percutaneous coronary interventions are most often performed via a transfemoral (TF) or
transradial approach. Traditionally, PCI was performed via a TF approach. The TF approach is
often associated with access site bleeding and major vascular complication, which are correlated
with a risk of successive morbidity, mortality, and cost (Megaly et al., 2019). Over time, TF
approaches have improved through the use of vascular closure devices (VCDs) The use of VCD
has facilitated earlier ambulation following PCI, though rates of vascular complication and
bleeding are similar in comparison to manual compression (Jabara et al., 2008; Seto et al., 2018).
The TF approach is associated with higher incidence of bleeding, vascular complications, and
blood transfusion despite avoidance strategies with bivalirudin and VCDs when compared to
TRA (Amin et al., 2017).
The use of TRA is a fairly new practice, as its first reported use was in 1989. The use of
TRA was quickly adopted in Europe and Asia but was met with hesitation in the US (Elfandi &
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Safirstein, 2018). As data regarding the safety of TRA has surfaced, its use in the US has
steadily increased (Elfandi & Safirstein, 2018). Implementation of the TRA is often identified as
one of the most significant improvements made to decrease complication rates. Transradial
approach is associated with fewer bleeding and access site complications, rapid ambulation,
increased patient comfort, decreased bodily pain, earlier post-procedure recovery, and improved
mortality outcomes in high-risk patient populations (Seto et al., 2018; Jabara et al., 2008; Koshy,
George, and Das, 2020). Within the US, the use of TRA is now recommended as the standard of
practice when feasible. From 2007 to 2017, the use of TRA increased from 1.2% to 37% within
the US (Seto et al., 2018).
The incorporation of TRA has improved the safety and feasibility of discharging patients
who have met criteria for SDD following elective PCI (Alyasin, 2016; Israeli et al., 2017;
Elfandi & Safirstein, 2018; Seto et al., 2018). When compared to a femoral approach, radial
access was associated with lower mortality rates, vascular complication rates, major adverse
cardiovascular events (MACE), major bleeding, and vascular complications in a meta-analysis of
24 studies (Ferrante et al., 2016). Due to lower associated complications and cost savings, TRA
is to be used whenever possible when discharging patients via SDD.
Criteria for SDD
Though SDD has been safe and effective in low-risk patients, there is a wide variation in
pre-procedural, peri-procedural, and post-procedural criteria that guide decision making in regard
to length of stay following elective PCI. Previous SCAI recommendations for SDD severely
limited patients eligible for SDD, while the newest SCAI recommendations suggest assessing a
patient’s readiness for discharge following PCI (Chambers et al., 2009; Seto et al., 2018). Seto
et al. (2018) describes three categories used to determine readiness for discharge including
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procedure, patient, and program. Procedural factors comprise a successful procedure, adequate
hemostasis, and no adverse complication. Patient factors include clinical stability at baseline
mental status with stable vital signs and comorbidities. Program factors include the ability to
safely monitor at home, appropriate evidence-based medical therapy, compliance with
performance measures following PCI, and timely post-procedure follow up (Seto et al., 2018).
Amin et al. (2018) found that implementing a patient centered protocol based on the
patient’s risk of complications rapidly increased the percentage of SDD from 0% to 77% in both
low and high risk patients with no increase in adverse events. The protocol utilized the NCDR’s
mortality risk stratification models to identify a patient’s risk of bleeding, mortality, and acute
kidney injury (AKI) with a safe contrast limit preoperatively. The use of avoidance strategies
was implemented based on patient risk. Patients in both the SDD group and OO groups were
similar and SDD was not associated with adverse outcomes (Amin et al., 2018). The success
rates of this study indicate that even higher risk and complex procedures can be safely and
efficiently executed when proper risk assessment and preoperative screenings are implemented
(Amin et al., 2018). Implementation of SDD with the inclusion of patient-centered risk
stratification and readiness for discharge factors from SCAIs guidelines has the potential to lead
to safe and effective SDD for patients at higher risk for procedural complications.
Evidence Based Practice Utilized in SDD Protocol
The SDD protocol incorporates many current evidence-based practice (EBP)
recommendations. Pre-procedure criteria incorporates suggestions from Seto et al. (2018) which
include available patient transportation following the procedure and adequate home support upon
discharge. Inversely, these recommendations were also incorporated into possible reasons to
admit the patient for overnight observation. Additionally, driving distance of less than 60 miles
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was incorporated based on Chen, Lin, & Marshall’s (2018) recommendations of including
patients that live less than one hour from the PCI facility. However, if a patient does not meet
the 60 mile criteria, the facility has opted to use its hotel to accommodate elective PCI patients
for one night at no cost following his or her procedure. Additional pre-procedure criteria
developed by the clinical site include patients with an elective procedure or outpatient status,
those not opposed to going home the same day as their procedure, compliance to medical
therapy, and a candidate for SDD per the operating physician.
Seto et al. (2018) recommended incorporating Centers for Medicare and Medicaid
Services (CMS) defined reasons for prolonged observation into reasons that a patient may admit
for overnight observation. These include persistent nausea and vomiting, electrolyte and fluid
imbalance, pain that is uncontrolled, arrhythmia, excessive bleeding, and unstable mobility and
mental status. These complications have been included in the exclusion criteria for SDD (Seto et
al., 2018). The protocol incorporates site specific reasons for possible overnight observation
which include anticipated discharge after 9 PM, hemodynamic instability during or after the
procedure, physician order, and frail, elderly patients.
The post-procedure checklist also incorporates EBP recommendations. Seto et al.
recommends considering patient, procedural, and program factors to determine readiness for
discharge when contemplating SDD as defined previously. All patient, procedure, and program
consensus recommendations as stated by Seto et al. (2018) have been utilized in the protocol
post-procedure checklist. Additionally, Seto et al. (2018) proposed a sample nursing discharge
checklist that has been adapted and utilized in the post-procedure checklist for the clinical site.
Recommendations include obtaining an EKG, assessing access sites, assessing readiness for
discharge, completing discharge education regarding antiplatelet therapy, post-procedure
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instructions, and numbers to call if complications develop, providing stent cards, scheduling
follow up appointments, delivering medications via in-house pharmacies, and providing cardiac
rehab information (Seto et al., 2018). Site specific criteria added to the post-procedure checklist
include physician approval of SDD, physician defined observation time, no significant anesthesia
complications, ability to void after the procedure, and clearance by the discharging APRN. See
Appendix K for pre-procedure criteria and post-procedure checklists. See Appendix L for SDD
protocol.
Impact of PCI and SDD on Health Care
Many randomized controlled trials (RCTs), observational studies, and meta-analyses
have confirmed low complication rates, high cost savings, increased patient satisfaction ratings,
and increased bed availability as a result of selective SDD (Amin et al., 2018; Din et al., 2017;
Madan et al., 2019; Shroff et al., 2016). The following sections detail specifics regarding current
evidence of SDD in relation to its impact on healthcare.
Access to Healthcare
The implementation of SDD has shown to increase bed availability leading to improved
bed utilization, an increase in access to healthcare, and improved cost effectiveness (Chen, Lin,
& Marshall, 2018; Din et al., 2017; Madan et al., 2019). In Canada, Madan et al. (2019) states
that the institution of SDD following elective PCI has emerged as a solution to reduce
overcrowding and bed shortages. The implementation of SDD has the potential to increase bed
availability and increase access to cardiovascular care (Din et al., 2017; Jabara et al., 2008;
Koshy, George, & Das, 2020; Ramharrack et al., 2018; Shroff et al., 2016). In contrast, others
have argued that SDD increases pressure to discharge patients quickly, could limit recovery time,
reduces opportunity for patient education, and could increase adverse outcomes (Chambers et al.,
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2009; Madan et al., 2019). For proper implementation of a SDD protocol, patient specific
education and readiness for discharge must be assessed to verify the appropriateness of SDD
(Seto et al., 2018; Shroff et al., 2016).
Cost Savings
In 2007, the US Centers for Medicare and Medicaid Services (CMS) changed criteria for
inpatient healthcare. Within the changes made, PCI, that is not associated with acute coronary
syndrome (ACS), is no longer eligible for inpatient reimbursement. PCI is now considered an
outpatient procedure by CMS unless the patient requires an inpatient stay that crosses two
midnights (Amin et al., 2017; Seto et al., 2018). CMS has provided justifiable medical reasons
for moving a patient from an outpatient status to an observation status following elective PCI.
These include prolonged or adverse effects from anesthesia; fluid or electrolyte imbalance,
ongoing pain, bleeding, ischemia, or dysrhythmia. These criteria justify OO and should be
included in the SDD protocol (Seto et al., 2018).
The change in reimbursement has increased financial pressure to eliminate OO for
elective PCI (Seto et al., 2018). Since the procedure is the most common cardiovascular
procedure performed, cost is an important factor. It is estimated to cost hospitals $2,000 to
$4,000 dollars when outpatient PCI cases are kept for OO (Amin et al., 2017). Costs associated
with PCI procedures within the US are projected to reach 918 million dollars by the year 2030
(Amin et al., 2017; Amin et al., 2018). Strategies to reduce cost related to elective PCI are
urgent.
The implementation of SDD reduces cost to the hospital. With the innovation of safe
strategies to perform PCI, various studies have validated cost savings of SDD without negative
effects on patient outcomes (Seto et al., 2018). In a study conducted by Madan et al. (2019), it
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was found that SDD PCI costs about 1200 Canadian dollars less than OO, which is equivalent to
883 US dollars. In the study conducted by Amin et al. (2018), the mean cost of SDD PCI was
compared to OO PCI. The adjusted hospital cost for SDD was found to be $7,331 per case lower
than OO (Amin et al., 2018). Though cost savings is not the only driving factor, SDD is
associated with higher efficiency and cost reduction (Din et al., 2017). It is estimated that
discharging 50% of patients who undergo PCI via SDD could save the US healthcare system
between $200 to $500 million dollars per year (Shroff et al., 2016). Indirect cost savings can
result from SDD implementation including the potential for decreased medical errors and
adverse effects, increased bed utilization for incoming patients, and decreased facility resources
use (Shroff et al., 2016).
Evidence indicates that TRA and SDD significantly reduce hospital cost following PCI.
Amin et al. (2017) further investigated the costs associated with access site and SDD following
PCI among Medicare beneficiaries. The NCDR CathPCI registry was utilized to examine costs
and outcomes associated with TRA and SDD. Of the 279,987 patients eligible for SDD, TRA
was utilized in 9.0% of patients and SDD was utilized in 5.3% of patients. Utilization of TRA in
comparison with TF resulted in lower adjusted costs of $916 per case. Utilization of SDD in
comparison with OO resulted in lower adjusted costs of $3,502 per case. It is important to note
that the cost difference between TRA and SDD and TF approach and SDD was $527 dollars.
When utilizing both TRA and SDD, the adjusted cost was $13,389, whereas the adjusted cost of
TF approach and OO was $17,076 with a difference per case of $3,689 (Amin et al., 2017).
Using a hypothetical calculation from study results, Amin et al. (2017) found that if a single
hospital performed 1,000 elective PCI procedures in a year and 30% of patients underwent PCI
via TRA with SDD, the potential cost savings was $1 million per year. Using the same data,
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Amin et al. (2017) estimated that if 600,000 PCI cases were performed nationwide with
approximately 50% being elective procedures eligible for SDD, potential US hospital cost
savings from converting current practice to TRA with SDD was estimated at $332 million per
year (Amin et al., 2017).
Patient Satisfaction
Same day discharge has been shown to improve patient satisfaction when compared with
OO. Evidence indicates that the majority of patients prefer to recover from a PCI procedure at
home rather than spend the night in a hospital (Kim et al., 2013; Seto et al., 2018; Shroff et al,
2016). In a controlled trial without randomization, patients that underwent SDD were asked,
“How did you feel about being discharged the same day?” Of the 145 patients surveyed, 144
responded with “extremely satisfied” (Amin et al., 2018). In a study of 300 randomized patients
to SDD and OO, patient satisfaction was measured at 30 days following PCI. Patients reported
79% satisfaction with discharge via SDD while 49% reported satisfaction via OO. Also, 37% of
patients assigned to overnight observation reported that they would have preferred an earlier
discharge, while 9% of SDD patients would have preferred to stay for OO (Kim et al., 2013).
With the innovation of TRA, various studies have validated patient satisfaction and cost savings
of SDD without negative effects on patient outcomes (Seto et al., 2018).
Barriers to SDD & Gaps in Literature
After reviewing the literature, there were a few barriers that were identified. At this time,
there is a lack of acceptance of SDD strategies (Koshy, George, & Das, 2020). The concept of
SDD is a new model of care that is being implemented within the US, which often means
providers have little experience with its implementation. The lack of experience often leads to
more conservative approaches. For SDD, many facilities are utilizing more conservative
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standards than current literature recommends, leading to fewer discharges via SDD (Chen, Lin,
& Marshall, 2018). An individual provider’s decision regarding SDD versus OO may be
influenced by controllability, personal experience, competence, perceived benefit, and personal
concerns (Chen, Lin, & Marshall, 2018). The lack of invested interest and buy-in of SDD could
impact the performance of a SDD protocol. To implement successful change, proper planning,
physician buy in, and communication is key (Koshy, George, & Das, 2020).
In addition to conservative implementation of SDD, poor adherence to guidelines and
recommendations has been noted as a barrier within the literature (Chen, Lin, & Marshall, 2018;
Koshy, George, & Das, 2020). Chen, Lin, and Marshall (2018) implemented a SDD protocol in
Australia and evaluated the process. It was found that guideline adherence varied, with overall
adherence ratings of 77.3%. The variations were contributed to physician and individual clinical
decision making. At this time, there is no established benchmark for guideline adherence (Chen,
Lin, & Marshall, 2018).
One gap in literature is the lack of consistencies in criteria for SDD in patients who
undergo elective PCI. While the 2018 recommendations from the SCAI are relatively new, there
is no current research that uses the suggested criteria at this time (Seto et al., 2018). In addition
to the lack of consistencies regarding criteria for SDD, protocols regarding SDD implementation
are not well described in the literature.
Throughout the history of PCI procedures, the standard of care following uncomplicated,
elective PCI included OO to monitor for potential complications. Current recommendations
conclude that advances in clinical practice have supported the implementation of SDD protocols
following elective PCI (Seto et al., 2018). Many studies have noted the safety and feasibility of
implementing a SDD protocol following elective PCI in both low risk and high risk patients
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(Abdelaal et al., 2013; Amin et al., 2018; Brayton et al., 2013; Din et al., 2017; Heyde et al.,
2007; Madan et al., 2019). Following the review of literature, it is determined that the strength
of evidence is sufficient to support the implementation of a SDD protocol at an inpatient facility
in Pulaski County, Arkansas following elective PCI. Barriers found during literature review
must be addressed during the creation and implementation of this DNP quality improvement
project. Implementation of a safe, cost effective evidence-based practice SDD protocol has the
ability to improve bed utilization and increase access to care while also preserving patient safety,
improving patient satisfaction, and lowering healthcare costs.
Theoretical Framework
The utilization of EBP theoretical models aid in the implementation of current research
findings into nursing practice (Schaffer, Sandau, & Diedrick, 2013). According to Schaffer,
Sandau, and Diedrick (2013), EBP models are useful for providing an organized approach to
EBP implementation. The use of models can help researchers avoid partial implementation,
increase resource utilization, and facilitate outcome evaluation (Schaffer, Sandau, & Diedrick,
2013; White, Dudley-Brown, and Terhaar, 2016). Rosswurm & Larrabee’s model was used to
guide the implementation team through the development and integration of EBP changes within
the clinical site (Rosswurm & Larrabee, 1999). This model was developed for implementation
of EBP protocols within the inpatient setting. The model utilizes six steps from an assessment of
needed change at the clinical site to the integration and maintenance following intervention
implementation. The incorporation of best practices from clinically relevant research, expertise
of clinicians, and patient preference leads to the most up to date EBP to ensure effective, patient
centered care (Rosswurm & Larrabee, 1999).
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The Model for Change to Evidence-Based Practice from Rosswurm and Larrabee was
selected as the theoretical framework most applicable to the implementation of the SDD protocol
following elective PCI for multiple reasons. First, the theory is driven to provide patient
centered care with best practice (Rosswurm & Larrabee, 1999). The SDD protocol included a
set of pre-procedure criteria that were used to determine the discharge pathway based on the
patient’s individual characteristics. Secondly, the model heavily relies on the use of research
evidence to guide implementation (Rosswurm & Larrabee, 1999). This particular DNP project
integrated extensive current evidence to create a safe and effective protocol following elective
PCI. Also, this model advocates for the collaboration between interdisciplinary teams to further
enhance the dissemination of EBP (Rosswurm & Larrabee, 1999). A large multidisciplinary
team was assembled to implement the planned intervention at an inpatient facility in Pulaski
Country, Arkansas. Lastly, an aspect of the model is to evaluate the process and outcomes of
project implementation (Rosswurm & Larrabee, 1999). For this particular project, it was vital
that processes were continually evaluated to make changes to better improve health outcomes of
this patient population (Rosswurm & Larrabee, 1999). See Appendix D for the theoretical
framework and Appendix E for the conceptual model.
Model for Change to Evidence-Based Practice
Rosswurm and Larrabee’s Model for Change to Evidence-Based Practice was constructed
from both research and theoretical literature. In this particular model, EBP, research utilization,
and change are interconnected to implement EBP practice changes. The model is composed of
six steps that are used to implement EBP into clinical practice (Rosswurm & Larrabee, 1999).
Step 1: Assess Need for Change in Practice
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The first step of the framework is to assess the need for practice changes with
stakeholders. An internal assessment in the form of a Needs Assessment was completed to
ascertain potential barriers and common adverse effects following elective PCI to establish a
safe, effective SDD protocol through key informant interviews. A multidisciplinary team was
assembled as suggested from Rosswurm and Larrabee’s framework (Rosswurm & Larrabee,
1999). The stakeholders included the president of the heart institute, the market director of the
cardiovascular service line, an interventional cardiologist, and an advanced practice registered
nurse.
Following the needs assessment, it was determined that there was a lack of cardiac bed
availability and very little utilization of SDD following elective PCI. Internal evidence was then
compared with external data from current literature. As identified previously, current data
indicates the safety and feasibility of SDD following elective PCI. This data supported the need
for a practice change within the organization (Rosswurm & Larrabee, 1999). Key stakeholders
expressed their interest in implementing change.
Step 2: Link Problem Interventions and Outcomes
The second step of the framework is to link the problem interventions and outcomes
(Rosswurm & Larrabee, 1999). During this phase, interventions were discussed that would
improve patient outcomes and access to cardiovascular care at the clinical site. It was
determined that the intervention needed to improve patient outcomes based on EBP was the
implementation of a SDD protocol following elective PCI. Outcomes that were evaluated
following EBP implementation included safety, cost effectiveness, and access to care.
Step 3: Synthesize Best Evidence

35
The third step of Rosswurm and Larrabee’s framework is to synthesize best evidence to
determine benchmarks. The purpose of evidence evaluation is to establish whether or not the
strength of evidence supports proposed practice changes (Rosswurm & Larrabee, 1999).
After an internal assessment was completed, an extensive literature search was conducted to
evaluate current research and clinical practice guidelines. Internal evidence was compared to
EBP from current literature. The problem, practice intervention, and identified outcomes were
key variables of the literature search and review. Inclusion and exclusion criteria can be found
within the review of literature. The literature was critically appraised to identify strengths,
weaknesses, and gaps. An evidence table was used to evaluate study design, strength of
evidence, and quality of evidence. Following research synthesis, it was determined that the
strength of the evidence was sufficient to support the implementation of a SDD protocol
following elective PCI at the clinical site (Rosswurm & Larrabee, 1999).
Step 4: Design Practice Change
The fourth step to Rosswurm and Larrabee’s model is design practice change (Rosswurm
& Larrabee, 1999). When designing the practice change, the current practices, resources needed,
and feedback from key stakeholders were considered. While designing the study, outcomes were
defined. Since the practice change was intended to affect the standard of care in a large hospital,
a pilot study was used to determine additional components and changes in processes that were
needed for further SDD protocol implementation (Rosswurm & Larrabee, 1999).
Step 5: Implement & Evaluate Change in Practice
The fifth step of the model is used to implement and evaluate the change in practice.
During this stage, the pilot testing for the implementation of a SDD protocol following elective
PCI took place over a 6-week implementation period. Data was collected and evaluated to
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determine the effectiveness and outcomes of the practice change. Results from the pilot test
were disseminated amongst stakeholders. Stakeholders then determined to continue to
implement practice change (Rosswurm & Larrabee, 1999).
Step 6: Integrate & Maintain Change in Practice
The last step of Rosswurm and Larrabee’s model consists of integrating and maintaining
change in clinical practice. Results of the pilot test were examined to determine whether or not
results supported the integration of new practice as the standard of care. The process was
frequently monitored by the principal investigator (PI) and project outcomes were evaluated.
Recommendations for future implementation were communicated to stakeholders and further
process changes were initiated. Stakeholders from the facility were involved in both planning
and the implementation of practice change, leading to further confidence related to effective
practice change and the feasibility of future change within that particular environment. Staff was
educated regarding practice changes. Following future implementation, it is expected that the
SDD protocol following elective PCI will become standard of practice. During the final phase,
results of practice change were disseminated, and the multidisciplinary team and stakeholders
worked together to create plans for future implementation and practice change sustainability
(Rosswurm & Larrabee, 1999).
Evaluation of Outcomes
The aim of this DNP quality improvement project was to improve access to healthcare by
creating and implementing a same day discharge protocol following elective PCI at an inpatient
facility in Pulaski Country, Arkansas. After the implementation period, data was collected to
determine if the implementation of the SDD protocol following elective PCI increased access to
cardiovascular care. Chart reviews were conducted to analyze the effect of change
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implementation. Specific outcomes that were measured to evaluate the intervention’s
effectiveness included bed utilization affecting access to cardiovascular care, safety of care, and
cost savings.
Implications for Practice
In summary, the Model for Change to Evidence-Based Practice by Rosswurm and
Larrabee (1999) was used to create and implement change at an inpatient facility in Pulaski
County, Arkansas through the creation of a SDD protocol following elective PCI. The changes
that were implemented reflect current guidelines and EBP recommendations that can have
positive effects of patient outcomes, access to care, patient satisfaction, and hospital costs. The
problem was identified, a needs assessment was completed, and current evidence was evaluated
to create EBP directed change. Then, a research design was created with stakeholders to
implement through a pilot study. Though implementation failed during the planned
implementation period, future implementation will begin in the coming months. Following
implementation, the SDD protocol can be integrated system wide if the practice change is
successful. Utilizing the model by Rosswurm and Larrabee acted as an outline and set of actions
required to translate current knowledge and research into clinical practice to reduce the theory
practice gap (White, Dudley-Brown, and Terhaar, 2016).
Methodology
Project Description
The DNP project was categorized as QI as the goal of the project was to improve
outcomes or processes of the healthcare being delivered (Melnyk & Fineout-Overholt, 2015).
The purpose of QI is most frequently to improve current health practices and improve patient
outcomes of a specific population (Hickey & Brosnan, 2017). This DNP QI project monitored
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the implementation of an evidence based SDD protocol following elective PCI to improve access
to cardiovascular care and improve health outcomes of patients with ischemic heart disease
(Hickey & Brosnan, 2017).
Project Design
The DNP quality improvement (QI) project utilized a quasi-experimental research design
aimed to increase access to cardiovascular care through the implementation of a SDD protocol
following elective PCI at an inpatient facility in Pulaski County, Arkansas. A quasiexperimental approach was useful as it introduced an independent or treatment variable but did
not require randomization or an experimental group (Melnyk & Fineout-Overholt, 2015; Moran,
Burson, & Conrad, 2017). This DNP project was unable to utilize randomization thus making a
quantitative quasi-experimental design an appropriate approach (Melnyk & Fineout-Overholt,
2015). Convenience sampling was to be used as potential participants were scheduled for
elective PCI procedures. The project anticipated the ability to capture data from approximately
2,000 elective PCI procedures between the pre-implementation and post-implementation periods.
The DNP project employed a pre-implementation group and post-implementation group
(Melnyk & Fineout-Overholt, 2015). The intervention that was to be implemented was a SDD
protocol following elective PCI. The pre-implementation group included all patients who
underwent an elective PCI procedure regardless of discharge timing the six weeks prior to SDD
protocol implementation. The post-implementation group included all patients who underwent
an elective PCI procedure within the six-week implementation period. The percentage of
patients who discharged via SDD in the pre-implementation group were compared to the postimplementation group.

39
The overall desired outcome of the project was to improve access to cardiovascular care
by creating and implementing a SDD protocol following elective PCI. Following
implementation, the project expected to increase the percentage of patients that undergo SDD
following elective PCI. Objectives of the project included the creation of a tool to determine
each patient’s pre-procedure eligibility of SDD, the implementation of a SDD protocol following
elective PCI for all identified patients who met pre-procedure criteria, and the evaluation of care
management of patients who underwent PCI following SDD protocol implementation. The
project attempted to demonstrate the impact of implementation of a SDD protocol following
elective PCI on access to care, patient safety, and cost savings. The project aligned with the
clinical site’s objectives and project objectives to increase access to cardiovascular care. To
achieve this objective, implementation of a SDD protocol following elective PCI was attempted
to reduce OO and improve bed utilization. The number of procedures performed during the preimplementation and post-implementation period were compared. Project implementation
occurred over a six-week period, but the data collection included the six-week preimplementation period and only four weeks during the implementation period.
Setting
The DNP QI project took place in an inpatient facility within Pulaski County, Arkansas.
This particular facility served as a major cardiovascular care facility for the central Arkansas
region. The project implementation was attempted within the Cath lab and two cardiology units
within the facility. Outpatient evaluation, procedure scheduling, and post-procedure follow-up
were to take place at the facility’s corresponding cardiology clinic.
Study Population
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The study participants included all patients with IHD who underwent elective PCI within
the six weeks prior to protocol implementation and all patients with IHD who underwent elective
PCI within the six-week implementation period. Patients that were considered for SDD involved
those who met inclusion criteria for SDD following elective PCI based on pre-procedural, periprocedural, and post-procedural criteria. The inclusion criteria for SDD comprised patients over
18 years old, patients undergoing an elective procedure, patients who are not opposed to
discharge via SDD with home support, and patients with a driver present. Exclusion criteria for
SDD comprised patients presenting with non-ST elevated myocardial infarction (NSTEMI) or
ST elevated myocardial infarction (STEMI); noncompliance to medical therapy; lack of
available driver; inadequate support at home; hemodynamic instability during or after PCI
procedure; post-procedural complications; late cases that result in discharge after 9 PM unless an
exception is made by a physician; and frail, elderly patients. Inclusion and exclusion criteria
were adapted from suggested criteria from Seto et al. (2018) and Rao et al (2021). See Appendix
K for the Pre-procedure Criteria Checklist. The sample size was unknown during project
planning, as the sample size was dependent on the number of patient’s scheduled for elective PCI
procedures within the implementation period. The facility reported completing approximately
2,000 PCI procedures per year. Sampling was gathered through convenience sampling without
randomization.
Subject Recruitment
All patients with IHD being scheduled for elective PCI during the implementation period
were to be screened using the pre-procedure criteria checklist for SDD at the facility’s
corresponding cardiology clinic. Retrospective data was collected via chart reviews on all
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eligible study subjects. Consent has been waived by the University of Arkansas (UARK)
Institutional Review Board (IRB) and clinical site IRB.
Consent Procedures
This DNP project is a QI project that utilized a retrospective chart review. Consent was
waived by both the UARK IRB and clinical site IRB. Consent was not needed as the practice of
SDD is projected to become the clinical site’s standard of care for elective PCI procedures. The
patients signed a procedure consent prior to the elective PCI.
Study Measures
Conceptual Definitions. For the purpose of this DNP project, the conceptual definition
of the term same day discharge was an evidence-based change in practice that involved a patient
discharging from the hospital on the same calendar day as his or her scheduled elective PCI
procedure.
Operational Definitions. For the purpose of this DNP project, the operational definition
of the term same day discharge was described as a discharge that occured within 4 to 8 hours
following elective PCI procedure completion on the same calendar day as the scheduled
procedure. SDD was be measured by conducting chart reviews to determine the number of
patients that were discharged on the same calendar day as his or her scheduled procedure. Same
day discharge must occur at least 4 hours after procedure completion via TRA and at least 6
hours after procedure completion via transfemoral access. Pre-implementation and postimplementation data were compared following implementation.
Outcome Measures. The outcome measures of this DNP project were intended to assess
the impact of the implemented evidence-based practice change (Melnyk & Fineout-Overholt,
2015). To address the project’s specific aim and clinical outcome measure, the percentage of
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discharges completed via the SDD protocol following elective PCI were measured.
Retrospective chart reviews were conducted at the clinical site to gather data regarding all
elective PCI procedures that occurred six weeks prior to project implementation and during the
implementation period. The outcome measures compared pre-implementation and postimplementation data to determine the project’s impact. Chart review data was used to determine
if protocol implementation or other SDD methods led to increased access to cardiovascular care
through an increase in the SDD percentage. The inpatient facility estimated a baseline
percentage of SDD at 15% out of the total number of elective procedures completed. The goal
for SDD was to increase to 50% or more of the total number of elective procedures completed by
March 31, 2021.
Additional outcome measures to be evaluated included the comparison of preimplementation and post-implementation data detailing the total number of patients who
underwent elective PCI; the percentage of bed availability on two cardiology units; the length of
stay following elective PCI; and the percentage of patients with access via TRA. Baseline
percentages and projected goals for these outcome measures were unknown before
implementation. Demographic data collected included age, sex, race, type of health insurance,
and marital status will be gathered for all patients. Missing demographic data included education
level, income level, employment status, and job title.
Process Measures. The process measures of this DNP project were used to address the
efficiency of implemented change. The project utilized the Plan-Do-Study-Act cycle to plan,
implement, observe, and modify change as needed during DNP project implementation (Melnyk
& Fineout-Overholt, 2015). When problems in processes arose, change was refined and
implemented (Melnyk & Fineout-Overholt, 2015). Process observation and compliance

43
monitoring took place twice weekly by this PI. Process measures evaluated for the DNP project
included the percentage of SDD patients identified using the pre-procedure criteria, percentage
of adherence to the post-procedure checklist established to determine the patients’ readiness for
discharge, percentage of patients discharged via SDD who met SDD criteria, and percentage of
hotel usage in patient’s identified for SDD who lived further than 60 miles from the facility.
Benchmark percentages were not found in literature; however, process measure goals were
established as follows: 85% compliance of SDD patients identified using the pre-procedure
criteria; 85% adherence to the post-procedure checklist; 50% of patients discharged via SDD
who meet SDD criteria; and 100% compliance to hotel usage in patient’s identified for SDD who
lived further than 60 miles from the facility.
Balancing Measures. Balancing measures of this DNP project were used to evaluate
both positive and negative unintended effects of project implementation. Balancing measures for
the DNP project included patient safety and hospital cost savings. Safety was measured through
readmission and complication rates of patients who underwent discharge via both OO and SDD
following elective PCI at 14 days. To measure cost savings, a cost analysis was completed
comparing SDD to OO following elective PCI. Baseline data regarding balancing measures was
not available during project planning.
Benefits and Risks
Benefits of the DNP project included the implementation of an evidence-based practice
intervention through SDD following elective PCI. The benefits of PCI included improved blood
flow to coronary arteries and improved quality of life (Abbott & Cutlip, 2020). Additional
benefits of SDD included the ability to recover in one’s home, decreased length of stay, and
reduced exposure to the hospital environment. The DNP project’s implementation of SDD had
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very minimal risks, as immediate post-procedural care was unchanged from patients who stay for
OO; however, the patient or caregiver may feel stressed or anxious about caring for themselves
following the procedure. Procedural and post-procedural complications could occur with PCI;
however, evidence indicates that adverse events most often occur during the first six hours of
observation or after 24 hours, meaning OO is not superior to SDD (Jabara et al., 2008; Small et
al., 2007). Possible complications following PCI included bleeding, bruising, swelling, redness,
or soreness at the access site and chest discomfort or pain (Abbott & Cutlip, 2020). Patients that
were discharged home via SDD were provided education regarding signs and symptoms to
monitor for and numbers to call if complications or symptoms were to arise as standard practice.
There was a minimal risk of potential loss of the patient’s privacy and confidentiality through
data production and collection. This PI took all necessary precautions to minimize the loss of
privacy and confidentiality.
Subject Costs and Compensation
There were no costs incurred by the patients as a result of this DNP project. Patient
compensation is not permitted and did not occur during this DNP project. Patients who met
criteria, who were willing to discharge home, and who lived further than 60 miles from the
hospital met eligibility to stay in the facility’s hotel; however, the hotel cost was covered by the
facility. According to the clinical site, the cost of the facility hotel was approximately $79 dollars
plus tax per night as compared to inpatient OO with a calculated non-procedure cost of $1,479
dollars per night.
Resources Needed and Economic Considerations
There were costs associated with the implementation of the DNP project. Approximately
$110,000 per year was budgeted by the clinical site to pay the salary for the discharging APRN
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within the Cath Lab. Approximately $500 dollars was spent by the facility to provide preprocedure and post-procedure instructions and educational materials to patients who discharged
via SDD following elective PCI. There were minimal costs associated with printing the preprocedure criteria and post-procedure checklists. Additional resources that were used included
this PI’s personal laptop and Microsoft Excel; however, no additional costs were required. See
Appendix R for the estimated SDD implementation budget.
Implementation
Study Interventions
The DNP project intervention was the implementation of an evidence based SDD
protocol following elective PCI at an inpatient facility in Pulaski County, Arkansas. The SDD
protocol was created by the project stakeholders and PI based on current evidence-based practice
from Seto et al. (2018) and Rao et al. (2021). The validity and reliability of the SDD protocol
was unknown during project planning as it had not been used previously in clinical practice.
Implementation has not taken place to date due to several barriers; however, the
following paragraphs describe the intended intervention and implementation processes. Patients
were to be screened for SDD eligibility within the outpatient cardiology clinic before being
scheduled for an elective PCI procedure. Pre-procedure and post-procedure instructions were to
be given to each patient upon procedure scheduling in the outpatient cardiology clinic.
Following a successful, uncomplicated procedure and recovery period, SDD eligible patients
were to be discharged home via the SDD protocol. See Appendix I for educational materials and
Appendix L for the SDD protocol. See Appendix O for implementation evolution over time.
Pre-Implementation Phase
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During the pre-implementation phase, many interdisciplinary team meetings were held to
discuss current and future processes. A SDD protocol following elective PCI was developed
with key stakeholders, including an interventional cardiologist. During the pre-implementation
stage, checklists detailing pre-procedure and post-procedure criteria were created to determine
patient eligibility for SDD based on clinical and socio-demographic factors. The pre-procedure
and post-procedure criteria checklists were based on current, evidence-based recommendations
from the SCAI (Seto et al., 2018). As tools were created during project planning, the validity
and reliability were unknown before implementation. See Appendix K for pre-procedure and
post-procedure criteria checklists and Appendix L for the SDD protocol.
After new processes were determined, this PI attended scheduled meetings with the
nurses within the cardiology clinic, Cath lab, and two involved cardiology units to detail the
background and significance of the problem; current evidence used to describe the safety and
effectiveness of the intervention; projected start date; updated practices and processes; project
expectations; and pre-procedure and post-procedure checklists. During the scheduled meetings,
this PI addressed any staff questions and concerns and left a telephone number for additional
questions. A frequently asked questions (FAQ) flyer was also created and emailed to
management to deliver to the staff. The clinical site administration took ownership for physician
engagement beyond the physician that was involved in SDD protocol creation.
The facility began an independent pilot test utilizing updated SDD processes on patients
who underwent electrophysiology (EP) procedures on June 1, 2020 with two EP physicians.
Though this was not studied by this PI, the pilot test was used to better facilitate implementation
of the SDD protocol following elective PCI. The pilot test was very successful. From August
10, 2020 through April 1, 2021, there were 345 patients discharged via SDD processes following
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EP procedures with two EP physicians. The estimated cost savings based on previous
calculations was $510,255.
Chart reviews to gather pre-implementation data were delayed due to a lack of access to
the EMR at the clinical site. Chart reviews began on March 10, 2021. Baseline data gathered
included the total number of elective PCI procedures completed in the six weeks preceding
implementation, the number of patients that were discharged via SDD and OO, length of stay,
procedural complications, post-procedural complications within 14 days following elective PCI,
readmissions within 14 days following elective PCI, and demographic data. It was intended that
pre-implementation data and post-implementation data were to be compared. Data governance
requests were made at the clinical site to capture the data needed.
Implementation Phase
The elective PCI SDD protocol was approved by key stakeholders and piloting
interventional cardiologist before project implementation, but the implementation phase did not
unfold as originally expected. The lack of physician engagement, administrative support, and
clinical site communication led to implementation failure within the clinical site. During the
implementation phase, there were no patients discharged via the established SDD protocol. The
following sections detail variations in implementation, as well as specifics of planned, actual,
and future implementation phases.
Planned Implementation Phase.
As stated above, implementation was not successful and was ultimately delayed by the
clinical site. This section will detail the intended implementation process steps from clinic
procedure scheduling and eligibility screening to discharge via the SDD protocol. See Appendix
L for the SDD protocol.
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When an elective PCI procedure was scheduled, the patient was to be advised that he or
she might discharge home on the same day as the procedure. Upon scheduling an elective PCI
procedure, patients were to be screened for SDD eligibility using the pre-procedure criteria
checklist and given pre-procedure and post-procedure educational handouts in the cardiology
clinic. See Appendix K for the pre-procedure criteria checklist and Appendix I for the preprocedure and post-procedure educational handouts. Elective PCI procedures were to be
scheduled as early in the day as possible and noted as “SDD” in the comments on the Cath lab
schedule to alert the Cath lab nurses of a potential SDD candidate.
Discharge planning was to begin upon the patient’s arrival to the Cath lab for the
scheduled elective PCI procedure. The patient would be assessed for distance from the hospital;
proper home support; the presence of a driver; and the willingness to pay for medications prior to
discharge. If the patient lived further than 60 miles from the facility and the procedure was
successful with no complications, arrangements for the facility’s hotel would be made by the
Cardiovascular Service Line Director at no cost to the patient.
As part of implementation, the physician asked that verification of new medications,
specifically DAPT, be an included requirement for SDD eligibility. Medication verification was
incorporated into the SDD protocol. As requested, the facility was to utilize the in-hospital
“meds to bed” pharmacy to deliver all new medications to the patient before discharge.
The use of the TRA was strongly encouraged, though it was not mandatory per the
facility. Same day discharge utilizing TRA was to occur at least 4 hours after procedure
completion and at least 6 hours after procedure completion via transfemoral access. If
complications arose during the procedural or post-procedural periods, the patient was to stay for
OO. See Appendix K and Appendix L for details regarding possible reasons for OO.
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The SDD protocol was established to guide decision making for SDD versus OO
following elective PCI. After a successful procedure was completed as identified by the
patient’s physician, the nurses in the Cath lab or on the cardiology units were to continue
evaluating the patient for complications and to use the post-procedure checklist to determine the
patient’s readiness for discharge. See Appendix K for the post-procedure checklist. Once the
patient met all discharge criteria per the post-procedure checklist and was without complication,
the patient was to be evaluated by the discharging APRN. The APRN was to assess access sites;
complete education regarding new medications, disease process, incision care, and cardiac rehab;
and give the patient all post-procedure information. The post-procedure education materials
detailed signs and symptoms to monitor for and numbers to call if a complication were to occur.
The patients were to be advised to seek emergency care if bleeding or chest pain developed
following his or her procedure. Once deemed medically stable by the discharging APRN, the
patient would either discharge home or to the facility’s hotel. If the patient’s discharge was to
take place after 6 PM, the patient would be moved to one of the two cardiology units to complete
the remaining observation period and post-procedure checklist items. Discharges to home were
not be completed after 9 PM for safety reasons, unless specifically indicated by the operating
physician. The patients would then be called by the discharging APRN the morning after his or
her discharge to assess for any complications. See Appendix L for the SDD protocol.
Actual Implementation Phase.
The implementation phase was to take place between February 8, 2021 and March 20,
2021. As stated previously, the implementation phase of the DNP project was not successful for
various reasons. During the implementation phase, there were no patients that were sent home
via the established SDD protocol and processes. One interventional cardiologist agreed to be the
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SDD protocol’s piloting interventionalist, though his schedule for elective PCI cases was very
limited due to other obligations. One major barrier was the lack of effective communication
between the PI and the piloting interventional cardiologist. Initiation of communication with the
piloting interventionalist took place almost daily, but there were limited responses back to this
PI. This PI then spoke with another interventional cardiologist who voiced that he was unaware
of the SDD protocol implementation taking place. Moving forward, there were many efforts
made to engage other interventional cardiologists, though none were ready to begin
implementation immediately. The PI continued to extend correspondence to the piloting
interventionalist with little response and no successful SDD implementation. The lack of
physician engagement and hesitation led to implementation failure and subsequent delay. It is
likely that implementation will take place in the coming months, though exact timing is
unknown. See Appendix O for Implementation Evolution Over Time. The following will detail
portions of the implementation phase that were completed and others that did not occur.
When an elective PCI procedure was scheduled, it was the standard of practice that the
patient was advised that he or she might discharge home on the same day as the procedure.
Upon scheduling an elective PCI procedure, the patient was given pre-procedure and postprocedure educational handouts in the cardiology clinic. Unfortunately, there was 0% adherence
to pre-procedure eligibility screening using the criteria checklist during the implementation
phase. This was thought to be related to the lack of physician engagement.
Elective PCI procedures were to be scheduled as early in the day as possible and noted as
“SDD” in the comments on the Cath Lab schedule to alert the Cath Lab nurses of a potential
SDD candidate. No elective PCI procedures were scheduled via these established methods. As
there were no participants that were sent home via the established SDD protocol, the post-
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procedure checklists were not utilized; no patients were discharged to the facility’s hotel; and the
use of the in-hospital “meds to bed” pharmacy was not documented.
Chart reviews were intended to be conducted at least weekly to determine the total
number of elective PCI procedures scheduled, procedure start time, the number of patients that
were discharged via SDD, length of stay for patients who discharge via SDD, procedural
complication, post-procedure complications, and readmissions or complications within 14 days
following SDD. See Appendix H for data collection sheet. Due to a lack of access to the clinic
site EMR, chart reviews were delayed until March 10, 2021, almost one week from
implementation completion.
Process observation took place at least twice weekly and deviations from protocol
processes were noted. Due to the lack of participation, there was no data regarding compliance
of patient eligibility screening or post-procedure checklist use to be evaluated. The request for a
cost analysis of each elective PCI procedure was not processed before professional reporting, but
previous calculations were used to estimate the hospital costs savings between OO and SDD.
Future Implementation Phase.
Future implementation of the SDD protocol at the clinical site is expected within the
coming months, though the exact timing is unknown. This PI would continue to recommend that
the clinical site use the established SDD protocol and processes as outlined above to complete
further implementation. The discharging APRN will take over SDD multidisciplinary team
leadership, though this PI will still be available to offer additional support if wanted or needed by
the clinical site.
Plan-Do-Study-Act Cycles.
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During the implementation phase, Plan-Do-Study-Act (PDSA) cycles were used to
address various issues as they surfaced. When a problem or issue was identified, various
strategies were utilized to modify processes and improve implementation strategies. During the
implementation phase, the following concepts were identified and addressed using PDSA cycles.
See Appendix P for additional details regarding weekly PDSA cycles during the implementation
phase.
Pre-Procedure Checklist Compliance.
During the implementation phase, it was identified that patients were not screened for
SDD eligibility in the clinic using the pre-procedure checklist. Efforts made to increase
compliance included additional teaching with the clinic nurses, clinic schedulers, and physicians.
These efforts did not increase compliance. Both the hospital and clinic were non-compliant to
pre-procedure checklist utilization. There were no patients screened for eligibility using the
established checklists. To improve process measures compliance and meet to process measure
goals in the future, additional teaching with the clinic nurses, clinic schedulers, and physicians
must take place.
Post-Procedure Checklist Compliance.
During the implementation phase, the use of the post-procedure checklist was also nonexistent from the Cath lab and Cardiology unit staff. Since there was very little physician
engagement, there were no patients identified as potential SDD candidates, thus making the use
of the post-procedure checklist obsolete. Despite the lack of eligible patient identification, staff
education, staff reminders, and increased observation were strategies used to increase
compliance, though these were ineffective. The post-procedure checklists were not used at all
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during the implementation phase. During future implementation, additional education,
reminders, and observation must take place to ensure that process measure goals are reached.
Physician Engagement & Buy-in.
Engagement and buy-in from the interventional cardiologists were issues identified early
in implementation and was found to be the most notable barrier to implementation. Though
many physicians knew of potential efforts to implement SDD following elective PCI at the
clinical site, not all were aware or involved in SDD protocol and process creation. This PI began
meeting with individual physicians to discuss the SDD protocol and processes during weeks two
through six of implementation to gain physician trust and buy-in. Following individual
meetings, there was substantially more physician input and engagement; however, the physicians
were not prepared to begin implementation immediately. Due to this skepticism, no patients
were discharged home via the SDD protocol.
Communication and Identification of Potential SDD versus Overnight Observation.
During implementation, the discharging APRN often found that she was having to ask the
piloting interventional cardiologist on a case-by-case basis about potential same day discharge
patients to no avail. Several meetings were held to discuss possible solutions to improve
communication from the clinic to the hospital. There were many discussions regarding adding
same day discharge procedures to the clinic and clinical site EMR to initiate staff decision
making; however, this addition was ultimately vetoed by the clinical site administration as
previously established processes were reinforced and felt to be adequate for SDD procedure
scheduling based on the EP pilot study. For future implementation, reinforcing the established
scheduling processes will be vital to success.
Post-Implementation Phase
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Data extraction via chart audits began on March 10, 2021. Originally, data collection
was to include the six weeks prior to and six weeks of implementation, from December 27, 2020
to March 20, 2021. Unfortunately, the data collected only included a 10-week time period
between December 27, 2020 and March 6, 2021 due to the lack of accessible clinical data despite
data requests. Since implementation and the utilization of the SDD protocol did not take place, it
was not likely that the remaining data would contribute to project data and results.
Following data extraction, data analysis was conducted. Originally, the preimplementation and post-implementation outcomes measures were to be compared, but after a
lack of SDD protocol implementation, the data collected was analyzed as a whole to describe the
practices of the clinical site over the 10-week period between December 27, 2020 and March 6,
2021. The data gathered represented the clinical site’s baseline data. This PI utilized multiple
UARK SMSS consultant sessions to review data collected, discuss statistical testing, and analyze
data. Following data analysis, the results were disseminated to the DNP project committee, key
stakeholders, and the interdisciplinary team at the clinical site.
Process Comparison
A comparison of pre-implementation processes, proposed processes, and final processes
was completed. The pre-implementation processes featured patients recovering in the Cath Lab,
moving to a cardiology unit, staying overnight, and discharging 24 hours or more after the
procedure. The proposed process flowchart included a same day discharge process that
incorporated pre-procedure criteria assessment in the clinic; assessment and evaluation by the
discharging APRN; medication delivery via the in-hospital “meds to bed” program; postprocedure checklists used to determine readiness for discharge; and the use of the facility’s hotel
for eligible SDD patients that lived further than 60 miles from the hospital.
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The proposed process flow chart should also act as the final process flowchart. This PI
would continue to recommend the proposed flow chart despite implementation failure and
subsequent delay. This process will continue to change as implementation occurs and can be
modified as needed by the clinical site. See Appendix B for pre-implementation and final
process flowcharts.

Project Timeline
The actual project timeline differed greatly from the initial, projected timeline. Initially,
implementation was projected to take place from October 2020 through March 2021; however,
due to delays in clinical site IRB review and non-research designation and a lack of physician
engagement and participation, implementation failed and was postponed. There were no
participants discharged via the established SDD protocol during the implementation period from
February 8, 2021 through March 20, 2021. Data gathering via chart reviews was initially
projected to occur between October 2020 through March, though it actually took place between
March 10, 2021 through March 24, 2021 due to clinical site EMR access delays. Data was
analyzed between March 25, 2021 and April 13, 2021 and later disseminated to the clinical site
and the University of Arkansas doctoral committee during the DNP intensive. See Appendix F
for the Gantt charts depicting the original DNP project timeline and the actual DNP project
timeline.
Evaluation of Results
Data Maintenance and Security
A Microsoft Excel spreadsheet was created and used for data collection. On March 10,
2021, retrospective chart reviews were conducted by this PI to obtain data regarding all elective
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PCI procedures completed in the pre-implementation and implementation periods. Data
collected for all subjects included the patient’s medical record number (MRN), operating
interventionalist, procedure date, age, race, sex, marital status, primary language, insurance type,
type of discharge, distance from hospital, procedural complications, post-procedural
complications before discharge, complications within 14 days of discharge if applicable,
readmission within 14 days of discharge if applicable, total length of stay in hours and minutes,
access site used, and use of a closure device.
Some data was unable to be collected due to delayed EMR access and the lack of SDD
protocol implementation. Missing data included income level, education level, employment
status, and individual procedure cost. Additionally, if implementation of the SDD protocol had
taken place, information regarding process measure adherence would have been collected and
included screening with the pre-procedure criteria checklist, facility hotel use, adherence to the
post-procedure checklist, SDD of those who met eligibility criteria, and reasons for overnight
observation if applicable. See Appendix H for data collection sheets.
All project data was stored electronically and only this PI had access to the data. All
collected patient data was saved and stored in a Microsoft Excel spreadsheet on this PI’s
password protected desktop computer within the clinical site. The computer was connected to a
server maintained by the clinical site. The document was password protected to increase subject
privacy and confidentiality. No other individuals had access to this computer. Initially, the
patients were identified by the MRN and procedure date on the Microsoft excel spreadsheet.
Since consent was waived for the DNP project, the patient’s MRN and procedure date were
deleted and destroyed on March 24, 2021 following data extraction, transcription, and
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verification. The data was destroyed in such a way that the identifiers cannot be linked to patient
data.
Data Analysis
Data analysis included descriptive statistical methods to summarize the baseline data and
clinical site practices during the project implementation period. Originally, inferential statistical
methods were to be used, but the lack of data variations and SDD protocol implementation made
inferential methods unnecessary. Demographic data, outcome measures, process measures, and
balancing measures were analyzed via descriptive statistics to describe the patient population and
practices of the clinical site.
Due to the lack of participation using the SDD protocol, comparisons regarding SDD
via the established protocol and its impact on readmission rates at 14 days, complication rates at
14 days, TRA usage, and procedure cost were unable to be evaluated. Though the SDD protocol
implementation failed during the planned implementation period and was ultimately delayed at
the clinical site, pre-implementation data and post-implementation data were compared and later
combined to describe baseline data and clinical site practices. Analyzing the data collected was
useful to establish baseline data for the clinical site and to identify areas of focus for future
implementation.
Data was analyzed via Excel Tool Pack with the assistance of the SMSS tutors available
from UARK to describe baseline data and clinical site practices over the 10-week data collection
period. There were 55 patients (N=55) that underwent elective PCI with 10 interventional
cardiologists between December 27, 2020 and March 6, 2021. An average of 5.5 elective PCI
procedures were completed per week during the 10-week data collection period. Of the 55
procedures completed, 20 patients were discharged home via non-established SDD methods and

58
35 were discharged following OO. See Figure 1 for the weekly breakdown between SDD vs.
OO. As displayed, there were no elective PCI procedures that occurred during week 8 as a result
of statewide inclement weather and subsequent elective procedure cancellation.

Figure 1
Breakdown of Overnight Observation versus Non-Established SDD Methods per Week
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Note: This breakdown does not represent implementation of the SDD protocol during the
implementation period, but rather SDD via non-established SDD methods. The SDD was not
implemented.
The mean age of the patients was 65.18 years old with a range from 41 years old to 88
years old. There were 39 males (70.91%) and 16 females (20.09%) in the sample of 55 patients
(N=55). Thirty-four patients were white, 18 were black, 2 were pacific islander/Hawaiian, and 1
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was Asian. English was the primary language identified for the entire patient population.
Thirty-four patients stated that they were married, 11 were single, 5 were widowed, 4 were
divorced, and 1 was separated. Of the 55 patients, 22 had only private insurance, 20 had both
private and public insurance, 7 had only public insurance, 3 had federal insurance, and insurance
information was unavailable for the 3 remaining patients. Missing demographic data included
education level, income level, employment status, and job title. These were unable to be
obtained due to a lack of SDD protocol implementation, inconsistent documentation, and delayed
EMR access at the clinical site.
Table 1
Demographic Data for Elective PCI (N=55)
Demographic Data for Elective PCI (N=55)
Frequency
Percentage
Age
19-35
36-50
51-65
66-79
80+

0
4
26
20
5

0.00%
7.27%
47.27%
36.36%
9.10%

Race
White
Black or African American
Asian
Pacific Islander/Hawaii

34
18
1
2

61.82%
32.73%
1.82%
3.64%

Gender
Male
Female

39
16

70.91%
20.09%

Marital Status
Married
Single
Divorced
Widowed
Separated

34
11
4
5
1

61.82%
20.00%
7.27%
9.09%
1.82%
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Primary Language
English

55

100.00%

Insurance Type
Private
Public
Public + Private
Federal
Unavailable

22
7
20
3
3

40.00%
12.73%
36.36%
5.45%
5.45%

Many of the interventional cardiologists expressed that they felt that SDD protocol
implementation would likely require them to change their work schedules to accommodate for
SDD as the procedures must be scheduled and completed early in the day. This PI analyzed
procedure start times to better describe the usual practice habits. It was found that out of the 55
procedure, 21 took place between 0700 and 0900 (38.18%); 15 took place between 1000 and
1200 (27.27%); 17 took place between 1300 and 1700 (30.91%); and 2 took place at 1600 or
later (3.64%). As per the clinical site’s request, the SDD protocol incorporated recommended
case completion times via TRA and TFA. The SDD protocol states that cases via TRA must be
completed by 5 PM and cases via TFA must be completed by 3 PM to be considered for SDD.
This data indicated that at least 65.45% of the elective PCI procedures were scheduled and
started at appropriate times (0700 to 1200) to facilitate SDD. Increasing early or mid-morning
cases would help the clinical site capitalize on greater SDD eligibility.
Outcomes Measures
The objective of this DNP project was to evaluate how the implementation of a SDD
protocol following elective PCI effected access to cardiovascular care. Outcome measures were
evaluated and compared pre-implementation data to post-implementation data to determine the
impact of the DNP project. Five outcome measures for the DNP project were identified during
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project planning that included the percentage of SDD of the patients who underwent elective
PCI; the total number of patients who underwent elective PCI; the percentage of bed availability
on two cardiology units; the average length of stay; and the percentage of patients who
underwent elective PCI with access via TRA.
Retrospective chart reviews were conducted at the clinical site to gather data regarding all
elective PCI procedures that occurred during the six weeks prior to project implementation and
during the implementation phase. Originally, data collection was to include the six weeks prior
to and the six weeks of implementation, from December 27, 2020 to March 20, 2021.
Unfortunately, the data collected only included a 10-week time period between December 27,
2020 and March 6, 2021 due to the lack of accessible clinical data despite data requests.
Outcome Measure #1: Percentage of Same Day Discharge.
The specific aim, and the first outcome measure, was to increase the percentage of SDD
from the estimated baseline rate of 15% to 50% by March 31, 2021. According to one of the
interventional cardiologists, the quality metric goal for SDD following elective PCI was 25% or
greater, though this PI was unable to verify this metric with clinical site administration.
To address the project’s specific aim and clinical outcome measure, the percentage of
discharges completed via SDD following elective PCI were to be measured; however, no
discharges occurred according to established SDD processes. Despite the lack of SDD protocol
implementation, data from the 10-week collection period was analyzed to relay accurate baseline
data to the clinical site and to describe current clinical practice.
As stated above, the estimated baseline percentage of SDD reported from the clinical site
prior to implementation was 15%; however, the percentage of elective PCI SDD from October
2019 through September 2020 was 25.3% out of the total number of elective procedures
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completed. During the 10-week data collection period, the percentage of SDD increased from
previous percentages. Data from the pre-implementation period indicated that 15 of 35 patients,
or 42.86%, discharged via non-established SDD methods while 5 of 20 patients, or 25%,
discharged via non-established SDD methods during the planned implementation period. It is
likely that statewide inclement weather over week 8 of the planned implementation period
played a role in both the decreased number of elective PCI procedures completed and the
variation in SDD percentages during the pre-implementation and planned implementation
periods. When both the pre-implementation and planned implementation period data were
combined, it was found that 20 out of the 55, or 36.36%, were discharged via other nonestablished SDD methods. The outcome measure of increasing the SDD percentage to 50% by
March 31, 2021 was not met. See Figure 2.
Of the 55 elective PCI procedures performed, 19 of 55 were performed by three
interventional cardiologists who do not regularly operate from the clinical site. Of these 19
elective PCIs performed, 8 patients discharged via non-established SDD methods. If the
procedures performed by these three were excluded, 36 procedures were performed by regular
interventional cardiologists with 12 of 36 discharge via non-established SDD methods for a
percentage of 33.33% during combined pre-implementation and post-implementation periods.
Figure 2
Percentage of Same Day Discharge

63

Percentage of Same Day Discharge
45%

42.86%

40%

36.36%

35%
30%
25%

25%
20%
15%
10%

Pre-Implementation

Post-Implementation

Combined

Note: The SDD protocol was not implemented during the planned implementation period. Also,
Pre-implementation period represents 6 weeks of data as compared to 4 weeks during the postimplementation period.

Outcome Measure #2: Total Number of Patients who Underwent Elective PCI.
The second outcome measure was to compare the total number of patients who
underwent elective PCI during the pre-implementation phase to the post-implementation phase.
Data comparisons are skewed as the pre-implementation data collection period included six
weeks, while the post-implementation data collection period included only four weeks. It was
found that 35 patients underwent elective PCI during the pre-implementation phase and 20
patients underwent elective PCI during the post-implementation phase. See Figure 3.
Figure 3
Total Number of Patients who Underwent Elective PCI
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Note: Pre-implementation period represents 6 weeks of data as compared to 4 weeks during the
post-implementation period. The “combined” bar represents the 10-week data collection period.

Outcome Measure #3: Percentage of Bed Availability.
The third outcome measure established was to compare the percentage of bed availability
on two cardiology units during the pre-implementation and post-implementation phases.
Unfortunately, this data was not able to be obtained despite many requests made by this PI to the
clinical site administration. Data that was obtained included the average daily census during the
previous fiscal year; however, staffing shortages skewed bed availability numbers as beds were
blocked at times to assist with staffing shortages. In addition to staffing shortages, COVID-19
caused many patients to delay seeking care and further skewed bed availability numbers. During
the last fiscal year, the average daily census on 2 northwest was 16 out of 24 available beds and
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10 out of 18 available beds on 2 east. The clinical site will need to continue following bed
availability percentages to further evaluate SDD protocol implementation effects on access to
cardiovascular care. See Figures 4 and 5 below.
Figure 4
Bed Utilization on 2 Northwest
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Figure 5
Bed Utilization on 2 Northwest
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Outcome Measure #4: Average Length of Stay.
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The fourth outcome measure established was to compare the length of stay following
elective PCI between the pre-implementation and post-implementation phases. The average
length of stay of patients who underwent elective PCI during both the pre-implementation phase
and the post-implementation phase combined was 1372.18 minutes or 22.87 hours. See Figure 6
below. The average length of stay during the pre-implementation phase was 1143.40 minutes as
compared to 1772.55 minutes during the post-implementation phase. The difference in the
averages was 629.15 minutes. During the post-implementation period, there were two patients
that had a substantially longer length of stay due to post-procedure complications. These outliers
likely skewed the average length of stay. See Figure 7.

Figure 6
Average Length of Stay in Minutes: Pre-Implementation & Post-Implementation Combined
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Figure 7
Average Length of Stay in Minutes: Elective PCI
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Outcome Measure #5: Percentage of Access via TRA.
The fifth and final outcome measure established was to compare the percentage of
patients who underwent elective PCI via TRA between the pre-implementation and postimplementation phases. Because of the lack of SDD implementation, data from the preimplementation and post-implementation phases were combined. It was found that 26 patients
underwent access via TFA, 27 patients underwent access via TRA, and 2 patients underwent
access via both TFA and TRA. Additionally, there were two patients in which the right femoral
vein was used and one patient in which the right jugular vein was used for transvenous pacing
purposes in addition to the catheterization access site. See Figure 8.
Figure 8
Comparison of TRA versus TRA Usage
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Note: The graph represents cumulative data from the pre-implementation & post-implementation
phases.
Process Measures
The process measures of this DNP project were used to address the efficiency of
implemented change at the clinical site. The project utilized Plan-Do-Study-Act cycles to plan,
implement, observe, and modify change as needed during DNP project implementation (Melnyk
& Fineout-Overholt, 2015). When problems with processes arose, change was refined and
implemented in an effort of continuous quality improvement (Laverentz & Kumm, 2017;
Melnyk & Fineout-Overholt, 2015). Process observation and compliance was monitored twice
weekly by the PI. During the implementation phase, PDSA cycles were used to identify barriers
to implementation at weekly intervals. See Appendix P for weekly PDSA Cycles. During
implementation, different strategies and processes for SDD were identified and modified as
needed using the PDSA cycles. See Appendix O for Implementation Evolution Over Time.
There were four process measures that were evaluated for the DNP project. These
process measures included the percentage of SDD patients identified using the pre-procedure
criteria; percentage of adherence to the post-procedure checklist established to determine the
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patients’ readiness for discharge; percentage of patients discharged via SDD who meet SDD
criteria; and percentage of hotel usage in patient’s identified for SDD who live further than 60
miles from the facility. Benchmark percentages were not found in current literature; however,
process measure goals were established as follows: 85% compliance of SDD patients identified
using the pre-procedure criteria; 85% adherence to the post-procedure checklist; 50% of patients
discharged via SDD who met SDD criteria; and 100% compliance to hotel usage in patient’s
identified for SDD who lived further than 60 miles from the facility. Unfortunately, none of the
process measure goals were met due to failed and subsequently delayed SDD protocol
implementation at the clinical site. Some patients were discharged via other SDD methods,
though they were not discharged using the established SDD protocol. Please see the below for
details regarding individual process measures.
Process measures are conveyed using descriptive statistics and displayed via Run Charts.
The Institute for Healthcare Improvement (IHI) (2021) states that run charts are used to depict
data over time. Run charts are often used to display how well or poorly a certain project process
is performing (Institute for Healthcare Improvement [IHI], 2021). See Appendix S for run charts
with associated data inputs.
Process Measure #1: Compliance of Patient Identification Using the Pre-Procedure
Criteria.
The first process measure identified was cardiology clinic staff compliance of using the
pre-procedure criteria to identify patient eligibility for SDD. The goal was to reach 85%
compliance each week during the implementation period. The delay of implementation led to
0% compliance of checklist use. See Figure 9. The lack of compliance was likely due to the
lack of physician engagement and will be discussed in further detail later as a limitation.
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Figure 9
Pre-Procedure Checklist Compliance: Identification of Patient Eligibility for SDD
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Process Measure #2: Compliance Using Post-Procedure Checklist.
The second process measure identified was Cath lab staff compliance of using the postprocedure checklist to determine patient readiness for discharge. The goal was to reach 85%
compliance each week during the implementation period. The delay of implementation led to
0% compliance of checklist use. See Figure 10.
Figure 10
Post-Procedure Checklist Compliance to Determine Readiness for Discharge
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Process Measure #3: Compliance of SDD for Patients who Met SDD Criteria.
The third process measure addressed compliance of discharging SDD eligible patients via
SDD following elective PCI. The goal was to reach 50% each week during the implementation
period. Physician hesitation, the delay of implementation, and the lack of participants led to 0%
compliance. There were no patients that were screened using the SDD protocol’s criteria or
checklists. See Figure 11.

Figure 11
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Compliance of SDD for Patients who Met SDD Eligibility Criteria
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Process Measure #4: Compliance of Utilizing Facility Hotel.
The final process measure identified was compliance of utilizing the facility hotel for
patients who lived further than 60 miles from the clinical site. The goal was to reach 100%
compliance each week during the implementation period. Due to the delay of implementation
and physician hesitation, there was 0% compliance of utilizing the facility’s hotel. No patients
were discharged to the facility’s hotel during implementation. See Figure 12.
An average distance from the hospital was calculated. It was found that the average
distance that the patients lived from the hospital was 53.6 miles. See Figure 13. Twenty-one
patients within the sample lived further than 60 miles from the hospital. Of the 21 patients that
lived further than 60 miles from the hospital, 9 patients discharged on the same day and traveled
the entire distance home despite facility hotel availability, none of which had post-procedural
complications. One of the 21 patients who lived further than 60 miles from the hospital had a
post procedure complication that required OO. Complications are discussed below. Based on
this information, it can be inferred that 20 patients could have potentially discharged to the
facility’s hotel for one night at no cost following his or her procedure.
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Figure 12
Compliance of Utilizing the Facility’s Hotel for Patients who Lived Further than 60 miles from
the clinical Site.
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Figure 13
Average Distance from the Hospital: Elective PCI
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Balancing Measures
Balancing measures of the DNP project were used to evaluate both positive and negative
unintended effects of project implementation. Balancing measures for the DNP project included
patient safety and cost savings. Safety was measured through readmission and complication
rates of patients who underwent SDD following elective PCI at 14 days. Cost savings was
completed comparing SDD to OO projections from the clinical site. Since implementation was
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delayed at the clinical site, there were no additional unintended effects discovered, either positive
or negative.
Balancing Measure #1: Safety
The first balancing measure identified was to monitor the safety following the
implementation of a SDD protocol after elective PCI. Despite the lack of implementation of the
SDD protocol, safety was evaluated through the conduction of chart reviews on all patients who
underwent elective PCIs within the 10-week data collection period. There were zero
complications or readmissions within 14 days of discharge identified via chart reviews of all 55
patients who underwent elective PCI within the pre-implementation and post-implementation
periods. As stated previously, 20 of the 55 patients discharged via non-established SDD
methods. Of the 20 patients, there were no complications or readmissions identified via chart
reviews. This finding further supports the safety of implementing the SDD protocol within the
coming months.
Additionally, chart reviews included procedural and post-procedural complications
before discharge. Evaluation of these complications was not originally included during project
planning; however, they were identified as important values for measuring implementation
safety. This information was only collected to verify that patients who had complications were
kept for OO. Of the 55 patients, three had procedural complications (5.45%) and five had postprocedural complications (9.09%).
The three procedural complications included two patients with bradycardia requiring
transvenous pacing and one patient who had significant complications including bleeding at the
access site, hematoma at the access site, cardiac tamponade, coronary artery dissection, and
perforation. One patient who had procedural bradycardia requiring temporary pacing discharged
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via non-established SDD methods as bradycardia resolved during the immediate post-operative
period. The five post-procedural complications included one patient with a hematoma, one
patient with a contrast allergy, one patient with post procedure bleeding, one patient with ST
depression on EKG in lateral leads, and one with atrial fibrillation requiring amiodarone and
Cardizem infusions before rhythm conversion. Of these with complications, one patient had
both procedural and post-procedural complications.
One of the patients who had procedural bradycardia requiring temporary pacing
discharged via non-established SDD methods as bradycardia resolved during the immediate postoperative period and was felt to be safe for discharge by the operating physician. All others with
procedural and post-procedural complications were appropriately monitored via OO. The
average length of stay for patients who experienced either a procedural or post-procedural
complication before discharge was 2483.29 minutes or 41.39 hours.
Balancing Measure #2: Cost Savings
The second balancing measure identified was to evaluate the cost savings when
comparing SDD to OO following elective PCI. Originally, this PI was to calculate an average
cost of SDD versus OO using individual procedural costs. The request for a cost analysis of each
elective PCI procedure was not processed at the clinical site before professional reporting.
Instead, previous calculations were used to estimate the hospital costs savings between OO and
SDD.
The clinical site conducted a proforma in January of 2020 that noted a 5.4% increase in
Cath lab volume over the previous year. The increase in case volume caused difficulties with
throughput in all the cardiac areas which led to consistently full cardiac units. The proforma
analyzed the average cost of an atrial fibrillation ablation minus the procedure costs to determine
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the difference in hospital cost between OO and SDD. It was calculated that the average cost of
OO minus procedural costs was $2,787 compared to $1,307 for those who discharged via SDD.
The total cost savings of SDD equated to approximately $1,479 dollars per case. The clinical site
felt that the cost savings for OO versus SDD would be the same following elective PCI.
During the 10-week data collection period, 20 of the 55 patients, or 36.36%, who
underwent elective PCI were discharged home via non-established SDD processes. If the
clinical site had met its goal for increasing the percentage of SDD to 50% by the end of the data
collection period, there was a potential of an additional $11,092.50 dollars in hospital cost
savings during that period of time alone using the previous calculations.
The clinical site averaged 5.5 elective PCI procedures during the 10-week data collection
period. If the clinical site was able to continue the average of 5.5 elective PCI procedures per
week, they would have completed 286 elective PCI procedures in 52 weeks. If the goal of
discharging 50% via SDD were met (143 of 286), there would be a potential for $211,497 dollars
in hospital cost savings within 52 weeks at a rate of 5.5 elective PCI procedures per week.
Interpretation of PDSA Findings & Evaluation of Project Results
After reviewing information yielded from Plan-Do-Study-Act (PDSA) cycles completed
during the implementation phase, various conclusions were identified. The goal of the DNP
project was to increase SDD percentages from the baseline of approximately 15% to 50% or
more of the total number of elective procedures completed by March 20, 2021. The overall goal
of increasing the percentage of SDD to 50% was not achieved. Following six weeks of the
planned implementation period, there were no patients discharged via the established SDD
protocol. Of note, there were some SDDs completed by individual physicians; however, the
discharges were not completed using this PI’s established SDD protocols.
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Additionally, there were many barriers that were identified before and during
implementation that caused deviations in developed processes and a lack of SDD protocol
implementation. These barriers included limited staffing in the IRB department at the clinical
site causing a prolonged IRB waiting period; inclement weather with subsequent elective
procedure cancellation; breakdowns in communication between administration, SDD team, and
physicians; lack of physician engagement and buy-in; issues with access to project data; and lack
of identification of potential SDD patients. Notably, the most substantial barrier was physician
engagement. Many physicians expressed that they were unaware of the established SDD
protocol until implementation had begun with the piloting interventional cardiologist. This led to
physician hesitation, limitation of SDD participants, and implementation delays. Another barrier
of this DNP project was the lack of access to the clinical site’s EMR. This led to delayed data
collection.
Originally, the DNP project was projected to include a maximum of 1,000 SDD
participants during the implementation phase; however, implementation delays, a shortened
implementation period, and the lack of physician engagement severely limited DNP project
participation. The lack of participation and shortened implementation period negatively
influenced the validity and reliability of DNP project results.
When compared to the SDD program established by Chen, Lin, and Marshall (2018), this
DNP project might have had similar results if the implementation period were the same length.
In Chen, Lin, and Marshall’s (2018) study, 308 patients underwent PCI during the six-month
implementation period. Of the 308 who underwent PCI, 258 did not meet pre-procedure criteria.
Of the remaining 50 patients, 47 met criteria and 3 did not meet criteria but were considered
eligible by the physician. Of the 50 patients that were determined to be eligible, only 22 were
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sent home via SDD. It was noted that both physician preference and individual clinical decision
making contributed to deviations from the SDD guideline implementation (Chen, Lin, and
Marshall, 2018). The results of the DNP project were consistent with Chen, Lin, and Marshall’s
(2018) findings.
The DNP SDD protocol implementation results were not as what were originally
expected. The clinical site conducted a pilot study for electrophysiology (EP) procedures using
the established SDD processes. The pilot study was very successful as strong EP physician
engagement and leadership was crucial in the process changes and success of EP SDD
implementation. It was expected that PCI SDD protocol implementation and results would be
similar to the EP pilot study; however, poor PCI physician engagement and leadership led to the
lack of the PCI SDD protocol implementation. Koshy, George, and Das (2020) reviewed current
literature regarding SDD following elective PCI and noted difficulty in changing culture, lack of
physician buy-in, and conservative practice as barriers to implementation. These barriers were
consistent with the DNP project and subsequently impacted performance of the SDD protocol
(Koshy, George, & Das, 2020).
Evaluation of Project Results.
The overall goal of the DNP project was to improve access to cardiovascular care at an
inpatient facility in Pulaski County, Arkansas through the creation of a SDD protocol following
elective PCI. This gap in care was not improved through the implementation of the SDD
protocol during the implementation period as implementation failed and was subsequently
delayed at the clinical site. The SDD percentage was higher during the 10-week data collection
period as compared to the previous four quarters and the estimated baseline percentage; however,
the increases were not a result of DNP project implementation.
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Overall, the project was not very successful due to the lack of physician engagement. To
improve this gap in care in the future, physician engagement and buy-in must occur so that
patients can be sent home via the SDD protocol following elective PCI. After it was identified
that the interventional cardiologists had not been engaged, positive adjustments were made that
led to positive changes. Physician buy-in substantially increased following individual meetings
with this PI, though the cardiologists were hesitant to begin implementation immediately.
The clinical site made negative adjustments during DNP project planning that led to poor
project implementation. The clinical site administration voiced and owned plans for physician
engagement early during DNP project planning. Unfortunately, the engagement efforts were not
effective. This PI was met with significant resistance and hesitation once different strategies
were initiated to increase physician engagement during implementation. The SDD protocol is
still projected to become the standard of practice at the clinical site per the hospital
administration, but physician engagement and buy-in must be achieved for implementation to be
successful. For future implementation of the SDD protocol, the interventional cardiologists must
be included in decision making. Though the project was not successful during the planned DNP
implementation period, implementation will continue to take place at the clinical site over the
coming months and years.
Discussion
At this time, the impact of SDD protocol implementation is somewhat unknown as
implementation has not occurred to date. There were barriers, limitations, and bias that led to
the delay of SDD protocol implementation that will be discussed below. Of note, the clinical
site still expects to implement the SDD protocol following elective PCI using this PI’s
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protocol; however, efforts to increase physician engagement and buy-in must take place before
implementation will begin.
Healthcare Quality Impact
The implementation of a SDD protocol following elective PCI was created based on
current, evidence-based practice recommendations from the SCAI (Seto et al., 2018). Evidence
indicates that advances in clinical practice have made selective SDD following elective PCI a
safe process that is associated with high patient satisfaction and no adverse effect on patient
safety (Amin et al., 2018; Seto et al., 2018). Regardless of discharge timing, the patient
continues to receive high quality cardiovascular care at the clinical site. Out of the 55 patients
that underwent elective PCI procedures between December 27, 2020 and March 6, 2021, there
were no documented complications or readmissions within 14 days of discharge. Of these 55
patients, 20 underwent SDD via non-established processes. This data further supports the
safety of SDD following elective PCI. Though the established SDD protocol was not
implemented at the clinical site, safety data and current evidence support further
implementation efforts.
Economic and Cost Benefits
There are substantial economic benefits of implementing a SDD protocol following
elective PCI for the clinical site. As stated above, the clinical site conducted a proforma in
January 2020 that recognized a 5.4% increase in Cath lab volume over the previous 12 months.
The increase in case volume caused difficulties with throughput in all the cardiac areas which led
to consistently full cardiac units. The proforma analyzed the average cost of an atrial fibrillation
ablation minus the procedure costs to determine the difference in hospital cost between OO and
SDD. It was found that the non-procedural cost difference between one night of OO and SDD
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was $1,479 per case. The clinical site felt that the cost savings for OO vs. SDD would be the
same following elective PCI. During the 10-week data collection period, 20 of the 55 patients,
or 36.36%, who underwent elective PCI were discharged home via non-established SDD
processes. If the clinical site had met its goal of increasing the percentage of SDD to 50% by the
end of the data collection period, there was a potential of an additional $11,092.50 dollars in
hospital cost savings during that period of time alone using the previous calculations.
Within the last 4 reported quarters, October 2019 through September 2020, there were
324 elective PCI procedures completed with an average SDD percentage of 25.3%. If the clinical
site had met its goal of increasing the percentage of SDD from 25.3% to 50% during that time,
there was a potential cost savings of $239,598 dollars by discharging 162 of the 324 patients via
SDD. It was estimated that the savings acquired with SDD PCI during the last four quarters was
$121,236.59 which is a difference in potential savings of $118,361.41 if the goal had been met.
Increasing the percentage of SDD following elective PCI during future implementation could
drastically increase clinical site cost savings. Shroff et al. (2016) estimated that discharging 50%
of patients who undergo PCI via SDD could save the US healthcare system between $200 to
$500 million dollars per year.
Additionally, if SDD protocol implementation increases access to cardiovascular care
with improved bed utilization as expected, there remains an opportunity for additional revenue
due to previously impossible patient admissions. The hospital hired a discharging APRN for
approximately $110,000 dollars per year who has been discharging all eligible patients following
elective EP procedures. The clinical site expects that she will facilitate discharges following
elective PCI procedures as well. The clinical site must continue to justify the discharging APRN
position with increased revenue following SDD protocol implementation. If implementation is
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successful and has a substantial financial impact, it is likely that the SDD protocol will become
the standard of practice at the clinical site and within other facilities in the health organization.
Limitations
There were many limitations that were identified during the DNP project
implementation. The limitations that were identified included physician engagement, clinic
engagement, administrative support, implementation timeline, sample size, and Cath Lab
scheduling. These limitations likely impacted results of the DNP project.
Factors Affecting Project Result
As previously stated, there were a number of factors that were identified as limitations
during DNP project implementation. The following factors listed below may have negatively
affected the results of the DNP project.
Physician Engagement & Buy-In.
As stated previously, the lack of physician engagement and buy-in was the chief barrier
in the implementation of the SDD protocol following elective PCI. The lack of engagement
affected project results negatively and ultimately caused the failure of implementation efforts.
The clinical site administration voiced and owned plans for physician engagement early during
the DNP project. Unfortunately, the engagement efforts that were utilized were not effective.
Though many physicians were aware of upcoming changes, not all were involved in the
multidisciplinary team meetings in which the SDD processes and protocol were established.
Many voiced that they were not aware of the established SDD protocol until implementation
was set with the piloting interventional cardiologist.
There were many efforts made to minimize this limitation. This PI encountered
significant resistance and hesitation from the interventionalists when various strategies were
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utilized to increase physician engagement. This PI created educational flyers for the physicians
that detailed the background and significance of the problem; the current evidence regarding
safety of SDD following elective PCI; the success of the EP SDD protocol implementation at
the clinical site; the proposed SDD PCI protocol; and additional information regarding what
would be required from the physician for implementation. This flyer was emailed to the
physicians by administration. Following delivery of the physician flyer, no further physician
support was gained.
The most notable efforts made to improve engagement was through individual, inperson meetings. This PI conducted individual, in-person meetings with almost all
interventional cardiologists to gain support and engagement, but the efforts to begin
implementation during the set implementation period were futile. This PI did meet with one
physician that was very encouraged by the efforts to implement the SDD protocol. This
particular physician has since spear-headed efforts for future implementation.
This limitation must be addressed for future implementation. Since attempted project
implementation began with the piloting interventionalist, individual and group meetings with
the interventionalists have taken place with ever improving group support. It is likely that SDD
protocol implementation will take place within the coming months at the clinical site.
Clinic Engagement & Procedure Scheduling.
Clinic engagement may have limited project implementation as there were no efforts
made by the nursing staff to begin screening patients for SDD eligibility when scheduling
elective PCI procedures. Efforts made to minimize this limitation included emailed staff
education, frequent reiteration of education, and frequent contact with clinic managers via
zoom meetings. None of the strategies that were used improved engagement. This lack of
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engagement was likely due to the lack of physician engagement. In future implementation, the
SDD processes must be reinforced with the clinic staff to effectively implement the SDD
protocol. The physicians suggested that the clinic schedulers should ask about patient
eligibility with each elective PCI procedure that was scheduled.
Administrative Support.
The lack of administrative support was a notable limitation for the DNP project. As
stated previously, administration took ownership of important project roles that were not
fulfilled. This lack of communication contributed to implementation failure. After this PI
realized there was an apparent lack of physician engagement and buy-in, this PI and the
director of performance excellence at the clinical site met with administration to determine an
action plan to improve physician engagement and to minimize the limitation. Following the
meeting with administration, this PI began efforts to gain physician buy-in and engagement
through individual, in-person meetings with the interventionalists.
Implementation Timeline & Sample Size.
The implementation phase of the DNP project was limited to 6 weeks, December 27,
2020 to March 20, 2021, and data collection was limited to 4 weeks, December 27, 2020 to
March 6, 2021, due to limited access to data. During project planning, the implementation
period was projected to take place over a six-month period; however, this was not possible due
to time constraints and delays. The limited timeline inhibited true project implementation. A
longer implementation timeline would have allowed more time for support and implementation
given the project’s barriers. A lengthened timeline would have also allowed a larger sample
size. Statewide inclement weather during the second week of the planned implementation
period forced elective PCI procedure cancellation and further limited the potential sample size.
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This PI attempted to minimize this limitation through conducting individual meetings with the
interventional cardiologists to gain support to begin implementation. Though SDD protocol
implementation did not take place during the established implementation period, the clinical
site expects that implementation will begin in the coming months.
Cath Lab Scheduling & Staffing.
Other potential limitations were Cath lab scheduling and Cath lab staffing. According to
the clinical site, there was one fewer Cath lab in rotation due to poor lab staffing. The
problems with staffing decreased the clinical site’s ability to complete as many procedures as
expected during the established implementation period. Though SDD protocol implementation
failed, the lack of Cath labs could have created limitations on the number of procedures that
could be completed and further difficulties with patient throughput. This PI spoke with
administration regarding this limitation.
Factors that Limit Transferability
The established SDD protocol was created specifically by and for the clinical site. Due
to the specificity of this DNP project and patient population, the SDD protocol and processes
could not be used in other units within the facility. After future implementation by the clinical
site, implementation results may be utilized to initiate change in other facilities within and
outside the hospital system. Though similar processes could be utilized, variations must be
considered to make the protocol successful for other facilities.
Of note, the discharging APRN was a huge asset in the implementation of SDD of EP
procedures and will be vital in continued SDD PCI efforts. Other facilities may or may not
have the Cath lab volume to support a similar position. If the facility is not able to support the
position, the SDD protocol would require additional process changes.
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Factors that Affected Internal Validity
Despite the failure of SDD protocol implementation, there were factors identified that
either affected or will affect internal validity in future implementation. These include patient
and physician bias.
Patient Bias.
There was a potential for bias of the patient concerning their opinion and preference
regarding SDD following the elective PCI procedure. When the SDD protocol is implemented,
patient preference will affect who is discharged home via SDD verses OO and thus will affect
the results of implementation. The clinical site must take all necessary precautions to minimize
patient bias.
Physician Bias.
Another potential bias identified was physician bias. This bias affected project results
tremendously as the apprehension, lack of engagement, and lack of buy-in caused project
implementation failure. Efforts must be made to relieve apprehension and improve physician
engagement to decrease the potential for physician bias and during future implementation.
Sustainability
At this time, the usefulness of the SDD protocol following elective PCI is unknown.
With the success of the EP SDD protocol, the clinical site is encouraged that implementation of
the PCI SDD protocol will also be successful. The clinical site has made a commitment to
implement the SDD protocol following elective PCI within the coming months. The facility
has a vested interest in the success of this project due to its potential of increasing access to
cardiovascular care, cost savings, and patient satisfaction. The facility will continue efforts to
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make the SDD protocol the standard of care within this patient population following future
implementation.
Recommendations
Further Implementation
This PI would recommend that the clinical site continue SDD protocol implementation
efforts as it has the potential for substantial impact on access to care, patient satisfaction, and
hospital cost savings. In future efforts, both administration and physician engagement and buyin will continue to be key factors for project success. As implementation begins, it will be
important that the discharging APRN owns implementation and continually refines the process
as is necessary. It will also be important that administration shows greater support to the
discharging APRN.
Practice Implications
Implementation of the SDD protocol has the potential to spur necessary practice
changes. After the SDD protocol is implemented, it is likely that it will become the standard of
practice for the clinical site and will be implemented in other facilities within the health
organization. Though the SDD protocol was not utilized, there were patients that were sent
home via other SDD methods as opposed to OO. Of the patients that discharged via SDD
methods, none had complications or readmissions within 14 days of discharge. This further
supports the safety of SDD following elective PCI. Healthcare quality and safety will be
preserved as the SDD protocol was created with safety in mind using the most current
evidence.

Policy Implications
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There are no current national, state, or site healthcare policies associated with this
project. The effects on state or national policies are unclear at this time; however, there have
been efforts from the clinical site’s national system to move towards SDD following elective
PCI. The clinical site voiced that they intend to continue implementation efforts with the
potential of creating a SDD policy and expanding to other facilities within the state if
implementation is successful. After further implementation, data analysis will take place to
determine if the evidence supports the site’s goals of practice and if the protocol should become
the standard of practice with expansion into other facilities.
Dissemination
Site and DNP Committee Reporting
This PI will disseminate the baseline data to the multidisciplinary team and key
stakeholders during a SDD meeting in April 2021 via video conference. Based on previous
attendance success, video conference methods will be used as they consistently had higher
attendance. Though implementation did not take place as planned, this PI will discuss the
baseline data and specific strategies that can be used to improve implementation in the future.
The clinical site has expressed that they would like this PI to remain part of the
multidisciplinary team for future implementation of the SDD protocol.
This PI will also present the project results and baseline data to the doctoral committee
at the University of Arkansas Eleanor Mann School of Nursing on April 14, 2021 at 1300
during the DNP intensive.

Professional Reporting
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At this time, the DNP project results will not be professionally reported as
implementation did not take place; however, this PI will consider publication after
implementation takes place if desired by the clinical site. The clinical site has expressed some
interest in publication after further implementation. If implementation is successful, it is likely
that results will be utilized to initiate change in other facilities within the organization. This PI
would be glad to assist in the presentation of the SDD protocol result and discuss SDD
processes at other facilities as desired by the clinical site.
The nursing journals that have been considered for future publication include the
Journal of Nursing Care Quality and the Journal of Cardiovascular Nursing. This PI would
also consider submitting an abstract for poster presentation at either a Sigma Theta Tau or an
American Association of Nurse Practitioners conference during 2022.
Conclusion
Cardiovascular disease remains the leading cause of death worldwide with significant
disease prevalence throughout the United States. There is an ever-increasing shortage of
cardiovascular bed availability that leads to decreased access to cardiovascular care. The
clinical site completed a proforma in January 2020 that noted an increase in Cath lab volume of
5.4% in the previous 12 months that was causing difficulties in throughput in cardiac areas and
shortages of bed availability in the cardiac units.
A multidisciplinary team created and attempted to implement a SDD protocol following
elective PCI to combat the lack of cardiac bed availability as evidence supports the safety of
implementation with associated improvements in access to cardiovascular care, hospital
savings, and patient satisfaction. The SDD protocol that was created incorporated all current
evidence regarding SDD following elective PCI. Strengths of the DNP project included the
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incorporation of a discharging APRN, hotel accommodations for patients who live greater than
60 miles away from the hospital, and the in-house “meds to bed” program to deliver all new
medications prior to discharge. Unfortunately, implementation was delayed by the clinical site
due to a lack of physician engagement and buy-in. The SDD protocol has not been
implemented at this time.
Overall, the project was not successful during the planned implementation period.
Though implementation was not successful, data from December 27, 2020 through March 6,
2021 was analyzed to serve as baseline data for future implementation at the clinical site. It
was found that baseline SDD rates were higher than previously estimated as physicians were
utilizing SDD on occasion via non-established processes. During the 10-week data collection
period, it was found that 36.36% of patients were discharged via other SDD methods. The
clinical site’s goal was to increase the percentage of patients that underwent SDD following
elective PCI from 15% to 50% by March 31, 2021. Though improvements were made in the
percentage of SDD, there remains a substantial potential to increase SDD percentages.
Currently, the project’s contribution to nursing practice knowledge and further
implications are unknown as implementation has not taken place. Further research in this area
is needed to provide the Central Arkansas community with greater access to cardiovascular
care. This SDD protocol should be implemented at the clinical site in the near future to
continue to improve access to cardiovascular care. Following successful implementation, it is
likely that the PCI SDD protocol will become the standard of care within the facility and will
be implemented in other facilities within the health organization. Additional research
conducted should include evaluation of the patients’ perceived feelings, patients’ satisfaction,
and physician attitudes related to SDD.
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Appendix B: Pre-Implementation and Final Process Flowcharts
Patient referred to
interventional
cardiologist as
outpatient &
accepted

Patient
undergoes
elective PCI

RN
assigned to
recover
patient
from
procedure

What essential care is provided
overnight to include in SDD?
What acute complication are
seen/in what timeframe? Can
SDD improve health outcomes?

Patient educated about
disease process &
possible procedure
RN
assigned to
prep patient
for
procedure

Physician
places postprocedure
order sets

Patient
consents to
procedure

Patient discharged home the
next day, often after noon

Patient presents to
cath lab for
procedure

Patient recovered in
Cath Lab until bed
assigned
Patient moved to 2East or
2NW for overnight
observation for one night
after PCI

Specific education
provided about
impending procedure
Patient
scheduled for
future
procedure
Patient prepared to
stay for overnight
observation for one
night if PCI occurs

Patient is seen at follow
up appointment in 7
days, readmitted, or seen
acutely ill

Bed
assigned on
2East or
2NW

Staff on 2East or 2NW
resistant to take patient
(short staffing/delay in
report/room cleaning)
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Appendix C: Evidence Table
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Costerouss
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2 USA
0
1
3

Theoretical
framework
not specified

Independent
variable=SD
D following
PCI

Clinical
Outcomes

System
atic
Review
&
metaanalysis

Primary
outcomes:
incidence
of total
complicatio
n, MACE,
and
rehospitaliz
ation
within 30
days
following
PCI.
Total
complicatio
n defined
as cardiac
and
noncardiac
complicatio
n including
access site,
bleeding
and
vascular
complicatio
n, need for
blood
transfusion,
and
cerebrovasc
ular events,

Sample
(N =)
Method

N=13
5 RCT and 8
observational studies
1999-2011
Performed by
PRISMA and
QUOROM groups
for randomized trials
and Cochrane
Collaboration and
MOOSE group for
observations studies.
Sample sough to find
reports of studies
with SDD after PCI.
Databases: PubMed,
EMBASE, and
Cochrane Library.
Key terms: same day,
same day discharge,
outpatient, day case,
day care, short stay
AND PCI, PTCA,
angioplasty, and
coronary angioplasty.
No language
restrictions.

Data
Collection tools

Data extracted include
study design, sample size,
population demographics,
coronary angiographic
characteristics, access site
for PCI, procedural
adjuvant pharmacotherapy,
procedural success rates,
outcome, ad follow-up data.
Absolute # of events for
each outcome was extracted
for SDD and OO groups
and entered into statistical
software.
DerSimonian and Laird
random effects model with
weights calculated using
the Mantel-Haenszel
method to acute for
differences in studies to
account for study variation.
Dichotomous outcomes
data measured and reported
as odds ratio (OR) with
95% CI for randomized and
observational studies.
Heterogeneity across
studies examined with
Cochran’s Q statistic and I2
statistic test, with I2 value
<25% considered low
heterogeneity, 25% to 50%

Brief Summary of Results

Systematic review and comprehensive
meta-analysis completed on all available
data comparing SDD after PCI with OO to
evaluate impact on clinical outcomes.
12 of 13 studies was single center (n=4,182)
patients and 1 was a multi-center
observation al study (n=107,018).
Location: 3 in US, 3 in Canada, 5 in
Europe, and 2 in Asia.
Involved a total of 111,830 patients (2039
in randomized trials and 109,791 in
observational studies with 4,179 (3.7%) in
SDD and 107,651 (96.3%) in OO group.
Mean age = 62+/- 4.9 years.
64% men, 32% DM, 82% HTN, 79%
dyslipidemia, 39% prior PCI, 23% prior
CABG.
Found that utilization of TRA is lower in
US than other countries. In 12 studies
conducted outside of US, TRA usage was
45%, but with the large US observational
study, TRA was only used in 3%.
Of the 2,039 patients in randomized trials,
1023 were in the SDD group and 1016 to
OO group. Of the 1023 assigned to SDD,
851 were successfully discharged home,
and 172 developed an indication for OO
and crossed into OO. Reasons included
procedural related complicationsà very

Streng
th of
eviden
ce
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readmissio
n within 30
days.

Alyasin, N.

2 Australia
0
1
6

Theoretical
framework
not specified

N/A

N/A

Inclusion criteria:
randomized
controlled trials &
observational studies
comparing SDD and
OO following PCI,
clinical and outcome
data for up to 30 days
following index PCI
procedure available
for both SDD and
OO groups
separately, and
intent-to-treat or
protocol driven
analysis.

System
atic
review
of
qualitati
ve or

Exclusion criteria:
studies reporting only
in abstracts or
conference
presentation,
reporting only
outcome data on
SDD patients with no
OO group
comparison, studies
reporting on
chronology of events
but patients kept for
OO, studies with
mixed outcome data
between diagnostic
and interventional
procedures or missed
outcome data for
both SDD and OO,
with no ability to
separate.
N/A

moderate, and value >50%
was considered substantial
heterogeneity.
Funnel plots were
constructed and inspected
visually for evidence of
publication bias.
Sensitivity analysis was
performed according to
study design (randomized
and observational) and
population size to
determine the effect of the
largest study on the
outcome and meta-analysis.

few were a result of social reasons or
refusal after randomization.
After length of stay after PCI in SDD group
ranged from 4 to 11 hours with >77% sent
home between 4 and 8 hours.
Selection criteria for SDD varied between
studies, with the majority agreeing on the
following criteria: elective PCI for stable or
unstable angina, low to moderate risk ACS,
successful, uncomplicated PCI, stable
clinical condition post-PCI, and patient
willingness to go home with the ability to
reach emergency care within 40 to 60
minutes, and adequate social support.
In the randomized groups, total # of
complications in SDD group was 67 of
1023 (6.5%) versus 56 of 1016 (5.5%) in
OO (OR: 1.20, 95%CI: 0.82 to 1.74).
Total # of complications reported in SDD
group in observational study was 148 of
3,156 (4.7%) versus 10,272 of 106,629
(9.6%) for OO (OR: 0.67, 95% CI: 0.27 to
1.66).
Incidence of rehospitalization within 30
days after PCI between SDD and OO
groups in randomized trials was 41 of 1023
(4.0%) versus 37 of 1016 (3.6%). (OR:
1.10, 95% CI: 0.70 to 1.74).

Literature search of
CINAHL, Medline,
PubMed, Clinical Key, and
Turning Research into
practice using OVID.

Incidence of rehospitalization within 30
days after PCI between SDD and OO
groups in observational studies 131 of 1,645
(8.0%) versus 10,147 of 105,827 (9.6%).
(OR: 0.62, 95% CI: 0.10 to 3.98).
Recent literature focuses on the safety and
comfort of SDD via transradial approach
(TR-PCI).
It has been established that there are fewer
puncture site complications following TR-

V

106
descript
ive
studies

Inclusion; articles
discussion SDD PCI.

PCI as compared to Transfemoral PCI (TFPCI).

Articles published between
2007 and 2015 were
included, as this include the
recent nature of the practice
and evidence of SDD PCI.

Increased safety of TR-PCI is r/t to clinical
advances such as drug eluting stents,
reliable instantaneous pressure devices, and
early mobilization—all of which are said to
increase patient satisfaction and aid in SDD.

Primary search terms
include:
SDD TR PCI, cardiac
intervention, PCI, discharge
plan, radial PCI, radial
approach complications,
anxiety post PCI, and
anxiety after cardiac
interventions.

First report of successful SDD was
published as early as 1997. The patient
experienced no adverse cardiac or bleeding
complications within first 24 hours after
PCI.

Primary assessment of each
article based on title,
abstract, year of
publication, and conclusion
in relation to safety and
comfort of SDD TR-PCI.
Exclusion criteria: articles
exclusive to the discharge
process post PCI, unstable
angina, or STEMI/NSTEMI
patients.
Discusses some
recommendations from the
British Cardiovascular
Intervention Society (BCIS)
and Cardiac Society of
Australia & New Zealand
(CSANZ).

Many studies conducted to examine the
efficacy and safety of SDD TR-PCI
demonstrate primary end points of MACE
or bleeding within 24 hours and 30 days
after discharge.
Most important clinical question regarding
SDD TR-PCI is its concern for safety
versus OO.
Abdelaal et al. (2013) found that SDD had
a similar risk-profile as OO. They found
similar rates of MACE, readmission, and
overall complications between SDD and
OS.
Brayton et al. (2013) collected data from
14,032 patients who underwent TR and TF
PCI of which 10,065 dc’d via SDD. They
found SDD PCI safe in patients carefully
screened.
Saad et al.(2015) looked at outcomes of
elective PCI with SDD TR and TF versus
OO. This study examined next day troponin
levelsà did not appear to have short or
long term risks in SDD vs. OO in elective
PCI.
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Singh et al. (2015) recruited 56 patients in
SDD elective PCI TR group and compared
with OO group. The patients were followed
at 24 hours, 30 days, and 6 months post
procedure. No MACE occurred in the SDD
TR population.
Alyasin (2016) states that for practice
changes to occur, evidence based practice
(EBP) guidelines/recommendations on
screening must be present.
It is noted that in 2009, the American
College of Cardiology with SCAI
recommended SDD after PCI (TR or TF
approach) in elective, stable patients who
undergo uncomplicated, single vessel PCI
with no comorbidities.
Hodkinson et al. (2013) found both elective
and selective acute patients can be
discharged safely via SDD. Found no
association between death and
rehospitalization in SDD PCI patients.
The CathPCI Registry data shows SDD is
safe with nearly equivalent rates of death
and hospitalization at 2 and 30 days
compared with OS patients.
Alyasin (2016) demonstrates a table that
shows examples of SDD PCI
inclusion/exclusion criteria.
Mavromatis (2013) suggests 10-20% of all
patients who meet criteria for SDD might
need to stay for OO.
Bertrand et al. (2008) EASY study found
patients with acute coronary syndrome may
benefit from OO due to risk of bleeding
following high dose antiplatelet agents at
puncture sites.
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Valle et al. (2015) studied the impact of
patient distance from PCI facility with no
found association between increasing
distance and adverse outcomes (including
readmission and mortality at 30 days and 1
year after SDD PCI).
Important items that need to be addressed
for safe SDD include observation time,
social support, discharge lounge, and
patient’s ability to handle stress and anxiety
of early discharge.
Alyasin (2016) notes recommended
observation time should be 4 to 8 hours in
patients without complications. Previous
literature demonstrated virtually no
complications between 6 and 24 hours post
PCI, leading to no benefit of observation
after 6 hours.
Patient must have access to social support
and quick follow up after SDD. Patients
should be with responsible adult for at least
first 24 hours after DC and should be
educated on management of possible
complications/bleeding and urgent follow
up.
Discharge lounges that include a
multidisciplinary team can ensure
successful SDD program.

Amin, A.
P.,
CrimminsReda, P.,
Miller, S.,

USA
2
0
1
8

Theoretical
framework
not specified

Patient
Centered
approach to
Same Day
Discharge

Complicati
ons
(mortality,
bleeding,
acute

Contro
lled
trial
without

N=1752
230 underwent SDD
during intervention
period.

Researches utilized the
National Cardiovascular
Data Registry’s (NCDR)
CathPCI risk assessment
tools to identify each

Current practice in UK and Australia: SDD
via TR-PCI in uncomplicated cases with 4+
hours of observation. Patients to receive
written instructions including possible
complications prior to discharge. Patients
should be functionally independent or have
adequate home support following DC.
Risk were reviewed by interventional
cardiologist in preoperative holding to
determine bleeding avoidance and contrast
limits.
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Rahn, B.,
Caruso, M.,
Pierce, A.,
Dennis, B.,
Pendegraft,
M.,
Sorenson,
K., Kurz,
H. I.,
Lasala, J.
M.,
Zajarias,
A., Bach,
R. G.,
Kulkarni,
H., &
Singh, J.

(SDD)
protocol
following
elective PCI
Tool used to
guide the
provider to
utilize SDD
based on
bleeding
risk,
bleeding
avoidance
strategies
used, risk of
AKI,
exceeding
contrast
limit,
successful
PCI, and
ischemic
complication
s. If a risk is
identified,
the provider
is urged to
consider
overnight
observation
(OO).

kidney
injury)
Trend in
SDD over
time
Patient
satisfaction
Hospital
costs
(direct
variable
cost, direct
fixed cost,
and total
cost)

random
ization

Not sure how many
patients were
assessed postimplementation for
the possibility of
SDD.
Convenience
sampling based on all
patients who
underwent elective
PCIs between
September 1, 2013 to
September 30, 2015

patient’s risk of bleeding,
mortality, and acute kidney
injury (AKI) preoperatively
and developed a method for
estimating safe contrast
limits.
The ePRISM clinical
decision aid was developed
to assess each patient’s risk
before PCI. Risks were
reviewed by interventional
cardiologist in preoperative
holding to determine
bleeding avoidance
strategies and contrast
limits.
Following the procedure,
the patient was called
within 2 days to discuss
patient status, medication
compliance, access site
issues, and patient
satisfaction using an 11
item questionnaire.
3.5 years of control data
obtained—uncertain if from
EHR of NCDR
CathPCI registry data.
2 years of postimplementation data was
analyzed—uncertain of
where data obtained from.
SDD criteria recommended
from SCAI expert
consensus model was
compared to their “patient
centered” SDD population
to determine the proportion
of patients not meeting
SCAI criteria for SDD.

Procedural success was analyzed based on
risk reduction and stability following the
procedure. If all agreed (nurse, MD,
patient, and family) the patient completed
SDD.
SDD increased from 0% before the
intervention to 14% in the first quarter, to
nearly 78% in the last quarter regardless of
transradial access.
The association of SDD with outcomes of
bleeding, AKI, and mortality was examined
using fisher exact test.
Association of cost of SDD was examined
with propensity score analyses and
propensity adjust.
Adjusted cost associated with SDD
estimated with total costs as dependent
variable and SDD and quintiles of
propensity score as covariates in linear
regression model.
In femoral access cases, SDD increased
from approximately 1% in the third quarter
to 69.23% in the third quarter of 2009 (preintervention) to 69.23% in the third quarter
of 2015.
Characteristics of patients with SDD and
those with OO were comparable.
SDD discharge was not associated with
adverse outcomes with 0% of patients
experiencing bleeding and mortality, and
only 0.4% of patients experiencing AKI.
While OO reported events of death,
bleeding, transfusion, and AKI events.
Compared the OO group, the mean total
cost of PCI for SDD was 6,710, or a cost
saving in 39.15%,
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The adjusted per-patient cost difference
between SDD and OO groups was $7331.
It was estimated that if SDD rates stayed
approximately 75% with an average of 250
elective PCIs per year, the total annual cost
savings would be approximately 1.8 million
dollars.
When compared to SCAI experts’
recommendations for SDD, it was found
that 1628 or 92.9% of the patients were not
eligible, leaving only 16 patients eligible for
SDD. Utilizing the novel “patientcentered” approach allowed for an
additional 214 patients to utilize SDD with
no adverse outcomes.
Amin, A.
P.,
Patterson,
M., House,
J. A.,
Giersiefen,
H., Spertus,
J. A.,
Baklanov,
D. V.,
Chhatriawa
lla, A. K.,
Safley, D.
M., Cohen,
D. J., Rao,
S. V., &
Marson, S.
P.

2 USA
0
1
7

Theoretical
framework
not specified

Impact of
transradial
intervention
and SDD
following
elective PCI

Associated
hospital
costs
Primary
outcome=
hospital
cost
associated
with PCI
Secondary
outcomes=
post PCI
bleeding,
vascular
complicatio
ns, blood
transfusion
s, and
length of
stay.
Post PCI
bleedin
defined
according

Retrosp
ective
chart
review

N=279,987
Patient data collected
from third quarter of
2009 through third
quarter of 2012.
Created national
dataset in which they
linked Medicare
Claims to CathPCI
Registy using
probabilistic
matching using
hospital national
provider ID number,
date of birth, sex, and
admission dates.
749,366 of 831,357
CMS
claims/procedures
were matched to
CathPCI Registry.
Of the 749,366 the
following were

Data collected from third
quarter of 2009 through
third quarter of 2012.
Key data elements included
access site, estimation of
costs, and clinical
outcomes. If more than one
access site used, the PCI
was classified with access
used for majority of the
PCI.
Used hospital-level, cost
center-specific cost-tocharge ratios to estimate
cost associated with PCI
care. Cost was estimated
using data from RIF using
revenue codes as reported
to Medicare. When
hospital revenue codes
were mapped to specific
cost centers, Cost to charge
ratios were used to estimate
costs. When codes could
not be mapped to cost

Of 279,987, TRA performed in 25,301 and
SDD occurred in 14,812 (5.3%)
TRA and SDD occurred in 3,424(1.2%) &
TFA and SDD occurred in 11,388 (4.1%).
TRA and OO occurred in 21,877 (7.8%)
and TFA and OO was the most common
post-PCI pathway occurring in 243,298
(86.9%).
Demographics: Average age 71.8. 178,703
males & 101,284 females. White race
253,126 (90.4% of cases). See article for
additional demographics.
TRA and SDD occurred in younger men,
with lower prevalence of cardiovascular risk
factors and comorbidities. Fluro times were
higher in TRA, while contrast volume was
lower.
Hospital costs:
1) Adjusted PCI costs of TRA vs TFA was
$916, favoring TRA.
2) Adjusted PCI costs of SDD vs OO was
$3,502 favoring SDD.
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to CathPCI
Registry
bleeding
definition:
suspected
bleeding
with
transfusion,
decrease in
hemoglobin
of >3.0
g/dL or a
procedural
interventio
n to correct
the
bleeding
event.
Vascular
complicatio
ns collected
by CathPCI
included
access site
occlusion,
peripheral
embolizatio
n,
dissection,
pseudoaneu
rysm
formation,
AV fistula,
or other
vascular
access-site
complicatio
ns
requiring
interventio
ns.

excluded: procedures
clearly indicated for
inpatient stay like
STEMI, NSTEMI,
chronic total
occlusion (CTO),
IABP, cardiogenic
shock and cardiac
arrest within 24
hours, patients who
died in hospital
within 24 hours of
PCI, and those with
missing variables
(cost, etc.).
All Medicare fee for
service beneficiaries
undergoing PCI
between July 1, 2009
and December 31,
2012.
All inpatient and
outpatient procedures
included in analysis.
Inpatient PCI
population identified
using CMS RIF file
with codes 00.66,
36.06, and 36.07 &
Outpatient identified
using CMS
Outpatient RIF and
corresponding CPT
codes of 92982,
92980, 92981, 92984,
G0290, and G0291.
No consent needed
from IRB.

centers, the overall hospital
cost-to-charge ratio was
used to estimate costs.
After cost-to-charge ratio
determined, charges for an
episode of care for each
cost center was multiplied
by cost-to-charge ratio.
Costs were inflated to 2014
dollars using medical
consumer price index.
Outliers were Winsorized
by trimming the 99th
percentile.
Secondary outcomes= post
PCI bleeding, vascular
complications, blood
transfusions, and length of
stay.
Developed 3 propensity
score models:
1) logistic regression model
to predict use of TRA vs
TFA
2) logistic regression model
to predict SDD vs. OO
3) multinomial logistic
regression model to obtain
predicted probabilities of
TRA SDD, TRF SDD, and
TRA OO with TRF OO as
the comparator for all.
Patient level variable for all
3 propensity score models
included: age, sex, race,
smoking status, diabetes,
hypertension, dyslipidemia,
fam hx of CAD, prior MI,
CABG, current dialysis,
prior CVA, prior PVD ,
chronic lung disease, PCI
indication, procedure status,

3) Adjust PCI costs by various pathways—
see table. TRA SDD was associated with
cost savings when compared to all other
pathways. The most substantial difference
in adjust cost was between TRA SDD (least
frequent pathway) vs. TFA OO (most
common pathway) which results in $3,689
in costs savings to hospitals favoring TRA
SDD.
Secondary Outcomes:
Bleeding occurred in 2.8% of patientsà
1.4% in TRA and 3.0% TFA (p <0.001).
Rates of transfusion and vascular
complications were significantly lower in
TRA group as compared with TFA.
Length of stay as 2.2 +/- 4.4days in TRA
group compared to 2.4 +/- 3.5 days in TFA
group. A difference of 0.2 days favoring
TRA.
Budget impact analysis:
For a hospital performing 1,000 elective
PCI/year, impact of converting TFA OO to
TRA SDD was examined. If the hospital
only sent 30% TRA SDD, potential cost
savings of $1million annually.
Nationwide, if 600,000 PCI procedure
performed with 50% being elective
procedures eligible for SDD, if 30% were
converted to TRA SDD, potential savings
of $332 million annually.
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severity of angina, current
HF within 2 weeks, LV
dysfunction, perioperative
evaluation, prior cardiac
arrest, # of diseased vessels,
probability of bleeding
according to NCDR
mortality risk model,
probability of restenosis
according to NCDR target
vessel revascularization risk
prediction model, hospital
type, and regional census
divisions.
Anticoagulation agents and
LOS not included in
propensity model as they
were directly related to
access site and casual
pathway of costs.
The following models yield
adjusted costs of TRI vs.
TRF and SDD vs OO:
1) To estimate independent
cost of access siteà
generalized linear cost
model using inverse
probability weighting
(IPW), with total hospital
cost as dependent variable
and TRA as independent
variable.
2) Independent costs of
SDD vs OO were estimated
via a generalized linear cost
model developed using
IPW, with total hospital
cost as dependent variable
and SDD as independent
variable.
Individual weights were
stabilized in IPW models to
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account for effect of
extreme weights in model.
A generalized linear cost
model estimated
independent costs of
various combinations of
PCI care pathways. Total
hospital cost was dependent
variable and various
pathways was independent
variable.
Adjusted differences of
secondary outcomes
estimated using IPW
generalized linear
regression model for LOS
and IPW logistic regression
model for bleeding.
Budget impact analysis
utilized mean costs of care
pathways to estimate
impact of converting TFA
OO to TRA SDD, TRA
OO, and TFA SDD for a
hypothetical hospital
performing 1,000 elective
PCI procedures annually
and for the country
performing 600,000 PCI
procedure annually.

Brayton, K.
M., Patel,
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SDD after
PCI

Death, MI,
or target
lesion
revasculari
zation
(TLR)

Metaanalysis

Search number yield
through database
search=760. 695
remained after nonEnglish articles
removed. After
exclusion criteria, 84
full text articles were

SAS used with statistical
significance for all tests
defined as p < 0.05.
Data collected via
comprehensive lit. search
using PubMed, SCOPUS,
and the Cochrane Library in
August of 2012.
Key word searches of
American Heart

Transradial access site of 60.8% in RCTs
and transfemoral access site of 70.0% in
observational studies.
Of the 7 RCTs (n=2,738), the mean followup time was 28.3 days.
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Major
bleeding or
vascular
complicatio
ns

eligible. Following
further assessment,
37 were found to fit
criteria for metaanalysis.

Association (AHA),
American College of
Cardiology (ACC), and
google scholar were also
included.

N=12,803 patients in
37 studies

Data extracted by two
reviewers.

7 RCTs (n=2,738)
between 1999 and
2011

Extracted data included:
total # of patients, # eligible
for SDD, # actually
discharged, and criteria for
deferring discharge among
those eligible for SDD.

30 observational
studies (n=10,065)
with no identified
years of retrieval.
Studies published in
English were
included if they
reported outcomes in
patients successfully
discharged home
same day as PCI.
Excluded studies:
those that did not
follow up at >or= to
24 hours, transferred
patients sent back to
referring hospitals,
and those included
diagnostic coronary
angiography cases
only.
Search strategy,
study selection, and
analysis adhered to
QUORUM
guidelines for metaanalysis.

Variables extracted
included: presenting
diagnosis, age, sex, past
medical history, and
procedural information.
.

Of the 30 observational studies (n=10,065),
the mean follow-up time was 19.9 days.
RCTs:
Among randomized SDDs, 87.3% were
successfully discharged via SDD post PCI.
Nearly 1/2 of the cases of deferral of SDD
occurred in one trial due to randomization
before procedure. Additional cause for
deferral occurred due to access site
complications, MD/patient preference,
recurrent chest pain, noncardiac reasons,
orthostasis, and arrhythmias.
No difference was found between SDD and
OO in primary endpoints (death/MI/TLR)
(7.17% vs. 6.07%; OR: 0.90; 95% CI: 0.43
to 1.87; p=0.78) or major bleeding/vascular
complications (1.88% vs. 1.29%; OR: 1.69;
95% CI: 0.84 to 3.40; p=0.15) in RCTs.
For RCTs, data was combined to estimate
pooled odds ratios (OR) and 95% CI for
SDD compared to control.
Observational Studies:
14,032 patients were described as eligible
for SDD, but 10,065 (71.7%) discharged
home on same day.
In observational studies, cumulative rate of
each outcome for SDD was obtained from
pooled analysis.
Statistical analysis performed using STATA
The primary composite endpoint of
death/MI/TLR occurred at a pooled rate of
1.00% (95% CI: 0.58 to 1.68), and major
bleeding/vascular complications occurred at
pooled rate of 0.68% (95% CI: 0.35 to
1.32). There were 15 reported deaths in
SDD group, 11 of which occurred >24
hours procedure and the remaining 4 were
unclear regarding timing.
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Search terms not
listed within article
but states it is
provided online.
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Defining the
length of
stay
following
PCI

Facility
requiremen
ts
PCI
procedure
and risk
stratificatio
n
Data
supporting
use and
safety of
SDD
Defining
LOS for
post-PCI
patients
Matching
reimbursem
ent with
LOS

This
article
is the
previou
s
clinical
recomm
endatio
ns from
the
SCAI
regardi
ng
length
of stay
followi
ng PCI.

Review of Literature
with no explicit
sample size listed.

The guidelines were
developed by an expert
consensus group from the
Society for Cardiovascular
Angiography and
Intervention (SCAI). The
experts reviewed various
RCTs, observational
studies, systemic reviews,
and meta-analyses to
formulate recommendations
in 2009. They were
developed using collective
experiences reported in
other countries and
practical working
knowledge of patterns and
practice in the US. These
guidelines have since been
updated.

Before OO was used, patients often stayed
at least 2 days in the hospital after
uncomplicated PCI. Patients remained on
bedrest for 12-24 hours after sheath
removal, which was frequently deferred
until the morning following the PCI
procedure.
The current standard of care for a patient for
uncomplicated elective PCI was an OOà
which was a substantial decrease in
observation time from previous. Patients
stayed for OO d/t concerns for abrupt vessel
closure and resulting complications, access
site complications, and management of
comorbidities.
The article defines various lengths of stay.
Outpatient is defined as a same-day
procedure. The patient undergoes PCI and
returns home or to a non-patient facility the
same working day. Observation is
considered <24 hours. For PCI, the patient
stays for OO and then discharged <24 hours
after procedure is completed.
Facility requirements:
Suggests having a unit committed for caring
for only short-stay patients. Suggests QI
involvement in all aspects of care including
complications, sentinel events, and patient
satisfaction. Recommends importance of
education—reinforces that SDD should not
compromise education processes.
The article defines several factors that
increase the risk of PCI: older age,
decreased renal function (eGFR <60
ml/min, reduced LV EF <30%, female
gender, DM, HF (NYHA Class III or
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greater), more complex lesions, and a
thrombus containing lesion. These were
found in multiple studies to increase risk of
in-hospital mortality and adverse effects.
Cautions about complications that may
occur. In-lab complications would be noted
immediately and would prolong
hospitalization. The article cautions against
complications like contrast-induced
nephropathy and worsening CHF that
would not develop immediately.
It would be advised to use validated scoring
models to assess “at risk” patients with for
in-hospital mortality, and MACE after PCI.
At the time of publication, there were 3
randomized studies comprising <2000
patients in which early discharge was
compared to OOà all 3 employed
screening criteria that excluded patients due
to clinical, procedural, or social factors that
would preclude SDD.
It’s important to note that it was found in
Jabara et al. study that all complications
occurred within 6 hours, with none
occurring between 6 and 24 hours post-PCI
(n=45).
SCAIs statement supports the use of patient
criteria to rule out patients that should not
be sent home via SDD. The
recommendations suggest to include routine
follow up and patient education.
SCAI suggests specific protocols need to be
developed based on individual practice
patterns that extend beyond the definition of
level of care alone.
Recommendations for SDD Criteria:
- Presentation with stable angina with no
elevation in cardiac markers
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-Asymptomatic with abnormal stress testing
-No significant comorbidities including
heart failure, significant or symptomatic
chronic obstructive pulmonary disease,
symptomatic peripheral vascular disease,
known bleeding diathesis or coagulopathy,
other significant organ system disease, or
history of contrast allergy
-Normal renal function with estimated
glomerular filtration rate (eGFR) greater
than or equal to 60ml/min
-Normal or near normal left ventricular
ejection fraction with no valvular
regurgitation
-Full load with a thienopyridine and no
glycoprotein IIb/IIIa inhibitor used
-Single vessel PCI with <28 millimeter
stent, no balloon angioplasty alone, or other
interventional devices used
-Successful, uncomplicated procedure with
no occurrence of: “no reflow,” acute vessel
closure during procedure, vessel dissection,
compromised side branch flow.
-Immediate post procedure access site
stabilization with the use of a closure device
or secure manual compression, or via TRA
or brachial artery cut down.
-Patient and family willingness to discharge
via SDD, appropriate home support, and
rapid access to PCI facility and emergency
services should complications occur
Reports low incidences of TRA at 1.3% of
PCI procedures from NCDR.
Expert panel found it appropriate to reevaluate the level of care and LOS for
patients undergoing PCI as a cost reduction
strategyà identified four categories of care
following PCI with definitions, inclusion,
and exclusion criteria.
States the biggest concern is to develop a
system that does not cause harm or adverse
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consequences to the patient due to
premature discharge.
State that recommendations may change as
evidence surfaces.
The recommendations state that if a patient
can be managed as an outpatient, they
should be paid APC-level reimbursement.
Chen, Y.,
Lin, F., &
Marshall,
A.
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SDD and
SDD
processes
established

SDD
compliance
Individuallevel
knowledge,
attitudes
and beliefs,
organizatio
nal
processes
and
resources.

Quasiexperim
ental
Quantit
ative
study

N=1035 procedures
in 1000 patients.

Parallel
mixedmethod
s design
study

All outpatients
scheduled for
angiography with or
without PCI between
June 2016 and
December 2016 were
invited to participate.

Authors
studied
both
quantita
tive and
qualitati
ve
approac
hes.

Of the 1000, 342
PCIs were performed
on 308 patients.

Utilized convenience
sampling.

Process evaluation to help
understand what
contributed to the
outcomes.

SDD guideline was developed by nursing
and medical leaders at the facility and
implemented by the nursing management
team.

6 month implementation
period

Established process:
Eligibility for SDD assessed at 3 points:
Before, during, & after PCI.
The criteria guided the clinicians’ decision
about safe discharge following PCI.
Before: all patient assessed in outpatient
setting before procedure.
During: cardiologist would confirm the
procedure was successful and performed via
TRA as per the SDD guideline.
After: patients were observed for 4 hours in
short stay unit and sent home if no
complications arose during observation
period.

Lead author noted on-site
observations assessing
eligibility for SDD of all
patients undergoing PCI.
The number of patients
undergoing PCI was
documented with eligibility
for SDD before, during, and
after procedure.
Staff adherence to guideline
for SDD patients was
evaluated using 8 key
performance indicators:
electrocardiography,
follow-up appointment
made, seen by a cardiac
rehab nurse and pharmacist,
discharge information given
to patient, complete
discharge paperwork being
provided to patient, EMR
record entry made by senior
medical officer, and next
day phone follow up
conductedà All variations

Modifications to inclusion criteria were
made 4 months after implementation
beganà included patients >80 if
appropriate on Fridays if senior medical
officer was conducting follow up calls the
next day.
Of the 1000, 342 PCIs were performed on
308 patients. Among the 308, 12 patients
were admitted twice and had 1 PCI on each
admission; 22 had 2 PCIs during same
admission.
Of 308 who underwent PCI, 258 were
ineligible prior to procedure. Of the 50
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from procedure was
recorded.
Phone surveys were used to
evaluate patient and relative
satisfaction with SDD.
Patients & relatives were
called within 24 hours of
discharge to ask about
satisfaction with SDD
process—surveys can be
found online
SDD compliance and
survey data analyzed with
SPSS.

remaining, 47 met eligibility criteria and 3
did not meet criteria but were considered
eligible.
Of the 50 patients, only 22 patients were
sent home same day. The remaining 298
were initially deemed eligible for SDD, but
were admitted for OO.
2 patients were discharged via SDD that did
not meet renal requirements.
Adherence to guidelines found that the
highest rate of compliance=EKG attended
to, follow up appoints with cardiologists
made, and seen by cardiac rehab nurse and
pharmacist before SDD. Areas of poor
compliance=discharge preparation and
next-day follow up calls. Adherence was
variable over the 6 months evaluation
period from 62.5% to 100%. It is not clear
what actual compliance percentages were
and in what areas.
It is noted that physician preference and
individual clinical decision making
contributed to variations on SDD guideline
implementation.
44/50 consented to completing satisfaction
survey. All were surveyed regardless of
whether they remained eligible for SDD. 5
patients were not able to be reached by
phone. 29 relatives consented to study with
27 completing the survey (16 SDD relatives
and 11 OO).
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Elective PCI

LOS

Internat
ional
survey
of

N=505 interventional
cardiologist
respondents

Survey Monkey created—
with questions that covered
interventional cardiologists’
current practice of LOS

There are no recorded results in the study
regarding satisfaction. It is stated that
surveys were taken, but results were not
available in the article.
Chi-square test for comparison of
proportions from independent samples used
for categorical data.
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W. P.,
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interven
tional
cardiolo
gists
discussi
ng
opinion
on what
represe
nted an
appropr
iate and
safe
length
of stay
after
PCI.

Total of 505
respondents:
52% within US
17% within Canada
15% within UK
16% elsewhere
62% were SCAI
members.

following elective PCI &
factors that influence LOS
decision. Factors included
patient, procedure,
anatomic, complication,
and social factors based on
2009 SCAI consensus
document.
They used SCAIs
definitions of outpatients
(same day procedure),
observation (<24 hours),
and extended observation
(>/= 24 hours), & inpatient
admission (< or >24 hours)
to describe LOS in the
survey.
Survey sent to
interventional cardiologists
in US via SCAI, to
interventional cardiologists
in Canada via CAIC, and
the UK via BCS/BCIS
It was also available on
AHA’s “the heart” website.

Measures of concordance used were kappa
statistic and percent agreement.
Statistical analysis performed using
MedCalc software & Kruskal-Wallis test
utilized GraphPad Prism.
Total of 505 interventional cardiologist
respondents:
52% practicing in US
17% within Canada
15% within UK
16% elsewhere
62% were SCAI members
Response rates from major PCI societies
polls were SCAI 12%, BCIS 11%, CAIC
44%
Reported length of stay:
24% practice outpatient PCI, 70% practice
OO, and 6% practices extended obs or
inpatient admission; however, there was a
large geographic variationà SDD practices
by 14% of US cardiologists and 32% of
Canadian cardiologists (P=0.003) and 57%
from UK (P<0.0001).
Concordance with Guideline Criteria:
59% were not aware of any guidance or
statement defining LOS, though US
cardiologists were more aware (49% vs
32%, p=0.0003).
In the US, 14% reported SDD, 80%
reported OO, and 5% reported
inpatient/extended observation (p=0.0003).
It was found that when compared to SCAI
recommendations, there were high rates of
non-agreement in US cardiologists across
the 41 parameters and complete outside of
the US (55% vs 100%) (non-agreement
defined as >25% respondents outside of
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guideline)—found there was poor
concordance between responding
cardiologist and SCAI consensus with mean
weighted kappa for all respondents being
0.33 (95% CI 0.32-0.35).
Poor agreement with guidance was found
particularly low for patient factors and
complication parameters with <50%
agreement with recommendations.
Percentage agreement with each category of
recommendation was lower for non-US
respondents compared with US
respondents.
Length of Stay after elective PCI by
access site:
Default use of TRA for PCI reported by
46% US cardiologists and 68% of non-US
cardiologists
Patients with TRA had higher rates of
outpatient PCI with SDD than those with
TFA.
In PCI via TFA, cardiologists reported
higher rates of SDD if vascular closure
device was used compared to manual
hemostasis (31% vs 13%, P<0.0001).
Though, even with VCD, SDD were not as
high as TRA (31% vs 41%, P=0.008).
Length of stay after elective PCI
depending on Center/Operator volume:
Centers with higher PCI volumes and
higher volume individual operators were
more likely to utilize SDD.
Elfandi, A.,
&
Safirstein,
J. G.
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NA

NA

Benefit
s of
transrad
ial
access
with
SDD

NA

Traditionally, patients go
home following elective
cath, but stay for OO when
PCI occurs due to concern
of complication and
management of
comorbidities.

States the last recommended guidelines for
LOS following elective PCI were in 2009
from SCAI. AHA/ACC /SCAI published
guidelines for PCI in 2011; however, SDD
was not addressed—article states that since
publication, TRA in the US has been well
demonstrated as safe & feasible.
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after
PCI

Most dreaded/serious
complication=acute target
vessel closure—during
early angioplasty, this
occurred in as high as 25%
of PCI proceduresà now
DAPT and stent
improvement has provided
a rapid decrease in acute
vessel closure—now
reported in <1% of patients
following PCI
TRA (compared to TFA)
has demonstrated a
statistically significant drop
in vascular access
complications in numerous
trials, across all patient
subsets and clinical
presentations.
Recent studies demonstrate
TRA with lower access site
complications, quicker
recovery times, decreased
procedure costs, and higher
patient satisfaction—all of
which support SDD after
PCI.
Evidence demonstrated
zero complications
occurred between 6 and 24
hours post-PCI, which has
been reproduced in
additional studies.
Safety benefits from TRA:
when compared to TFA,
TRA reduced adverse
clinical outcomes including
composite of major
bleeding not related to
CABG, MACE, and allcause mortality.

Elfandi & Safirstein (2018) state that strict
exclusions based on pre-existing conditions
and age should not be a barrier to SDD, but
rather they suggest selecting patients based
on individual process and discretion of
provider.
Implementation of SDD:
Success relies on hospital, provider, and
patient receiving care. Operator concerns
are patient safety and procedural success
with safe discharge. Hospitals are
experiencing increased demand for hospital
beds and high volume of angiographic
casesà they are under constant pressure to
provide appropriate post-procedure care,
education, and safe disposition
A proposed solution is to shorten LOS
and avoid need for bed/OO.
Patients should be engaged in early DC—
ambulate ASAP, should leave with
medications in hand via in-house pharmacy
to alleviate some concern for
anticoagulation compliance
Social support plays crucial role in SDD.
Home proximity to hospital also plays
crucial role—should be included in
eligibility criteria
TRA has been associated with cost saving
of $830 US dollars per PCI
Cases that meet criteria should be
completed earlier in the day given
recommended 4-6 hours of observation
post-procedure
Staff involvement is vital to SDD protocol
implementation. Using a checklist of
potential hazards in evaluating patient for
SDD, staff plays a role in the ultimate
outcome.
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Contemporary stents (DES)
provide easier
deliverability, small
crossing profiles, better
trackability, and improved
vessel patency as compared
to older generation DES
and BMS.
Changes in antiplatelet
therapy play an important
role in decreasing acute
vessel closure.
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Radial
Access

Clinical
outcomes
for
coronary
interventio
ns in
patients
with
coronary
artery
disease
Primary
end points:
all-cause
mortality
and major
bleeding
Secondary
efficiency
and safety
outcomes
include:
MI, stroke,
MACE,
and major
vascular
complicatio
n

MetaAnalysi
s of
RCTs

N=24 trials in metaanalysis
Patient #: 22,843
with CAD
undergoing PCI were
included
Databases:
MEDLINE, Embase,
Cochrane Central
Register of
Controlled Trials,
and
ClinicalTrials.gov
Keywords: radial,
transradial, femoral,
transfemoral, and
randomized
controlled trial
No language,
publication date, or
status restrictions
were set.
All suitable
unpublished
completed registered
studies were

Meta-analysis performed
according to Preferred
reporting items for
systematic reviews and
meta-analyses 2009
guidelines.
Data extracted using a
standardized abstraction
form.
Studies assess with risk of
bias assessment tool for
RCTs.
Odds ratio with 95% CI for
endpoints were calculated
from available data.
Trial specific ORs were
combined with MantelHaenszel fixed effect model
or with DerSimonian and
Laird random-effects model
if heterogeneity was
statistically significant for
I2 >25%.
Also calculated trialspecific absolute risk
differences with 95% CIs

Impact of radial access was assessed across
subgroups identified as stable CAD,
NSTEMI, ACS, and STEMI.
All Cause Death:
TRA 176/11,359 (1.55%) compared to TFA
247/11,114 (2.22%)
OR 0.71
95% CI 0.59 to 0.87
Major bleeding:
TRA 123/11,467 (1.07%) compared to TFA
233/11,222 (2.07%)
OR 0.53
95% CI 0.42 to 0.65
MACE:
TRA 624/11,207 (5.56%) compared to TFA
730/10,948 (6.67)
OR 0.84
95% CI 0.75 to 0.94
MI:
TRA 431/10,240 (4.21%) compared to TFA
466/10,292 (4.52%)
OR 0.92
95% CI 0.80 to 1.05
Stroke:
TRA 45/9527 (0.47%) compared to TFA
43/9,595 (0.45%)
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considered for
inclusion.
Inclusion criteria:
randomized design
that compared TRA
and TFA for
coronary intervention
and inclusion of
patients undergoing
coronary
angiography
followed by PCI in at
least 50%
Exclusion: if TRA
and TFA were
compared in patients
only undergoing
diagnostic
angiography or PCI
in <50% cases
Studies assess with
risk of bias
assessment tool for
RCTs.

for each endpoint, which
were combined using fixedeffects or random effects
model as appropriate and
reported the number of
events avoided or caused
per 1,000 patients treated
with 95% CI.

OR 1.05
95% CI 0.70 to 1.59

Heterogeneity among
studies evaluated with
Cochran Q Chi-square test
with p<0.10 considered to
indicate statistical
significance. I2 of 25%,
50%, and 75% correspond
to low, moderate, and high
heterogeneity.

High risk of bias found in 19 studies with
low risk of bias found in 5 studies

Presence of publication bias
was investigated using
Harbord test and visual
estimate with contourenhanced funnel plots.

2 reviewers discussed
disagreements about
bias and
qualifications
Left with 24 trials in
meta-analysis
Heyde, G.
S., Koch,
K. T., de
Winter, R.
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Independent
Variable:

Dependent
Variable:

Same Day
Discharge
following
elective PCI

Primary
end points:
Major
cardiac and

Rando
mized
Control
led trial

800 consecutive
patients were entered
into the study 1 week
before their PCI
using computerized
randomization.
SDD group: 403

Patients interviewed via
telephone at 24 hours, 3
days, and 30 days post PCI
and those with reported
symptoms were referred to
own cardiologist.

Major vascular complications:
TRA 27/11,152 (0.24%) compared to
123/10,897 (1.12%)
OR 0.23
95% CI 0.16 to 0.35

No evidence of publication bias detected by
Harbord test for all endpoints, except for
major bleeding
Evidence for asymmetry found for the
endpoints of major bleeding, major vascular
complications and smaller asymmetry noted
for all-cause mortality
In overall population, TRA compared with
TFA, was associated with a lower risk for
all-cause mortality. Rates of MI and stroke
did not differ between TRA and TFA.
TRA was associated with fewer bleeding
events and major vascular complications.
Effect of the TRA on all clinical endpoints
was consistent across subgroups of stable
CAD, NSTE ACS, and STEMI
In subgroup pooled analysis of the RIVAL
and MATRIX studies, TRA compared with
TFA was associated with better clinical
outcomes among centers with high radial
expertise, but not among centers with low
radial expertise.
Effect of SDD on costs was conducted via
cost minimization analysis.
Events were counted towards the patient’s
randomized treatment allocation, regardless
of actual DC mode.
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cerebral
events.
(Cardiac
death,
myocardial
infarction,
stroke,
CABG, and
repeat PCI)
Severe
complicatio
ns of
arterial
puncture
with the
need of
blood
transfusion
or repeat
compressio
n from
randomizati
on until 24
hours after
PCI
Secondary
end
points=indi
cation for
extended
observation
,
occurrence
of major
adverse
cardiac
events, and
puncture
site
complicatio
ns for
randomizati
on until 30

Overnight
observation (OO)
group: 397
Enrollment occurred
between July 1, 2000
and March 21, 2003.
1453 PCI procedure
were considered
elective. Patient
chosen based on
eligibility of elective
vs urgent/emergent
PCI.
Inclusion: those
scheduled for elective
PCI who were able to
remain home before
procedure and who
did not have an acute
coronary syndrome.
Exclusion: ad Hoc
PIC, catheters >6
French, elective use
of glycoprotein
IIb/IIIa receptor
blockers, long term
systemic
anticoagulation use,
follow up difficult to
obtain, care person
not available at
home, no transport
home, patients who
lived >60 minutes
from the intervention
center, and no
informed consent
given.
Patients were asked
for written informed
consent provided that

Data on complications were
verified via EMR.
Data regarding clinical
events were obtained
through EMR.
Patient satisfaction was
measured following SDD
with a standardized
questionnaire 3 days post
PCI.
A 1-year F/U was
completed in all patients.

Successful PCI occurred in 383 of 403
patients in SDD group & 369 of 397 in OO
group.
During or immediately after PCI: Of 403
in SDD group, 67 (17%) required extended
observation & of 397 in OO group, 80
(20%) required extended observation
(P=0.26).
During 4 hr observation following PCI:
Of the 403 in SDD group, 10 (2%) required
extended observation & of 397 in OO
group, 5 (1%) required extended
observation.
Total 19% of SDD group and 21% of OO
group were identified for extended hospital
stay.
Patients were observed 4 hours after
observation for suitability for discharge. Of
SDD group, 82% (326 of 403) qualified ad
79% (312 of 397) of OO group qualified as
suitable for discharge.
Actual SDD occurred in 77% of patients
assigned to SDD group (311 of 403).
In both randomized groups, 15 patients
refused to comply with randomized
assignment and chose opposite discharge
policy.
Among both groups, the primary end points
as identified occurred in 9 (2.2%) of SDD
group and 17 (4.2%) in the OO group (risk
difference, -0.020; 95% CI, -0.045 to 0.004; P for noninferiority <0.0001)
Among all patients that qualified as suitable
for early discharge, primary end point
occurred in 1 of 326 (0.3%) SDD group and
2 of 312 (0.6%) OO group (risk difference,
-0.003; 95% CI, -0.014 to 0.007; P for
noninferiority <0.0001).

126
days post
PCI.

their home
circumstances were
conducive for SDD.

88% of patients completed patient
satisfaction survey. On scale of 0 to 100,
SDD patients gave 5.0 higher mean score
for discharge procedure compared to OO
group.
The mean difference of cost per patient was
258 Euro related to extra overnight stay.
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Transradial
Approach
Or impact on
access site

On clinical
outcomes
and
characterist
ics with
Same day
discharge

Retrosp
ective
descript
ive
study

N=352 patients
Convenience
sampling
Analyzed patients
who underwent
coronary
angiography for
elective or nonSTEMI acute
coronary syndrome
indications in Canada
at a hospital not
capable of PCI, that’s
why STEMI
excluded. Patients
would be reviewed
treated with
angiography and if
intervention needed,
would transfer by
ambulance to a
different hospital.
Patients were
excluded if: a
diagnostic angiogram
was performed with
no indication of PCI,
if PCI was performed
in a different day.

Data collected between
January 2011 and June
2017
Baseline clinical and
procedural data was
assessed and documented.
Planned to evaluate the
impact of access site on
clinical outcomes &
characteristics (TRA vs
TFA).
Bleeding complications
defined using Bleeding
Academic Research
Consortium (BARC)
definitions. the Early
Discharge After Transradial
Stenting of Coronary
Ateries (EASY)
classification was applied
for gradation of wrist
hematomas.
Compared continuous
variable using two sided ttest and categorical
variables were compared
using chi-square testing.
P value=<0.05.
Data analyzed with SPSS

Procedure: taken to cath lab and sheath
exchanged/upside in sterile manner, then
peri procedure anticoagulation and
antiplatelet strategies were. Access site was
at the cardiologist discretion.
If TRA, sheath was removed, and
hemostatic wristband applied for 1 hour to
achieve hemostasis. For TFA, sheath was
removed in cath lab followed by a closure
device insertion or manual compression in
holding room after achieving ACT <160
seconds.
Of the 352 patients, 36 were performed with
TRA & TFA of 316.
Patient demographics were similar.
Lower hemoglobin levels and higher
prevalence of peripheral vascular disease
were observed in the TRA group.
No patients in the TRA group experienced
bleeding or access related complications; In
the TFA group, 1 (0.3%) patient
experiencing minor oozing, and 9 (2.8%)
experienced access related complications
(P=0.606)—among which 2 patients had
post-procedural pseudoaneurysm that was
treated with local injection of thrombin and
1 patient required two PRBCs due to
bleeding from femoral access site. 6
patients had documented hematoma that
was treated conservatively and 1 had a
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catheter induced right aortic cusp tear that
progressed to the ascending aorta.
TRA group had significantly less contrast.
Study shows that inter-facility SDD PCI
after diagnostic angiogram appears to be
feasible and safe; with lower associated
complications and contrast use in the TRA
group.
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SDD after
PCI via TRA

Safety
Costeffectivene
ss
Primary
end
points=in
hospital
adverse
clinical
outcomes
including
death, MI,
urgent
target
lesion
revasculari
zation, and
access site
complicatio
n.

Retrosp
ective
observa
tional
study

Convenience
Sampling via
procedure record and
Conducted in large
tertiary referral center
on all patients who
underwent TRA-PCI
from 2004 to 2007.
Normal Allen’s test
confirmed before all
procedures.

N=450 patients
Data collected in a large
database
Data gathered: patient
demographics,
angiographic
characteristics, and
incidence & timing of
postprocedural
complications.
Adverse clinical events
were adjudicated by 2
cardiologists unaware of
patient histories
Demographics: 59 +/- 11
years; BMI 30 +/- 7, 13%
female, 27% DM, 64%
HTN, 71% HLPD, 6%
PVD, 5% CKD. Average
LV EF 54% +/- 9%.
Indications for intervention
included stable angina
(49%), unstable angina
(31%), NSTEMI (17%) and
STEMI (3%).

The article further highlights that lack of
adaptation to transradial approach, but also
enforces the safety with no complications
occurring in the TRA group.
After successful TRA under local
anesthesia, a 6Fr sheath was accompanied
by “cocktail” of intra-intravenous
vasodilating agents (nitro 200 mcgs, and
verapamil 2.5 mg, and 5000 IU heparin
bolus). All patients received heparin bolus
with infusion continued at 80 to 100 IU/kg
OR bivalirudin 0.75mg/kg bolus, followed
by 0.2mg/kg per hour infusion—all
anticoagulation terminated at end of
procedure.
At total of 24 (5.3%) postprocedural
complications were observed and divided
into 3 groups based on timing of occurrence
using 0-6 hours, 6 to 24 hours, 34+ hours.
Of the 24, 20 occurred during the first 6
hours and 4 occurred after 24 hours.
NO COMPLICATIONS OCCURRED
BETWEEN 6 AND 24 HOURS—the
assessed time interval between same-day
and next-day discharge (primary
endpoint)
WITHIN 6 HOURS:
Minor access bleeding occurred in 11
patients which were all noted within 6 hours
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630 lesions in 450 patients
treated with 540 stents.

and resolved with manual pressure and
reassurance.
Post-procedural MI observed in 8 patients
(1.8%) of whom 4 (0.4%) had no EKG
changes and were managed conservatively
without sequelae.
Intraprocedural dissection and hypotension
occurred in 2 cases (0.4%)-cardiac enzymes
next day, but otherwise treated medically
4 patients (0.9%) experienced chest pain
and EKG changes within first 6 hours—
emergent angiography in each case
indicated acute thrombosis and repeat PCI
was successful in all patients—with no inhospital mortality.
AFTER 24 HOURS:
4 postprocedural complications:
-1 CVA 28 hours post-procedure
-1 paroxysmal AFib 30 hours postprocedure
-1 referred for CABG 2 days after
procedure for unsuccessful treatment of
CTO
-1 underwent emergent CABG after
unsuccessful TRA-PCI of chronic right
CTO and died 3 days after procedure
Prolonged hospitalization:
57 (13%) had prolonged hospitalization
after TRA-PCIà 17 cases related to PCI
procedure, but none related to TRA. The
rest of the extended hospitalization
unrelated to PCI procedure
12 patients (2.7%) were discharged on same
day after successful uncomplicated TRAPCI—none had complications or
readmissions
Important to note the reduced access site
complication rat
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Also, NO complications occurred
between 6 and 24 hours, further
supporting SDD—the rare but dangerous
complication is subacute stent thrombosis
that usually occurs between 3-5 days, but
would not impact the choice of SDD vs.
OO
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SDD

Coping
Secondary
outcomes:
patients’
readiness
for
discharge,
anxiety
before
discharge,
satisfaction
, preference
for SDD
compared
with OO,
safety
outcomes,
and
adherence
to
clopidogrel
at 30 day
post PCI.

RCT

N=298
Patients recruited
Inclusion criteria:
<75years old with
type A or B lesion
who received closure
device after PCI.
Exclusion: recent
ACS & 3+ stents
placed.
March 2008 and
March 2010
undergoing elective
PCI via TFA at 2
medical centers
Randomized into OO
(148) and SDD (150)
groups

Data collected by trained
staff using standardized
questionnaires
Utilized post-discharge
coping difficulty scale
(PDCDS) via an interview
7 days post-PCI
procedure—primary
outcome
Baseline questionnaire
immediately before hospital
discharge. Computer
assisted telephone interview
used at 1 day after PCI for
SDD and 7 and 30 days for
all participants.
With sample size of 300,
had 80% power to conclude
noninferiority if lower
bound of 95% CI for the
difference in prevalence of
high coping for participants
randomized to SDD
compared to OO was <12
percentage points—
established by
investigators, no clinical
threshold guides difference
in high coping using
PDCDS available

The most commonly cited reason for OO
included surveillance for access site
complications, periprocedural events, and
abrupt target vessel closure.
Mean age of 55.9; 26% women, 33% white,
15% black, 35% Latino, 22% Asian.
Regardless off SDD or OO, >96% reported
being ready to discharge before discharge
21% SDD and 20% OO had scored of zero
indicating no coping difficulties.
High coping ability found in 79% SDD
(95% CI 73-86) and 77% OO (95% CI 7084)—difference of 2%—found that SDD is
non-inferior to OO in terms of patient
coping.
Clopidogrel adherence: 39 (13%) had low
adherence by 30 days—26 had score<6 and
13 had discontinued clopidogrel
15% SDD had low adherence and 11% OO
had low adherence to clopidogrel
No patients in SDD group reported chest
pain or MI within first day, though 3
reported visiting their doctor, and 1 went for
an emergency visit.—though no data
available for reasons for follow up care is
available—none experienced
rehospitalization or death at 30 days.
At 30 days, 111 in OO group and 3 in SDD
reported chest pain. other than CP, <5%
reported adverse events with no significant
difference across groups at 7 and 30 days.
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Baseline data included
sociodemographic,
smoking, pre-discharge
scale for readiness for
discharge, anxiety, postprocedure pain, and postdischarge care
coordination.
Post-discharge at 7 & 30
days: assessed with 10 item
PDCDS and about
satisfaction with discharge.
Items measured on 11-piont
scale (0-10) with range in
scores from 0-100, with
higher scores indicating
greater coping difficulty
and less satisfaction.
Adherence to clopidogrel
assessed by using Morisky
Medication Adherence
Scale-8-scores range with
low adherence to
clopidogrel defined as
scores <6. Patient asked if
satisfied with timing of
discharge-would you have
wanted to stay longer or go
home earlier? If you had
another procedure, what
would you want to do?
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Review
of
previou
s
studies

N/A

T tests & Chi Squared used
with SAS. p<0.05
Article selection not
identified.

79% of SDD and 49% of OO reported being
satisfied. At 30 days, only 9% of patient
discharged via SDD reported wanting to
have stayed longer, whereas 37% of OO
would have preferred to discharge home via
SDD.
When asked about discharge timing if they
had another procedure, 80% of SDD and
69% of OO expressed preference of SDD,
while 9% SDD and 20% OO reported they
would want to stay for OO if they had
another procedure, and 10% SDD and 15%
OO reported no preference in discharge
timing.

Despite advances in practice, TFA remains
most common approach, though TRA has
lower risk of bleeding/quicker recovery
times.
Economics of SDD:
-Cost savings of SDD mirrored with patient
satisfaction with no significant added
concern of safety.
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-Increasing pressure to effectively utilize
hospital beds for those that require inpatient
status
-Risk of decreasing net returns associated
with OO after uncomplicated PCI
-Economic advantages comes from cost
benefit related to decreased LOS.
Cost savings associated with SDD: total
saving $4984, room and board cost $1842,
central supply cost savings $924à don’t
know what it was being compared to,
unclear in article
-TRA PCI with SDD improves payment
without compromising outcomes, increasing
patient satisfaction, and reducing bleeding
risk.
SDD & Outcomes:
-Found to be safe with no additional
mortality or morbidity
-SDD after successful PCI after 4-6 hours
observation
-Safety for SDD in patients with ACS
established as non-inferior to OO after PCI
-Evidence may indicate safety of SDD after
high-risk ACS, if successful PCI and stable,
but the consensus is not to send home
STEMI
SDD & Complex PCI:
-First studies completed on low risk PCI
patients
-Recent study looked at safety of SDD after
PCI of CTOà found SDD was comparable
to OO with consideration of MACE at 24
hours
Barriers to Implementation:
-Conservative recommendation—often the
culture of the cardiologists
-Difficulty in changing culture that has been
practice for over 20 years
-Lack of Buy-in
-Change of this capacity requires extensive
planning and strategies for success—must
involve administration and hospital staff
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Same day
discharge

Primary
Clinical
Outcomes
(end point
all-cause
mortality
and
hospital
readmissio
n for acute
coronary
syndrome
at 30 days
post PCI).
Secondary
clinical
outcomes
included
primary
endpoint at
1 year and
30 day and
1 year allcause
mortality,
all-cause
hospitalizat
ion, and
coronary
revasculari
zation.

Retrosp
ective
Cohort
Study

N=35,972
SDD=10,801 (30%)
OO=25,171 (70%)
Sample size from
patients older than 18
years who underwent
elective PCI in
Ontario, Canada from
October 1, 2008 to
March 31, 2016.
Exclusions: those
with invalid health
card numbers, nonOntario residents,
aborted PCI
procedures, those not
linked to the cardiac
registry, and those
who had >1
overnight stay. If
patients had multiple
PCI during study
period, the first
procedure was used,
and further
procedures excluded.

Data was obtained via
CorHealth Ontario Cardiac
Registry by coordinators at
each of the 17 cardiac
centers providing PCI.
Data gathered included
demographics, clinical
characteristics, procedural
characteristics, procedural
characteristics, and
comorbid conditions found
relevant.
Additional risk factors,
comorbidities, ER visits,
and hospitalizations were
identified using the
Canadian Institute for
Health Information (CIHI)
discharge abstract database,
the same day surgery
database, and the national
ambulatory care reporting
system.

-Might look at medication non-adherence as
a balancing measure, as SDD may affect
compliance
-Suggest nurse led phone calls could result
in increased self-management of angina and
medication compliance
-Should consider travel time to facility
-Must include process measures as a study
had poor staff adherence to protocols
Of the 35,972 patients who underwent
elective PCI during study timeframe,
10,801 (30%) underwent SDD while 25,171
(70%) stayed for OO.
Inverse probability of treatment weighting
propensity score was used to determine
differences in baseline and clinical
characteristic between SDD and OO.
No significant difference between groups
for primary end point at 30 days.
In the propensity weighted cohort, SDD had
no significant difference in 30-day death
rates or hospitalization for ACS (1.3%
versus 1.6%; hazard ratio: 0.84 [95% CI,
0.65-1.08]; P=0.17) compared to OO.
There was a trend of lower 30 day all cause
hospitalization in SDD group (5.8% versus
6.4%; P=0.056).
SDD and OO had no significant difference
in 30 day rates of mortality or coronary
revascularization.
SDD costs were roughly 1200 Canadian
dollars less than OO.
Increasing SDD can potentially reduce
length of stay costs, increase hospital
efficiency, and improve patient satisfaction.
SDD also allows otherwise full bed to
become up for other inpatient admissions
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Effect of
TRA for
chronic total
occlusion
PCI

Major
bleeding,
access site
complicatio
ns, inhospital Qwave, inhospital
mortality,
pericardial
tamponade,
emergency
bypass
surgery,
coronary
perforation,
procedure
fluoroscopy
time,
contrast
medial
volume,
and
technical
issues.

System
atic
Review
and
Metaanalysis

N=9 Studies included
TRA=4591 patients
(4606 lesions)
TFA=5999 patients
(6011) lesions
All studies published
before/through
November 2018
Databases: Medline,
Cochrane, & Embase
Keywords: chronic
total occlusion, CTO,
transfemoral,
femoral, transradial,
and radial.
Limited to English.
Included studies that
compared outcomes
of TRA versus TFA.
TRA group included
patients who had RA
(uni or bi lateral)
Sensitivity analyses
conducted that
compared radial only
verses femoral or
radial/femoral CTO
PCI cases.

Two investigators worked
together to extract data—
discrepancies were settled
through consensus
Data extracted includes
study, patient, and lesion
characteristics & outcomes
of interest.
All statistical analyses and
plots performed using
review manager software
and EZR.
Percentages used for
categorical variables with
SD for continuous
variables. Categorical
variable compared using
fisher exact or Chi-Square
test. Continuous variable
compared using
independent-t tests, all tests
were 2 tailed with P value
</= to 0.05 as statistically
significant. Summary
results recorded as OR with
95% CI-calculated at 95%
level for overall estimates
effects.
DerSimonian and Laird
random-effects model and
random effects generic
variance methods were
used to calculate ORs and
mean differences.
Potential publication bias
was assessed using Egger’s

for hospitals that operate with very few
open beds.
Baseline characteristics:
TFA: younger; DM, HTN, prior MI, PCI,
and CABG more prevalent. Lesions likely
>20 mm long, higher J-CTO score, and
higher PCI failure rate. Less likely to have
mod-severe calcification—more likely in
right coronary artery or left main coronary
artery.
TRA: associated with lower risk of access
site complication (OR 0.34; 95% CI 0.220.51; p<0.001) and major bleeding (OR
0.22; 95% CI 0.10-0.45; p<0.001)
compared with TFA.
With sensitivity analysis, TRA was still
associated with lower risk of access site
complication and major bleeding.
There was no difference between contrast
volume (mean difference -20.9mL; 95% CI
-51.15 to 9.34; P=0.18) or fluoroscopy time
(mean difference -2 minutes; 95% CI -5.7 to
-1.5 minutes) use between the groups.
TRA had similar risk of pericardial
tamponade (OR: 0.85; 95% CI 0.24 to 3.02;
P=0.8) perforation (OR 0.93; 95% CI 0.5 to
1.7; P=0.83) emergent CABG (OR 0.79;
95% CI 0.29 to 2.11; P=0.63), and Q wave
MI (OR 0.52; 95% CI 0.24 to 1.21; P=0.13)
compared to TFA.
There was no difference in technical issues
between TRA and TFA.
Radial only CTO was compared to other
access sites. It was found that TRA CTO
was associated with significantly lower
incidence of access site complications (OR
0.36; 95% CI 0.21 to 0.61; P<0.001) and
major bleeding (OR 0.27; 95% CI 0.12 to
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(phenotype)
of patients
appropriate
for SDD

Same Day
Discharge

Retrosp
ective,
descript
ive
study

N=2174
SDD=1530
OO=644
Between January 1,
2012 and June 30,
2014, all patients
who underwent
elective and
nonelective PCI
(2,174) performed by
1 interventional
cardiologist was
included in the study
via convenience
sampling.
Included all elective
PCI procedures
including stable and
unstable angina,
patients presenting
with ST elevation MI
and non-ST elevated
MI, and patients
awaiting staged
interventions.

Periprocedural details were
recorded in PCI registry
from patients EMR.
Data included patient
demographic information,
procedural information,
vessels disease and lesionspecific information,
cardiac presentation, preintervention risk factors,
major events after PCI, and
discharge information.
Readmission data was
acquired using the
hospital’s registration
system used for clinical and
financial reporting. A
query for patients’
readmission/reason for
admission was created.

0.6; P=0.002). There was no difference
found in technical issues, contrast or
fluoroscopy time, and the incidence of
coronary perforation or tamponade.
Patients were deemed safe for SDD
following at least 6 hours of recovery per
the MDs discretion based on the patient’s
clinical picture.

IV

70.4% of patients were discharged via SDD.
Random forest plot analysis indicated 6
predictors of SDD. These variables
included: age, cardiac presentation, angina
classification within 2 weeks of PIC,
contrast, indication for PCI, and previous
PCI on same admission.
Positive logistic regression utilizing a
model with all 6 predictors suggested the
model was able to differentiate between
patients with SDD and OO after PCI was
statistically significant (x2(7.12, N=2174) =
511.12, P= <.005).
The strongest predictor of the phenotype of
SDD was cardiac presentation with stable
angina.
Data analysis completed R version 3.2.3
with SPSS. version 20.
Primary analyses between group differences
were calculated using independent t tests for
continuous variable and Chi-squared or
Fischer exact tests, as appropriate
Readmission within 24 hours of SDD
following PCI was 0.91% (14 of 2174)
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Independent
Variable:

Dependent
Variable:

Observ
ational
retrospe

N=1635

Data collected using
CardioReport Coro (clinical

High complexity cases, patients with
multiple comorbidities, and different
presentations are candidates for SDD.
All patients received standard practice care
for the unit.
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Discharge

Early
outcomes
following
PCI
Major
cardiac or
cerebrovasc
ular events
following
PCI
(MACCE:
death,
myocardial
infarction,
stroke,
urgent
repeat PCI,
urgent
cardiac
surgery, or
major
vascular
complicatio
n)
Readmissio
n rates
within 24
hours
following
PCI

ctive
study

Sampling included
consecutive patients
who underwent PCI
on the ambulatory
cardiac care unit
between April 1,
2007 to April 30,
2016.
1,073 were managed
with SDD.
563 were admitted
for overnight
observation for at
least one night.

and procedure information
obtained)

All uncomplicated cases were monitored for
4-6 hours then sent home with EKG
completed before DC. Patients instructed to
call if they had symptoms (Exclusion
criteria established).
Patients had troponin and CPK assays
performed at local PCP & called to verify
their status the following day after PCI.
The difference between outcomes of SDD
and OO were compared, with special
attention to immediate outcomes.
Of the 563 patient that were admitted for
OO during the observational period, 60
patients (3.7%) experienced adverse effects
during PCI. 52 patients (3.2%) experienced
adverse events 4-6 hours after PCI, and 450
patients (27.5%) were hospitalized without
adverse events for monitoring.
Radial access was attempted in 97% of
patients. If radial access failed, 50% used
contralateral radial artery and 50% used
femoral artery.
Overnight group: increased proportion of
women, DM, three vessel disease, LAD
stenting, and prescription of triple
antithrombotic therapy. Radial access used
less often.
SDD group:
No MACCE recorded within 24hours after
PCI.
No early deaths or stent thromboses.
2 patients readmitted for chest pain, but no
repeat PCI required.
Troponin elevation to 5x upper limit of
normal (>70ng/mL) was noted in 38.6% of
patients with CPK value above upper limit
(195 U/L) noted in 12.7%.
Most of the reasons that 450 without
adverse events stayed for OO was due to
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living >1 hour from hospital, late case PCI,
existing renal dysfunction, and difficult or
lengthy procedure.
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Review of literature
with no explicit
sample size listed.

The guidelines were
developed by an expert
consensus group from the
Society for Cardiovascular
angiography and
intervention (SCAI). The
experts reviewed various
randomized clinical trials,
observational studies,
systematic reviews, and
meta-analyses to formulate
the most current
recommendations regarding
SDD following PCI.

The guideline is an update from the SCAI’s
2009 document titled “Defining the length
of stay following percutaneous coronary
intervention.”
The guideline provides a concise
description of results from prospective
studies of SDD following PCI since the
previous guideline was published.
Studies have further demonstrated the safety
of SDD in patients undergoing PCI and
have been able to quantify that most
complications occur within 6 hours or >24
hours after PCI.
Many studies have validated patient
satisfaction and costs savings with no
negative effects on patient outcomes.
The updated guideline provides new criteria
to assess a patient’s readiness for discharge
following PCI.
These criteria fit into three categories:
procedure, patient, and program, or the
“three Ps.”
Procedure factors: successful procedure,
adequate hemostasis, and without
complication)
Patient factors: clinically stable, at baseline
mental status and vital signs, stable
comorbidities.
Program factors: safe monitoring at home,
appropriate guideline-directed medical
therapy, compliance with PCI performance
measures, and timely follow up.
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No sample specified

Results in both Columns:

Literature search of
Pub-Med from
January 1, 1995 to
July 31, 2015

Timing of PCI
complications:
-Early complications
include abrupt vessel
closure, acute stent
thrombosis, and access site
complications
-Delayed complications
(several hours after
successful PCI) include
access site bleeding, nonaccess site bleeding,
development of CHF,
delayed contrast reactions,
subacute stent thrombosis,
complications related to
sedation, and arrythmias.
-Studies found that
likelihood of complications
between 6 hours and 24
hours was extremely low
-Some studies show no
measurable differences in
total complications in
MACE between SDD and
OO

Terms used
“angioplasty, PCI,
and outpatient, day
case, ambulatory, and
same day”
Utilized 3 Reviewers
Includes: RCTs,
observational studies,
meta-analyses, and
guidelines/consensus
opinion documents.
No formal inclusion
and exclusion criteria
were applied, and
formal meta-analytic
techniques were not
used

Choice of access site:
-The choice of TRA and
TFA does not appear to
effect safety of SDD
-More importantly, it was
seen that SDD in patients
that have been
appropriately selected is
safe (as safe as OO)
-The overall incidence of
complications (bleeding
and vascular related

Ultimately, discharge planning after PCI
should be a medical decision made based on
the provider’s discretion based on what is
best for the patient.
Procedural Outcomes:
-Patients to be sent home via SDD should
have a successful PCI, no compromise of
side branch at least 2 mm in diameter, and
no postprocedural chest pain
-Occurrence of any of the above should
result in OO
Stabilization of vascular access:
-Concerns of vascular access complications
related to access site bleed or vessel
disruption has been key in continued OO
-Vascular access site complications have
decreased tremendously with use of TRA
refinement of TFA and sheath removal,
reduction in size of arterial sheath, and
vascular closure devices
-Primary benefits of TRA are reduced
vascular access complications, improved
patient comfort, and decreased recovery
time
-VCDs reduce time of hemostasis and
ambulation compared to manual pressure—
should utilize if using SDD
Provision for DAPT:
-Essential after stent placement
-Must include patient education to discuss
indication, adverse effects, and duration
after PCI
-Must plan to ensure patient understanding
of new meds
-Also suggests the use of in-hospital
pharmacy before discharge
Post-Procedural Process:
-4 to 6 hours of observation seems to be
efficient
-May need to consider time of day of
sending patients home
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complications) is low—
does not appear to increase
risk of rehospitalization &
mortality
Economic impact:
-Notes EASY study found
50% relative reduction in
health system costs, saving
1,086 dollars per patient in
US; EPOS found savings of
$350 per patient in US
-CMS classifying PCI as
outpatient procedure,
meaning not getting
reimbursed for OO
-Estimated that US could
save 200 to 500 million per
year if 50% utilized SDD
after PCI
-Important to note that
there are other potential
savings including
potential for reduction of
medical errors and
complications, increased
bed availability for new
patients, and cost-savings
for facilities.
Assessment of suitability
for SDD:
-Many validated tools
available in predicting PCI
risk and mortality based on
many characteristics, but
there are currently no scales
to predict risk in lower risk
patients
-Factors such as frailty,
present of social support,
and health literacy, may be
important in determining
suitability.

-Education with written instruction with
prompts and teach backs should be included
-Contact names and numbers should be
provided if a complication occurs
-Follow up the next day to assess for
complications, address questions, and
confirm receipt of adherence to DAPT
Program Imperatives:
-Must be hospital specific
-Focus on developing standardized protocol
for ID’ing patients
-Understand 25% to 35% may not be
suitable for SDD
-Criteria should be developed with
interdisciplinary teams
-Patient should be at baseline ambulatory
level at baseline
-If complication occurs or if there is a
concern for inability to provide care, the
patient should stay for OO.
Nursing Perspectives:
-suitable patients should be targeted early in
the day to facilitate timely discharge
-Recovery staff must observe for
complications
-Clear criteria should exist
Barriers:
-Conservative recommendations from SCAI
in 2009—severely limited patients able to
go home—age >70, abnormal renal
function, DM taking insulin, contrast
allergy, presence of any chronic disease,
multivessel disease, left main disease,
proximal left anterior descending disease,
bifurcation disease, saphenous vein graft or
internal mammary disease, and use of
glycoprotein IIB/IIIA inhibitors.
-Physician resistance
Growing evidence indicates hospital
environment as hazardousà infectious
colonization, accidents, drug errors, and
posthospitalization stress syndromes—
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N=1,174
2,189 patients
underwent PCI
between
January 2005 and
June 2006
1,174 were
determined to be
intermediate or high
risk— were admitted
for OO postprocedure—these are
the patients that were
studied
1,015 were
determined to be low
risk and discharged
via SDD.

Collected information:
demographics,
angiographic
characteristics,
postprocedural
complications, and timing
of post-procedural events.
All data was collected form
retrospective chart reviews.
All patients referred were
assessed for adequate
collateral circulation with
Allen’s test.
Procedure Technique: Sheath inserted under local
anesthesia.
-Patients given vasodilating
mixture of verapamil and
nitroglycerine post sheath
insertion to protect against
radial spasm.
-Heparin 5000 IU given
following sheath insertion.
-Patients all pre-treated
with aspirin and clopidogrel
75mg/day with 300-600 mg
dose if clopidogrel naïve.
-Sheath was removed
immediately with
application of hemostasis
clamps.
-Air released in stages 1-2
hours following the
procedure.
-Clamp removed 2-3 hours
following the procedure.
-Pressure dressing applied
after removal.

one approach is to realize patients may
be safer at home than in hospital
Characteristics: Mean age=66; 76% Male;
20% had previous MI and 23% prior
revascularization.
Age, Sex, DM, & HTN similar between
groups.
Procedure indication: 29% emergent, 54%
urgent, and 17% elective—important to
note a significantly higher OO in urgent and
emergent cases.
In the inpatient intermediate and high risk
group, 90% of patients had type B2 or C
lesions. The majority of type A or B1
lesions were discharged home via SDD.
Post-procedure complications of 1,174:
-Bleeding: 13 had bleeding within 6 hours
of the procedure. No bleeding occurred
between 6 and 24 hours.
-Neurological symptoms: 8 (0.7%) had
neuro deficits (4 transient/minor; & 4 with
CVA with 3 having persisting neuro
deficits). All of these occurred during or
immediately following procedure. None
occurred between 6 and 24 hours.
-Emergent CABG: 6 patients (0.5%)
required emergent CABG—all of which
were performed immediately due to
procedural complications. No patients
needed CABG between 6 and 24 hours.
-5 (0.4%) returned to cath lab within 24
hours—2 of which had unrecognized
dissection related to initial procedure and 3
were found to have unchanged angiographic
appearance. One patient returned between 6
and 24 hours, though it was due to a guide
dissection during initial procedure that
involved his entire RCA, requiring multiple
stents—this would have excluded him from
SDD.
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-7 (0.6%) had post-procedural pericardial
effusions requiring drainage, all of which
were evident within 6 hours.
There were 22 patients that had
complications outside of 24 hours and
within 7 days including: access site
hematoma (1) non-access site bleeding (5),
emergent CABG (1), return to cath lab (4),
and Death (11).
It was found that even in higher risk
patients, complications occurring between 6
hours and 24 hours is rare. Important to
note that 2 patients of 1,174 did have postprocedure complications between 6 and 24
hours, though clinical deterioration was
evident within 6 hours—most nontarget
vessel complications will occur within 6
hours while target vessel closure usually
occurs >24 hours after the procedure.
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Appendix D: Theoretical Framework
Rosswurm & Larrabee’s A Model for Change to Evidence-Based Practice (1999)

Appendix E: Conceptual Model
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Appendix F: Gantt Charts

Initial DNP Quality Improvement Project Timeline
9/23/20

Proposal Presentation
Obtain IRB Approval from Facility and UARK
Conduct Chart Reviews
Conduct Educational Sessions with Staff
Implement SDD following Elective PCI
Collect Data
Analyze Data
Prepare for DNP Presentation to Committee
Prepare for Dissemination to Clinical Site
Prepare for Project Dissemination

11/12/20

1/1/21

2/20/21

4/11/21

5/31/21
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Appendix F: Gantt Charts
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Appendix G: Statement of Mutual Agreement for DNP Guidance
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Appendix H: Data Collection Sheets
Pre-Implementation Code Book

Post-Implementation Code Book

Patient Marker & Procedure Date were deleted following data
extraction
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Appendix I: Pre-Procedure Education Materials

Patient Name________________________
DOB ____________

Instructions for Out-Patient Cardiac Catheterization
1. Your Cath has been scheduled for: _________________________________
2. Please arrive at ___________ AM/PM and report to St. Vincent Infirmary in Little

Rock, AR. The address is 2 St. Vincent Circle. Enter the main entrance and check
in at Jack Stephens Cath Lab on the first floor.
3. Please do not have anything to eat or drink after midnight the night prior to your

procedure. If your procedure is scheduled after 12:00 PM (noon) you may have a
clear liquid breakfast before 08:00 AM. This should consist of sprite, Kool-Aid,
bouillon, Jell-o, grape juice, etc.
4. You may take your medications with a sip of water unless you are instructed

otherwise by your nurse.
5. Bring your current medications, detailed medication list, and an overnight bag.
6. If you have sleep apnea, please bring your CPAP machine with you to the

hospital.
7. Following your procedure, you will be taken to the recovery area and will have a

2-6 hour recovery period. Come prepared to stay at least one night in the
hospital. If you have an angioplasty, you may have to stay in the hospital
overnight. YOU WILL NEED A DRIVER TO TAKE YOU HOME FROM THE HOSPITAL
WHEN YOU ARE DISCHARGED.
8. Other Instructions:

______ Diabetic: ____________________________________ (Please hold
Metformin, Glucophage, Avandamet, Xigduo, Glumetza, Fortamet, Riomet, and
Glucovnace the day of the procedure and for two days after.
______ Coumadin/Pradaxa (Dabigatran)/Xarelto (Rivaroxaban)/Eliquis (Apixaban)
therapy: (Please hold coumadin/warfarin for 3 days prior to procedure. Please hold
Xarelto, Pradaxa, and Eliquis for two days prior to procedure.) If you are taking Plavix
or Aspirin, please do not stop these medications.
______ Diuretic: ____________________________________ (Please hold
Furosemide (Lasix), Torsemide, Hydrochlorothiazide (HCTZ), Bumex (Bumetanide),
and Metolazone the morning of procedure.
If you have any questions regarding this procedure, please feel free to contact our
office at any time between now and the time of your procedure.

Kanis Road
10100 Kanis Rd
Little Rock, AR 72205
P 501.255.6000 F 501.255.6400
Abdel Al Emam, MD
C. Douglas Borg, MD
Mangaraju Chakka, MD
Charles W. Clogston, MD
Debasis Das, MD
David D. Griffin, MD
Forrest D. Glover, MD
Yalcin Hacioglu, MD
Randy A. Jordan, MD
Tena E. Murphy, MD
Aravind N. Rao, MD
Scott W. Rypkema, MD
James E. Shuffield, MD
Sayyadul M. Siddiqui, MD
Thomas W. Wallace, MD
Muhammad Waqas, MD
North Little Rock
4000 Richards Rd Ste A
North Little Rock, AR 72117
P 501.758.5133 F 501.758.5173
Marvin W. Ashford, MD
John A. Colleran, DO
Yazan Ghosheh, MD
Prabhat K. Hebbar, MD
Morris E. Kelley, MD
Ethan Munzinger, MD
J. Rod Parkhurst, MD
Mark A. St.Pierre, MD
University Avenue
415 N University Ave
Little Rock, AR 72205
P 501.664.6841 F 501.664.0296
J. Lynn Davis, MD
Andrew G. Kumpuris, MD
Searcy – Unity Health Cardiology Clinic
711 Santa Fe Dr
Searcy, AR 72143
P 501.279.9393 F 501.279.9073
Leon Roby Blue, MD
Katherine J. Durham, MD
David M. Evans, MD
Bradley R. Hughes, MD
Eric J. Robinson, MD
Hot Springs
200 Heart Center Lane
Hot Springs, AR 71913
P 501.625.8400 F 501.625.8446
Yuba Acharya, MD
Michael Frais, MD
Oyidie Igbokidi, MD
Nazneen Tata, MD
Srinivas Vengala, MD
Monticello
766 H. L. Ross Dr
Monticello, AR 71655
P 870.412.4302 F 870.412.4178
Trace N. Garner, MD
Conway-Conway Regional Medical Ctr
525 Western Ave Ste 202
Conway, AR 72034
P 501.513.5337 F 501.513.5338
Lensey C. Scott, MD
Donald E. Steely, MD
Deepali Tukaye, MD
Cardiology and Medicine Clinic
5315 West 12th St
Little Rock, AR 72204
P 501.664.0941 F 501.666.3956
Anthony M. Fletcher, MD
Joe L. Hargrove, MD
Sidghat Tul Llah, MD

Pres/Administrator
Marcia L. Atkinson, MHSA
Fellows of the American College of Cardiology
www.chistvincent/heartclinic.com
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Appendix I: Post-Procedure Groin Education Materials

Post-Procedure Instructions following Percutaneous Coronary Intervention
(PCI) & Outpatient Cardiac Catheterization (GROIN)
Incision:
•

Your incision may be covered with a gauze or clear tape dressing: if so, the dressing
should be removed 24 hours after procedure. If you spend the night in the hospital, we
will do this for you prior to discharge. If you go home the same day as your procedure,
please remove your dressing the following day.

•

You may shower 24 hours after the procedure. Do not tub bathe, swim, or soak for 5
days. Please do not apply lotion, cream, ointment, and/or powder to your incision for
5 days.

•

For pain, you may take over the counter Tylenol as needed.

•

Notify a provider if you notice bleeding (Go to the emergency room if it is
uncontrolled), drainage, swelling, redness, fever, numbness, or tingling in your leg.

Diet After Discharge:
•

You should continue or begin to eat a heart healthy diet.

Activity After Discharge:

Kanis Road
10100 Kanis Rd
Little Rock, AR 72205
P 501.255.6000 F 501.255.6400
Abdel Al Emam, MD
C. Douglas Borg, MD
Mangaraju Chakka, MD
Charles W. Clogston, MD
Debasis Das, MD
David D. Griffin, MD
Forrest D. Glover, MD
Yalcin Hacioglu, MD
Randy A. Jordan, MD
Tena E. Murphy, MD
Aravind N. Rao, MD
Scott W. Rypkema, MD
James E. Shuffield, MD
Sayyadul M. Siddiqui, MD
Thomas W. Wallace, MD
Muhammad Waqas, MD
North Little Rock
4000 Richards Rd Ste A
North Little Rock, AR 72117
P 501.758.5133 F 501.758.5173
Marvin W. Ashford, MD
John A. Colleran, DO
Yazan Ghosheh, MD
Prabhat K. Hebbar, MD
Morris E. Kelley, MD
Ethan Munzinger, MD
J. Rod Parkhurst, MD
Mark A. St.Pierre, MD
University Avenue
415 N University Ave
Little Rock, AR 72205
P 501.664.6841 F 501.664.0296
J. Lynn Davis, MD
Andrew G. Kumpuris, MD
Searcy – Unity Health Cardiology Clinic
711 Santa Fe Dr
Searcy, AR 72143
P 501.279.9393 F 501.279.9073

•

Please rest and relax today. No lifting, pulling, pushing, or strenuous activity for 5-7
days.

Leon Roby Blue, MD
Katherine J. Durham, MD
David M. Evans, MD
Bradley R. Hughes, MD
Eric J. Robinson, MD

•

Driving is not permitted for 24 hours following your procedure.

Hot Springs
200 Heart Center Lane
Hot Springs, AR 71913
P 501.625.8400 F 501.625.8446

Special Instructions:
•

Drink plenty of water for the next couple of days.

Yuba Acharya, MD
Michael Frais, MD
Oyidie Igbokidi, MD
Nazneen Tata, MD
Srinivas Vengala, MD

•

If you are a diabetic and on metformin or Glucophage, hold this medication for 48
hours after your procedure.

Monticello
766 H. L. Ross Dr
Monticello, AR 71655
P 870.412.4302 F 870.412.4178
Trace N. Garner, MD

Smoking:
•

If you smoke, stop now. You can get help at: Arkansas Tobacco Quitline 1-800-QUITNOW or visit https://www.bewellarkansas.org/

Lensey C. Scott, MD
Donald E. Steely, MD
Deepali Tukaye, MD
Cardiology and Medicine Clinic
5315 West 12th St
Little Rock, AR 72204
P 501.664.0941 F 501.666.3956

Follow-up:
•

Conway-Conway Regional Medical Ctr
525 Western Ave Ste 202
Conway, AR 72034
P 501.513.5337 F 501.513.5338

You will have a follow up appointment in the cardiology clinic within 2 to 6 weeks. Your
appointment may be scheduled before you leave the hospital. If so, the date will be
included in your discharge paperwork.

Anthony M. Fletcher, MD
Joe L. Hargrove, MD
Sibghat Tul Llah, MD

Pres/Administrator
Marcia L. Atkinson, MHSA

PLEASE CALL MEDICAL EXCHANGE AT 501-663-6900 WITH ANY QUESTIONS/CONCERNS WEEKDAYS
AFTER 5PM & ON WEEKENDS. IF AFTER 10PM, PLEASE CALL 911 OR GO TO YOUR CLOSEST
EMERGENCY ROOM.

Fellows of the American College of Cardiology
www.chistvincent/heartclinic.com
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Appendix I: Post-Procedure Radial Education Materials

Post-Procedure Instructions following Percutaneous Coronary Intervention
(PCI) & Outpatient Cardiac Catheterization (RADIAL)
Incision:
•

Your incision may be covered with a gauze or clear tape dressing: if so, the dressing
should be removed 24 hours after your procedure. If you spend the night in the
hospital, we will do this for you prior to discharge. If you go home the same day as your
procedure, please remove your dressing the following day.

•

You may shower 24 hours after the procedure. Do not tub bathe, swim, or soak your
wrist for 5 days. Please do not apply lotion, cream, ointment, and/or powder to your
wrist area for 5 days.

•

For pain, you may take over the counter Tylenol as needed.

•

Notify a provider if you notice bleeding (Go to the emergency room if it is
uncontrolled), drainage, swelling, redness, fever, unusual pain, numbness, or tingling
in your wrist. Notify a provider if your arm becomes pale or cool.

Diet After Discharge:
•

You should continue or begin to eat a heart healthy diet.

Activity After Discharge:

Kanis Road
10100 Kanis Rd
Little Rock, AR 72205
P 501.255.6000 F 501.255.6400
Abdel Al Emam, MD
C. Douglas Borg, MD
Mangaraju Chakka, MD
Charles W. Clogston, MD
Debasis Das, MD
David D. Griffin, MD
Forrest D. Glover, MD
Yalcin Hacioglu, MD
Randy A. Jordan, MD
Tena E. Murphy, MD
Aravind N. Rao, MD
Scott W. Rypkema, MD
James E. Shuffield, MD
Sayyadul M. Siddiqui, MD
Thomas W. Wallace, MD
Muhammad Waqas, MD
North Little Rock
4000 Richards Rd Ste A
North Little Rock, AR 72117
P 501.758.5133 F 501.758.5173
Marvin W. Ashford, MD
John A. Colleran, DO
Yazan Ghosheh, MD
Prabhat K. Hebbar, MD
Morris E. Kelley, MD
Ethan Munzinger, MD
J. Rod Parkhurst, MD
Mark A. St.Pierre, MD
University Avenue
415 N University Ave
Little Rock, AR 72205
P 501.664.6841 F 501.664.0296
J. Lynn Davis, MD
Andrew G. Kumpuris, MD
Searcy – Unity Health Cardiology Clinic
711 Santa Fe Dr
Searcy, AR 72143
P 501.279.9393 F 501.279.9073

•

Please rest and relax today.

Leon Roby Blue, MD
Katherine J. Durham, MD
David M. Evans, MD
Bradley R. Hughes, MD
Eric J. Robinson, MD

•

No flexing or hyperextending your right or left wrist for 24 hours. No lifting, pulling, or
pushing with your wrist for 5 days.

Hot Springs
200 Heart Center Lane
Hot Springs, AR 71913
P 501.625.8400 F 501.625.8446

•

Driving is not permitted for 24 hours following your procedure.

Yuba Acharya, MD
Michael Frais, MD
Oyidie Igbokidi, MD
Nazneen Tata, MD
Srinivas Vengala, MD

Special Instructions:
•

Drink plenty of water for the next couple of days.

•

If you are a diabetic and on metformin or Glucophage, hold this medication for 48
hours after your procedure.

Smoking:
•

If you smoke, stop now. You can get help at: Arkansas Tobacco Quitline 1-800-QUITNOW or visit https://www.bewellarkansas.org/

Follow-up:
•

You will have a follow up appointment in the cardiology clinic within 2 to 6 weeks. Your
appointment may be scheduled before you leave the hospital. If so, the date will be
included in your discharge paperwork.

PLEASE CALL MEDICAL EXCHANGE AT 501-663-6900 WITH ANY QUESTIONS/CONCERNS WEEKDAYS
AFTER 5PM & ON WEEKENDS. IF AFTER 10PM, PLEASE CALL 911 OR GO TO YOUR CLOSEST
EMERGENCY ROOM.

Monticello
766 H. L. Ross Dr
Monticello, AR 71655
P 870.412.4302 F 870.412.4178
Trace N. Garner, MD
Conway-Conway Regional Medical Ctr
525 Western Ave Ste 202
Conway, AR 72034
P 501.513.5337 F 501.513.5338
Lensey C. Scott, MD
Donald E. Steely, MD
Deepali Tukaye, MD
Cardiology and Medicine Clinic
5315 West 12th St
Little Rock, AR 72204
P 501.664.0941 F 501.666.3956
Anthony M. Fletcher, MD
Joe L. Hargrove, MD
Sibghat Tul Llah,, MD

Pres/Administrator
Marcia L. Atkinson, MHSA
Fellows of the American College of Cardiology
www.chistvincent/heartclinic.com
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Appendix J: Needs Assessment Questionnaire with Analysis

Needs Assessment Questionnaire
The purpose of this questionnaire is to gather information regarding the care of patients who undergo
procedures with same day discharge. The information obtained will be used to improve health outcomes
and discharge processes within this patient population. All of the information collected from interviews
will be confidential. The interview should take approximately 15 minutes to complete.
Role: Administration (2), MD (1), APRN (1), RN (2)
Employment Status: Full time (6)
1. Other than hospital costs & patient satisfaction, what health outcomes are improved by sending
patients home same day? Each participant (6) spoke openly about their thoughts. Common themes
with percentage of participants that mentioned theme is listed below.
• Decreased Bleeding due to transradial approach (66.67%)
• Increased Use of Transradial access for PCI (66.67%)
• Increased Access for other patients due to more available cardiac beds (100%)
• Increased Self Care Management (50%)
• Decreased Exposure to Nosocomial Infections (50%)
2. What causes patients to be re-admitted or seen acutely ill following procedures? What is the
usual time frame? Only asked to MD (1). Identified reasons for readmission or acute illness are
listed below.
• Chest pain
• Hematoma
• Kidney Injury
• Usually seen within 7 days; mostly 24-48 hours following procedure
3. What are the most common complications experienced by patients before discharge? Question
only asked to target group (4). Each participant spoke openly about their thoughts. Common themes
and number of times mentioned are listed below.
• Bleeding (4/4)
• Occlusion (2/4)
• Chest Pain (3/4)
4. What percentage of PCI patients have transradial approach? Target group members (4) were
prompted with the following.
• <50% (25%)
• About 50% (75%)
• >50% (0%)
5. What poor health outcomes are seen that we need to address in our policy? Each healthcare team
member spoke openly about their thoughts. Common themes with percentage of participants that
mentioned the themes are listed below.
• Bleeding due to transfemoral approach with increased bed rest time (50%)
• Readmission (33.3%)
• Inadequate Self Care (50%)
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6. Do you believe that certain aspects of the discharge process need to be improved? If so, what do
you believe we could incorporate into the discharge process? Each participant (6) spoke openly
about their thoughts. Common themes with percentage of participants that mentioned theme is listed
below.
• Self-Care (83.3%)
• Personalized Education (66.67%)
• When to seek medical care (50%)
• Meds to bed (66.67%)
• Medication knowledge (50%)
7. Do you feel that the patients are given all the tools they need to be successful at home following
discharge? If no, explain why. (Examples: proper education related to medications, health, diet,
etc.) Each participant (6) spoke openly about their thoughts. Common themes with percentage of
participants that mentioned theme is listed below.
• No (50%)—Some feel that patients do not have the knowledge regarding medication and selfcare that they need to be successful at home before discharge.
• Yes (50%)
8. Do you feel that the staff is prepared to make changes in terms of the same day discharge
process? Each participant (6) spoke openly about their thoughts. Percentages of answers are listed
below.
• Yes (66.67%)
• Some Yes, Some No (33.33%) --Some feel that most of the staff will welcome change, while
others will be resistant to new processes
• No (0%)
9. Where do you think we may find resistance to change? Each participant (6) spoke openly about
their thoughts. Percentages of answers are listed below.
• Physicians (100%)
• Nurses (33.36)
10. Do you feel that management will support ideas to improve the same day discharge process?
Each participant (6) spoke openly about their thoughts. Percentages of answers are listed below.
• Yes (100%)
• No (0%)
11. Are you willing to help develop a program that seeks to streamline the same day discharge
process? Each participant (6) spoke openly about their thoughts. Percentages of answers are listed
below.
• Yes (100%)
• No (0%)

152
Appendix K: Same Day Discharge Pre-Procedure Criteria & Post-Procedure Checklist
Elective PCI Same Day Discharge Protocol
Overall Goal = Same Day Discharge (SDD) for all patients whenever feasible
Cases via femoral access to be completed by 3 PM to consider SDD
Cases via radial access to be completed by 5 PM to consider SDD
Certain exceptions can be made for cases completed after above cut off times; exceptions can be
made for in-town patients on a case-by-case basis; however, the guest house may be utilized
after 9 PM
**Physicians reserve the right to hold a patient for observation at their discretion**

Pre-Procedure Criteria Checklist for Same Day Discharge for PCI Cases
____ Elective procedure/Outpatient status (not presenting with NSTEMI/STEMI)
____ Not opposed to discharge same day following procedure
____ Does not live alone or has support staying overnight
____ Driver available to take patient home following the procedure
____ Lives within 60 miles from hospital (if >60, guest house arrangements to made/paid by clinical site)
• Patients to be discharged from Cath lab by 6PM
• Guest house arrangement to be made for discharge expected after 9 PM (unless exception
made by physician or discharging APRN)
____ Compliance to medical therapy
____ Candidate for SDD per MD discretion

•
•

•
•
•
•
•
•

Possible Reasons for Overnight Observation following Elective PCI
Lack of Dual-Antiplatelet Therapy in hand before discharge
Cases completed after cut-off time for SDD discharge based on access site**
o Radial Cases completed by 5 PM
o Femoral Cases Completed by 3 PM
Postoperative complications (persistent N/V, fluid/electrolyte imbalance, uncontrolled pain,
arrhythmia, excessive bleeding, unstable LOC/psychotic/mobility)
Hemodynamic instability during or after procedure
MD discretion
Inadequate support at home
Lack of transportation
Frail, elderly patients

**Patients to be discharged from Cath lab by 6 PM. If unable to be released from the hospital at 6PM, the
patient should be moved to 2NW/2E for remaining observation period. Cut off for safe discharge
home=9PM unless exceptions to be made for in-town patients on a case-by-case basis by operating
physician or discharging APRN; however, the guest house may be utilized after 9 PM**

153
Appendix K: Same Day Discharge Pre-Procedure Criteria & Post-Procedure Checklist
Elective PCI Same Day Discharge Post-Procedure Checklist
____

Physician performing procedure has deemed this patient a same day discharge candidate

____

New home medications in hand, delivered by Meds to Bed program from Heartland Pharmacy
Prescribed aspirin, P2Y12, Statin, and Nitro as appropriate

____

Completed Observation (4 hours flat time for radial access; 6 hours PLUS 1 hour with observed
ambulation for femoral access) before discharge

____

Post-Procedure EKG Completed

____

Stable vital signs

____

Mental status at baseline

____

Functional status at baseline

____

Baseline comorbidities stable (ex. DM, CHF, COPD, PAD, ESRD)

____

No significant anesthesia complications

____

Successfully voided post-procedure

____

Successful procedure including but not limited to:
Single or multivessel PCI, proximal LAD or bifurcation PCI
Uncomplicated CTO attempt
Regardless of number, length of stents used

____

Radial and/or Femoral Access Sites are WNL per discharge APRN (adequate hemostasis)

____

Provide/Document education related to antiplatelet therapy, post-procedure instruction, and
numbers to call for concerns/complications)

____

Patient and/or caregiver readiness for discharge (understands postoperative instructions &
restrictions)

____

Patient has copy of stent card

____

Adequate home support and transportation home

____

Follow up appointment scheduled for 2-6 weeks with Cardiologist

____

Verify consult to Cardiac Rehab has been ordered & cardiac rehab info included in discharge
paperwork

____

Clearance by Discharge APRN
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Appendix L: Same Day Discharge Protocol
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Appendix M: UARK IRB Exemption Letter
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Appendix N: Clinical Site IRB Non-Research Letter
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Appendix O: Implementation Evolution Over Time
Implementation Evolution Over Time
Implementation
Timeline

Progress

19-Nov-20

University IRB Approval

31-Jan-21

Awaiting Clinical Site IRB
Approval

1-Feb-21

3-Feb-21

New Changes

Non-Research Designation from Communicated IRB
the Clinical Site designation to both clinical
site and UARK.

SDD Interdisciplinary team SDD team decided to
meeting incorporate SDD orders into
clinic EMR to assist in
procedure scheduling and
potential SDD patient
identification. Information
was sent to IT.
“Soft” implementation date
set for February 8th, 2021 and
full implementation set for
February 15th, 2021 with one
pilot interventional
cardiologist.
SDD algorithm was updated
to include “DAPT in hand” to
the protocol

8-Feb-21

12-Feb-21

Soft Implementation No patients were sent home
via SDD processes on 2/8.
SDD Interdisciplinary team Request for improved
meeting physician engagement and
physician fact sheet/education
regarding SDD processes.
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12-Feb-21

19-Feb-21

Efforts to increase physician Individual meetings with
engagement interventional cardiologists
began; though were
postponed due to inclement
weather and Cath lab elective
procedure cancellations.
End of Implementation Week 2 Zero Elective PCI SDDs.

16-Feb-21

Physician Education Physician fact sheet/education
completed and emailed to
administration as requested.

17-Feb-21

SDD Interdisciplinary team Identified that there were no
meeting further elective PCIs
scheduled until March 5th with
piloting interventional
cardiologist.
Additional efforts for
physician engagement were
activated. PI to conduct
individual meetings and reach
out to interventional
cardiologists via text.

19-Feb-21

Continued efforts to increase Meetings conducted with 2
physician buy-in and engagement interventional cardiologists
during rounds.

20-Feb-21

End of Implementation Week 2 Zero Elective PCI SDDs.

23-Feb-21

Telephone meeting with one Identified the need to verify
interventional cardiologist to gain that the patient going to go
support and engagement home via SDD processes is
outpatient. Also identified that
if there is another attending,
they must be looped into
communication by
discharging APRN.
An additional interventional
cardiologist agreed to review
SDD processes.
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25-Feb-21

27-Feb-21
1-Mar-21

SDD Interdisciplinary team Emails were sent to Cath lab
meeting and telemetry unit nurse
managers to schedule inservices.
End of Implementation Week 3 Zero Elective PCI SDDs.
In-person meeting with one The interventional
interventional cardiologist to gain cardiologist requested
support and engagement additional baseline
information to present to the
interventional cardiologists
during their monthly meeting.
Emails were sent to
administration (Cath lab
manager and Cardiovascular
service line director)
requesting data.

2-Mar-21

SDD Interdisciplinary team Clinic staff reported that they
meeting would not be incorporating
SDD orders into clinic EMR
as EP schedulers have had
success adding to order notes.

4-Mar-21

Data Request Data was also requested from
Director of Performance
Excellence.

6-Mar-21

End of Implementation Week 4 Zero Elective PCI SDDs.

8-Mar-21

Data Request Data was requested from
clinical site NCDR CathPCI
liaison.

10-Mar-21

Data Received Data received from clinical
site NCDR CathPCI liaison.

13-Mar-21
18-Mar-21

End of Implementation Week 5 Zero Elective PCI SDDs.
Meeting Scheduled Interdisciplinary team
meeting scheduled for 3/22/21
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to discuss future
implementation.
20-Mar-21

End of Implementation Week 6; Zero Elective PCI SDDs.
Implementation Completed

21-Mar-21

Pre-implementation period chart Pre-implementation period
reviews chart reviews completed.

22-Mar-21

Implementation period chart Implementation period
reviews (February 7, 2021 through
March 6, 2021 chart reviews
completed
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Appendix P: PDSA Cycles
PDSA Cycle #1
OBJECTIVE: Arrange a meeting with the interdisciplinary team regarding final steps before implementation
Change Idea: Arrange a meeting with the interdisciplinary team regarding final steps of project planning while awaiting IRB approval and
implementation.
Person Responsible

Due Date

Plan: An interdisciplinary team meeting will be arranged by the principal investigator
regarding final steps of project planning and same day discharge processes while awaiting IRB
approval and project implementation. During this meeting, the process from the initial visit in
the cardiology clinic to the telephone follow up after discharge will be walked through to
determine if there are any other process adjustments that should be made prior to
implementation.
Principal Investigator

01/21/21

Principal Investigator

01/21/21

Principal Investigator

01/24/21

Principal Investigator

01/28/21

Do: Email correspondence took place with the clinical site director of performance excellence
to determine possible meetings times. A text was sent to several physicians regarding planned
meeting time. An email was sent from the President of the Heart Institutes executive assistance
on 1/21/21 to the interdisciplinary team regarding a meeting for 1/27/21.
Study: Meeting invitations were sent as of 1/21/21. Now, I will prepare for the meeting by
creating an agenda and incorporate all previous suggestions from the previous meeting to
improve the same day discharge processes within the clinical site. Once the clinical site gives
me feedback and/or requests revisions, the changes will be incorporated into the protocol and
re-submitted. Following IRB approval from the clinical site, an implementation date can be
established.
Act: Following the upcoming interdisciplinary meeting, I will incorporate any further
recommendations for process changes before project implementation.
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PDSA Cycle #2
OBJECTIVE: To communicate with Clinical Site IRB regarding approximate IRB approval timeframe. Prepare meeting agenda.
Change Idea: Meeting preparation and IRB communication.
Person Responsible

Due Date

Plan: Complete meeting agenda and review DNP project proposal for refresher regarding
current evidence, implantation plans, data analysis, & project measures. Communicate with the
interdisciplinary team regarding upcoming meeting.
Call and speak to Clinic regarding IRB review update and projected review timeline
Do: Create a meeting agenda including SDD processes and potential failures. Send a reminder
regarding upcoming meeting. Speak with piloting Interventional Cardiologist, regarding SDD
implementation with his elective PCIs.

Principal Investigator

1/29/21

Call Clinical Site IRB/leave voicemail if needed for IRB protocol update.

Principal Investigator

1/29/21

Principal Investigator & Director
of Performance Excellence

1/28/21

Study: A meeting agenda was completed on 1/28/21 with Director of Performance Excellence.
A reminder was sent on 1/29/21 for next week’s meeting on behalf of the President of Heart
Institute. Telephone call with piloting interventional cardiologist took place on 1/28 to reschedule the meeting for 2/4/21 based on his availability and to discuss implementation. He
stated he is ready for implementation following our upcoming meeting.
Clinical Site IRB was called on 1/26/21 regarding an update on the IRB protocol review.
Clinical Site IRB stated that it will likely be 2/3/21 before they are able to review the IRB
protocol. An email was sent to the Research Council Chair, regarding possible pull with IRB.
Act: Will complete the meeting on 2/4/21 and continue to review and revise the meeting
agenda as needed. Will need to follow up with Clinical Site IRB this next week for another
update. Will send a text reminder of the meeting on Wednesday, 2/3/21.

Principal Investigator

2/1/21
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PDSA Cycle #3
OBJECTIVE: Hold interdisciplinary team meeting and establish an implementation date.
Change Idea: This PI will hold an interdisciplinary team meeting to establish an implementation date for PCI Same Day Discharge on 2/4/2021.
Person Responsible
Due Date
Plan: Finalize and review meeting agenda with Director of Performance Excellence, at the clinic
site. Agenda items to include PCI Same Day Discharge processes from start to finish, continued
issues with SDD procedure scheduling, Further Nursing Staff education for the clinic and hospital,
scheduler education, Meds to Bed Program, potential failures, and establishing an implementation
date.
This PI received final word from Clinical Site IRB on 2/1/2021 that assigned the project as quality
improvement/non-research. Due to this information, setting an implementation date during the
meeting is essential.
Do: Make final edits and review the meeting agenda with Director of Performance Excellence. The
meeting agenda items are as above. Create a typed agenda to send out to team members. Send a
reminder to the Piloting Interventional Cardiologist and his Nurse Practitioner via text. Send a
meeting reminder to the interdisciplinary team via email with the zoom meeting link and password.
Make all final edits to previously used process maps and algorithms.

Principal Investigator

2/3/21

Share the news of the Clinical Site IRB non-research designation with Dr. Stewart, Dr. Kilmer, &
Dr. Bradley.
Study: The meeting agenda was reviewed and finalized with Director of Performance Excellence at
the clinical site on 2/3/2021. A reminder was sent on 2/3/2021 and on 2/4/2021 to the interventional
Cardiologist and his APRN. An additional meeting reminder to the entire interdisciplinary team
meeting was sent on 2/3/2021 on behalf of President of the Heart Institute with the zoom meeting
link and password. The meeting was then completed on 2/4/2021 by this PI and the Director of
Performance Excellence. Many great ideas were identified during the meeting to improve processes
including adding an option in the clinic and hospital EMR to include same day discharge procedures
so that they are better captured for data collection and evaluation. Initial implementation was set for
Monday, February 8th, with one elective PCI on the schedule.

Principal Investigator & Director
of Performance Excellence

2/3/21

An Email was sent to Dr. Stewart, Dr. Kilmer, & Dr. Bradley on 2/1/2021 to notify them of the
clinical sight IRB designation.

Principal Investigator & Director
of Performance Excellence

2/3/21

164
Act: Following the meeting, I will update all education for the clinic and hospital staff. I will begin
working on physician education as requested. I will also make final changes to the protocol
algorithm to include "DAPT in hand" to the protocol. Once all edits are made, I will re-distribute the
Same Day Discharge Protocol/Algorithm documents to the interdisciplinary team and share the
education with the nurse managers for the clinic, two cardiac nursing units, and the cath lab. I will
also call IT to begin working on adding same day discharge procedures for improved scheduling for
same day discharge procedure. I will be present for implementation on Monday morning for the first
elective PCI. During my presence, I will observe process adherence.

Principal Investigator

2/8/21

PDSA Cycle #4 (Week 1 of Implementation)
OBJECTIVE: Begin SDD PCI implementation, complete process observation, and create further physician education/fact sheet for PCI SDD.
Change Idea: This PI will begin project implementation and complete process observation to ensure Same Day discharge processes are being executed
correctly.
Due
Person Responsible
Date
Plan: Begin “soft” implementation with the piloting interventional cardiologist’s elective PCI procedures
starting on February 8th, 2021.
Complete process observation in the Cath Lab on 2/8/2021 to reinforce previous education regarding the
same day discharge processes. Process observation to include adherence to physician identification, preprocedure checklists, and post-procedure checklist adherence, guest house use, meds to bed program use,
etc.
Create a fact sheet/educational flyer regarding the Same Day Discharge processes for elective PCI. Due to
a lack of physician engagement, this PI will continue to seek engagement by carrying out individual
meetings with interventional cardiologists.
Do: Implement the Same Day Discharge for elective PCI on 2/8/2021.

Principal Investigator

2/8/21

Principal Investigator

2/12/21

Complete process observation on 2/8/21, 2/11/21, and 2/12/21.
Create a typed fact sheet/educational flyer regarding the SDD processes and current research. Attach the
pre- and post-procedure checklists for review. Attach the SDD protocol algorithm for review.
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Study: Same Day Discharge processes for elective PCI were implemented on 2/8/21; however, the
piloting interventional cardiologist had two patients who underwent elective PCI but he did not send his
patients home via same day discharge processes.
Process observation was completed on 2/8/21 and 2/11/21. This PI could not complete process observation
on 2/12/21 due to inclement weather and procedure cancellation. During process observation, it was noted
that physician to discharging APRN was not taking place. It was also noted that clinic identification and
pre-procedure checklists were note applicable as the procedures were scheduled prior to implementation.
Post-procedure checklists were not utilized as patients did not go home via SDD processes.
The physician fact sheet/educational flyer regarding the SDD processes and current research was
completed on 2/12/21 and sent to the Director of Performance Excellence on 2/12/21.
Act: Implementation must be stronger in following weeks. To increase physician engagement, this PI will
conduct individual meetings with the interventional cardiologists to gain support. Additionally, the
physician flyer will be sent out for the physician’s review.

Principal Investigator

2/12/21

Principal Investigator

2/19/21

This PI will need to continue to reinforce SDD processes to increase process adherence. Additional
educational sessions will be held for newer employees. An email will be sent by the unit managers to
reinforce established SDD processes and highlight differences from EP SDD processes, included in-hand
medication verification. This PI will also call the schedulers at the clinic within the next week to discuss
any issues with SDD identification and scheduling. As procedures are scheduled for the next week, this PI
will continue process observation with emphasis on post-procedure checklists and variances from EP SDD
processes.
Once approval has been gained from the clinical site, the physician education will be sent to all pertinent
parties.
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PDSA Cycle #5 (Week 2 of Implementation)
OBJECTIVE: Improving Communication with the interventional cardiologists
Change Idea: This PI will begin talking with interventional cardiologist to gain support and momentum for Same Day Discharge Project.
Due
Person Responsible
Date
Plan: Begin individual meetings with interventional cardiologists in the hospital to gain support
and momentum for SDD PCI.
Distribute the fact sheet/educational flyer regarding SDD processes for elective PCI to the
Market Administrator so that it can be given to the cardiologists.
Complete process observation in the Cath Lab.
Do: Complete process observation on 2/19

Principal Investigator

2/19/21

Conduct meetings with 2 interventional cardiologists in the hospital during rounds on 2/19.
Principal Investigator
Study: The Fact Sheet/educational flyer regarding SDD processes and additional files were sent
to the market administrator on 2/16.

2/19/21

Distribute the completed fact sheet/educational flyer regarding the SDD processes and current
research to the Market Administrator on 2/16. Attach the pre- and post-procedure checklists for
review. Attach the SDD protocol algorithm for review.

This PI met with 2 interventional cardiologists during rounds on 2/19. At this time, they both
voiced that they would look over the SDD processes and reach out. This PI will send a reminder
in the following week.
Process observation was completed on 2/19. Same day discharge processes were not being
utilized at that time due to inclement weather. Elective PCI cases were cancelled for the entire
week.
Act: Implementation must be stronger in following weeks. To increase physician engagement,
this PI will continue to conduct individual meetings with the interventional cardiologists to gain
support. Additionally, the physician flyer will be sent out for the physician’s review by the

Principal Investigator

2/19/21
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market administrator.
This PI will need to continue to reinforce SDD processes to increase process adherence as
implementation has been very slow. Additional educational sessions will be held for newer
employees as they were not able to take place due to inclement weather. An email will be sent
by the unit managers to reinforce established SDD processes and highlight differences from EP
SDD processes, included in-hand medication verification in the upcoming week. This PI will
also call the schedulers at the clinic within the next week to discuss any issues with SDD
identification and scheduling as the clinic was closed. As procedures are scheduled for the next
week, this PI will continue process observation with emphasis on post-procedure checklists and
variances from EP SDD processes.

Principal Investigator

2/19/21

PDSA Cycle #6 (Week 3 of Implementation)
OBJECTIVE: Improving physician engagement and physician recruitment
Change Idea: This PI will continue talking with interventional cardiologist to engage and recruit them gain for Same Day Discharge PCI.
Due
Person Responsible
Date
Plan: Continue individual meetings with interventional cardiologists in the hospital to gain
support and momentum for SDD PCI.
Contact interventionalist to schedule individual meetings.
Complete process observation within the Cath Lab.
Conduct Touch Base Meeting with the interdisciplinary team.
Discuss process failures and determine strategies to avoid further failures.
Do: Conduct telephone meeting with one interventional cardiologist on 2/23 and prepare to
conduct another in-person meeting with another interventional cardiologist on 3/1.
Complete process observation on 2/22.

Principal Investigator

2/25/21
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Conduct touch base meeting with SDD interdisciplinary team on 2/25.
Discuss process failures and avoidance strategies on 2/23 with the interventional cardiologist
and discharging APRN.
Principal Investigator

2/28/21

Process observation was completed on 2/19. Same day discharge processes were not being
utilized at that time due to no cases with the participating interventionalist cardiologist. One
patient was sent home using some of the same day discharge processes; however, this patient
should have never been considered for our same day discharge processes as the patient did not
meet criteria. This was discussed with the discharging APRN and the cardiologist. We have
included another line on the post-procedure checklist that asks the recovery nurse if the patient is
inpatient vs. outpatient. Additionally, it was decided that this PI should conduct additional inservices with the cath lab staff.
Principal Investigator

2/26/21

Study: This PI met with 1 interventionalist cardiologist over the phone on 2/23. At this time, he
voiced he would continue looking over SDD processes and reach out.
This PI was able to establish an in-person meeting with another interventionalist on 2/26 for
March 1st at 3 PM.

Act: Again, implementation must be stronger in following weeks. To increase physician
engagement, this PI will continue to conduct individual meetings with the interventional
cardiologists to gain support.
This PI will prepare for the meeting on 3/1 by reading over the SDD protocol and all
checklists/criteria on 2/28. The meeting will take place on 3/1/21 at 3 PM in the Cath Lab.
This PI will re-distribute post-procedure checklists to the Cath lab and nursing staff of the 2
telemetry units.
This PI will contact the nurse managers for the Cath lab and 2 telemetry units to coordinate inservices to re-discuss same day discharge processes.
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This PI will need to continue to reinforce SDD processes to increase process adherence as
implementation has been very slow.
As procedures are scheduled for the next week, this PI will continue process observation with
emphasis on post-procedure checklists and variances from EP SDD processes.

Principal Investigator

3/1/21

PDSA Cycle #7 (Week 4 of Implementation)
OBJECTIVE: Improving physician engagement and physician recruitment
Change Idea: This PI will continue talking with interventional cardiologist to engage and recruit them gain for Same Day Discharge PCI.
Due
Person Responsible
Date
Plan: Conduct in-person meeting with one interventional cardiologist.
Conduct a SDD touch base meeting with interdisciplinary team.
Brainstorm ideas for improving physician engagement and continue individual meetings with
interventional cardiologists in the hospital to gain support and momentum for SDD PCI.
Communicate with piloting interventional cardiologist regarding scheduled procedures.
Complete process observation within the Cath Lab.
Principal Investigator
Do: Conduct meeting with one interventional cardiologist on 3/1/21 at 3PM.
Conduct a SDD touch base meeting with interdisciplinary team on 3/2/21 at 12:30 PM.
Continue to talk with the team about strategies to gain physician support and hold meetings as
needed. Completed on 3/5/21.
Communicate with piloting interventional cardiologist on 3/4/21 to discuss potential SDDs for
3/5/21.

3/5/21
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Complete process observation on 3/5/21.
Principal Investigator

3/5/21

Principal Investigator

3/5/21

Principal Investigator

3/5/21

Study: This PI met with 1 interventional cardiologist on 3/1/21 who expressed great interest
and support of SDD efforts, but he requested more baseline statistics to bring to the next
interventional cardiologist monthly meeting. This data was requested on 3/1/21 from the
interdisciplinary team. This interventional cardiologist verbalized that he would like to meet
again following data procurement.
SDD meeting was completed on 3/2/21. It was decided by the clinic staff that SDD orders would
not be incorporated into GEMMS, but rated SDD would be added to the notes as they were with
EP procedures.
This PI spoke with the interdisciplinary team on 3/5 regarding the lack of SDD cases. Additional
brainstorming regarding physician engagement took place. The cath lab manager and site
champion were asked to participate in the efforts.
This PI sent a text to the discharging APRN and the piloting interventional cardiologist on
3/4/21 to discuss potential SDD candidates of upcoming cases on 3/5/21. No correspondence
was reciprocated.
Process observation was completed on 3/5; however, SDD processes were not being utilized at
that time due to no identified cases with the piloting interventionalist cardiologist.
Act:
Again, implementation must be stronger in following weeks. To increase physician engagement,
this PI will continue to conduct individual meetings with the interventional cardiologists to gain
support.
This PI will continue to discuss the post-procedure checklists with Cath Lab staff and 2
telemetry units.
This PI will need to continue to reinforce SDD processes to increase process adherence as
implementation has been very slow.
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PDSA Cycle #8 (Week 5 of Implementation)
OBJECTIVE: Improving physician engagement and physician recruitment
Change Idea: This PI will continue efforts to improve physician engagement with individual meetings and touch base communication.
Person Responsible

Due
Date

Plan:
Conduct in-person communication with as many interventional cardiologists as possible during
rounds.
Reach out to various employees at the clinical site to gain access to the EMR and gather project
data.
Obtain requested data of an interventional cardiologist regarding physician habits and baseline
data from NCDR CathPCI Liaison.
Communicate with piloting interventional cardiologist regarding scheduled procedures.
Complete process observation within the Cath Lab.
Principal Investigator
Do: Conducted in-person meetings with 2 interventional cardiologists during rounds on 3/9 &
3/11
Reached out to various employees at the clinical site to gain access to the EMR and gather
project data on 3/8 and 3/9.
Obtain requested data of an interventional cardiologist regarding physician habits and baseline
data on 3/11/21 form NCDR CathPCI Liaison.
Communicate with piloting interventional cardiologist on 3/11/21 to discuss potential SDDs for
3/12/21.

3/9/21
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Complete process observation on 3/12/21.
Principal Investigator

3/12/21

Principal Investigator

3/12/21

Study: This PI briefly met with two interventional cardiologists during rounds on 3/9 and 3/11
to discuss potential SDD implementation. No further correspondence from the cardiologists took
place following communication.
This PI reached out to various employees at the clinical site to gain access to the EMR and
gather project data on 3/8 and 3/9. The liaison for the NCDR CathPCI Registry for the clinical
site was able to forward all data regarding PCI procedures between December 27, 2020 through
March 6, 2020 on March 9, 2021. Data regarding the average daily census during the previous
12 months was obtained from the Clinical Site Champion on 3/9/21.
This PI obtained requested data from an interventional cardiologist regarding physician habits
and baseline data on 3/11/21 form NCDR CathPCI Liaison. After data was received, the data
was forwarded to the interventionalist on 3/12/21. A meeting will be set after the
interventionalist reviews the data.
This PI sent a text to the discharging APRN and the piloting interventional cardiologist on
3/11/21 to discuss potential SDD candidates of upcoming cases on 3/12/21. No correspondence
was reciprocated.
Process observation was completed on 3/12; however, SDD processes were not being utilized at
that time due to no identified cases with the piloting interventionalist cardiologist.
Act: Implementation will not likely take place for the remainder of the implementation period
due to the lack of engagement. To increase physician engagement, this PI will continue to
conduct individual meetings with the interventional cardiologists to gain support.
This PI will follow up with the interventional cardiologist who requested data. A meeting should
be set within the upcoming 2 weeks to discuss next steps.
This PI will continue to reach out to the discharging APRN and piloting interventional
cardiologist for potential SDDs following elective PCI.
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This PI will need to continue to reinforce SDD processes to increase process adherence as
implementation has not occurred.

Principal Investigator

3/12/21

PDSA Cycle #9 (Week 6 of Implementation)
OBJECTIVE: Discuss Implementation Sustainability with the Clinical Site
Change Idea: This PI will hold a meeting with the Director of Performance Excellence at the clinical site to discuss plans for future
implementation and project sustainability.
Person Responsible

Due
Date

Plan:
Discuss the end of implementation with DNP preceptor.
Discuss sustainability with clinical site director of performance excellence.
Reach out to NCDR CathPCI Liaison at the clinical site regarding the remaining clinical data.
Complete process observation within the Cath Lab.
Schedule meeting with interventional cardiologist regarding baseline data from NCDR CathPCI
Registry
Principal Investigator
Do:
End of the implementation period was discussed with Preceptor on 3/18.
A meeting was held with the Director of Performance Excellence at the clinical site to discuss
plans for future implementation and project sustainability on 3/16.
Email sent to NCDR CathPCI Liaison at the clinical site regarding the remaining clinical data on
3/18/21.

3/19/21
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Process Observation completed on 3/19/21.
A meeting was scheduled with the interventional cardiologist on 3/17.
Principal Investigator

3/19/21

Study:
The end of the implementation period was discussed with Preceptor on 3/18. We discussed
barriers, limitations, and bias that led to the failure of implementation. We also discussed ways
in which barriers, limitations, and bias could be minimized or avoided for future
implementation.
During the meeting with the Director or Performance Excellence (DPE) this PI expressed her
continued interest in project success despite implementation period completion. The DPE voiced
that he would like the PI to remain part of the multidisciplinary team during future
implementation.
An email sent to NCDR CathPCI Liaison at the clinical site regarding the remaining clinical data
on 3/18/21. Further follow up will take place on 3/22 if needed.
Process observation was completed on 3/19; however, SDD processes were not being utilized at
that time due to no identified cases with the piloting interventionalist cardiologist.
This PI scheduled a meeting with the interventional cardiologist to discuss baseline data. The
meeting was set for March 22, 2021 at 16:30. An email and invite was sent on 3/17.
Principal Investigator
Act:
This PI will use the barriers, limitations, and bias that were discussed with her preceptor to
incorporate into final paper and dissemination. Additionally, methods to minimize or avoid these
limitations for future implementation will be discussed.

3/19/21

Meeting will take place on 3/22/21 at 16:30 with Discharging APRN, interventional
cardiologist, and DPE.
Additional emails will be sent on 3/22 to NCDR CathPCI Liaison at the clinical site regarding
the remaining clinical data if needed.

Principal Investigator

3/19/21
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Appendix Q: Demographic Table
Demographic Data for elective PCI (N=55)
Frequency
Percentage
Age
19-35
36-50
51-65
66-79
80+

0
4
26
20
5

0.00%
7.27%
47.27%
36.36%
9.10%

Race
White
Black or African American
Asian
Pacific Islander/Hawaii

34
18
1
2

61.82%
32.73%
1.82%
3.64%

Gender
Male
Female

39
16

70.91%
20.09%

Marital Status
Married
Single
Divorced
Widowed
Separated

34
11
4
5
1

61.82%
20.00%
7.27%
9.09%
1.82%

Primary Language
English

55

100.00%

Insurance Type
Private
Public
Public + Private
Federal
Unavailable

22
7
20
3
3

40.00%
12.73%
36.36%
5.45%
5.45%
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Appendix R: Estimated SDD Implementation Budget
Estimated Budget for SDD Protocol Implementation
Discharging APRN within the Cath Lab

$110,000/year

Printed Patient Materials and Folders

$500.00

Additional Resources (printed checklists, PI’s laptop, Microsoft

No Additional Costs

Excel, etc.)
Total Initial Cost: 110,500.00
**Additional costs will be required for long-term implementation as the Discharging
APRN salary is a yearly cost.
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Appendix S: Run Charts with Associated Inputs
Percentage

Pre-Procedure Checklist Compliance

100
90
80

Goal

70
60
50
40
30
20
10
0
Week 1

Date / Observation

Week 1
Week 2
Week 3
Week 4
Week 5
Week 6

Week 2

Value

Week 3

Median

0
0
0
0
0
0

Week 4

Goal

0
0
0
0
0
0

85
85
85
85
85
85

Week 5

Week 6
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Appendix S: Run Charts with Associated Inputs
Percentage

100
90
80
70
60
50
40
30
20
10
0

Post-Procedure Checklist Compliance
Goal

Week 1

Date / Observation

Week 1
Week 2
Week 3
Week 4
Week 5
Week 6

Week 2

Value

Week 3

Median

0
0
0
0
0
0

Week 4

Goal

0
0
0
0
0
0

85
85
85
85
85
85

Week 5

Week 6
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Appendix S: Run Charts with Associated Inputs
Percentage

Percentage of SDD Compliance for Patient Who Met Eligibility

60
50

Goal

40
30
20
10
0

Median
Week 1

Date /
Observation

Week 1
Week 2
Week 3
Week 4
Week 5
Week 6

Week 2

Value

Week 3

Median

0
0
0
0
0
0

Week 4

Goal

0
0
0
0
0
0

50
50
50
50
50
50

Week 5

Week 6
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Appendix S: Run Charts with Associated Inputs
Percentage
100

Facility Hotel Utilization
Goal

90
80
70
60
50
40
30
20
10
0

Median
Week 1

Date /
Observation

Week 1
Week 2
Week 3
Week 4
Week 5
Week 6

Week 2

Value

Week 3

Median

0
0
0
0
0
0

Week 4

Goal

0
0
0
0
0
0

100
100
100
100
100
100

Week 5

Week 6
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Appendix T: DNP Project Title Form

4/23/2021

182
Appendix U: University of Arkansas Professional Doctoral Committee Form

4/23/2021

